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Iodotyrosine deiodinase (IYD) promotes reductive dehalogenation of chloro-, bromo-, and 
iodotyrosines (Cl-Tyr, Br-Tyr, and I-Tyr, respectively). This activity decreases dramatically for 
phenolic substrates lacking the zwitterion due to their inability to close an active site lid. Enhancing 
this activity will provide an attractive approach to bioremediation of halophenols. A combination 
of computational design with Rosetta, library construction and screening was employed to promote 
IYD’s activity towards 2-iodophenol (2IP, a model for halophenol). The lid sequence of IYD from 
Homo sapiens (HsIYD) was redesigned by a fixed backbone approach to stabilize lid closure in the 
presence of 2IP. This approach successfully yielded a variant UD08 that moderately improved 2IP 
deiodination by 4.5-fold compared to HsIYD. UD08 expressed a disorder-to-order transition of the 
lid induced by 2IP as predicted by Rosetta and verified via limited proteolysis. This resembles the 
induced lid closure by I-Tyr in HsIYD. IYD from Haliscomenobacter hydrossis (HhIYD), as an 
easy-to-work with alternative to HsIYD, was subsequently redesigned via a fixed backbone 
approach and a loop remodeling approach to further improve IYD-2IP interactions. Rosetta once 
again demonstrated stabilization of the targeted enzyme•2IP complex with loop remodeling 
although an active 2IP deiodinase was not generated from these approaches. 
IYD from a thermophilic bacteria Thermotoga neapolitana (TnIYD) was characterized for 
its potential to facilitate engineering and provide a crystal structure of the fully reduced IYD. 
TnIYD is the smallest iodotyrosine deiodinase characterized to date and therefore represents a 
minimal structural requirement for reductive dehalogenation. TnIYD exhibits many unique 
properties different from those of mesophilic IYDs such as the formation of FMN semiquinone 
during purification and its tight binding of tyrosine (Tyr). The oxidized FMN in crystals of I-Tyr, 
Tyr, and fluorotyrosine (F-Tyr) bound TnIYD was readily reduced to the FMN semiquinone, but 
not to the hydroquinone form upon dithionite treatment. High resolution crystal structures of I-Tyr, 
F-Tyr, and Tyr bound TnIYD with oxidized and semiquinone FMN suggested that no major 
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conformational changes from the oxidized structure were needed to support the FMN semiquinone 
and other radical intermediates generated during catalysis. An additional binding site for I-Tyr was 
identified on the surface of TnIYD and this might explain the substrate inhibition of IYDs observed 
under steady-state conditions. The reduction of TnIYD and HsIYD by dithionite was inhibited by 
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Chapter 1 Introduction 
1.1 Halophenols: pervasive, persist, and toxic: 
The wide distribution, persistence, and toxicity of halophenols pose a great threat to the 
environment and human health. Halophenols such as pentachlorophenol (PCP), bromoxynil, 
triclosan, and tetrabromobisphenol A are widely used in agriculture and industry as pesticides, 
wood preservative, herbicides, antimicrobial agents, and flame retardants (Scheme 1-1). The United 
States import of PCP reached 14 million pounds in 2013 alone.1 Triclosan, an antimicrobial agents 
banned in Europe but still used in the United States as a toothpaste additive, is now one of the most 
commonly detected compounds in the country’s water systems.2 Halophenols are resistant to 
environmental degradation and bioaccumulate in animal tissues due to their lipophilicity.3 
Bromoxynil could still be detected in the blood of 19.3% tested residents in Saskatchewan, Canada 
5 months after the herbicide was applied in the region.4 Four chlorophenols including PCP are listed 
as priority pollutants by the United States Environmental Protection Agency and can lead to severe 
health problems such as cancer, DNA damage, organ damage, or even acute death.5–7 Structurally 
similar to endogenous thyroid hormones, the flame retardant tetrabromobisphenol A and 
polybrominated diphenyl ethers can potentially disrupt thyroid hormone homeostasis via binding 
and inhibition of corresponding receptors and metabolic enzymes.8,9 Due to the negative impact of 
halophenols on the environment and human health, they must be properly detoxified and degraded. 
1.2 Bioremediation of halophenols: a look at Nature’s toolbox: 
Traditional physically and chemically based pollutant remediation procedures such as 
landfill, soil washing and incineration may generate secondary pollutants such as waste water and 
toxic gas that require additional effort and cost to dispose. In contrast, bioremediation utilizes 
microbes and enzymes to detoxify or degrade pollutants and is environmentally friendly since the 
end product of bioremediation is usually less toxic and more readily degraded to non-hazardous 
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substances such as carbon dioxide and water.10,11 Dehalogenation, the cleavage of carbon-halogen 
bond catalyzed by dehalogenases, is usually the first step towards the biodegradation of 
halogenated compounds.12,13 Therefore, the search, design and improvement of dehalogenase 
activity towards halophenols is essential for the bioremediation of these compounds. 
 
Scheme 1-1 Examples of halophenols. Pentachlorophenol, a pesticide and wood preservative; 
bromoxynil, an herbicide; triclosan, an antimicrobial agent; tetrabromobisphenol A, a flame 
retardant. 
 
Nature has developed oxygenation, hydrolysis, and reduction-based strategies for 
dehalogenation (Scheme 1-2).14 Oxygenolytic dehalogenases function by substituting the halogen 
in halogenated phenols with a hydroxyl group derived from molecular oxygen. These enzymes 
participate in the aerobic degradation of many chlorophenols.15,16 However, many other 
halogenated aromatics, more heavily halogenated in particular, resist microbial degradation under 
aerobic conditions.12 The requirement of oxygen also make oxygenolytic dehalogenases less 
suitable for applications in anaerobic environment like aquatic sediment and soil. 
Hydrolytic dehalogenases substitute the halogen with a hydroxyl group derived from water. 
While many halogenated aliphatic compounds such as haloalkanes and haloacids are able to be 




Scheme 1-2 Enzymatic dehalogenation strategies. 
 
Reductive dehalogenases employ a two-electron reduction to substitute halides with 
hydrogen. An early example of this class is tetrachlorohydroquinone dehalogenase, a key enzyme 
in the biodegradation pathway of PCP that catalyzes two sequential reductive dechlorination of 
tetrachlorohydroquinone with glutathione as a cofactor.21 Recently, dehalogenases participating in 
halorespiration in anaerobic bacteria have gained attention as they are able to catalyze the reductive 
dehalogenation of many halogenated aromatics to power cellular respiration.22 For polyhalogenated 
aromatics such as polychlorinated biphenyls and hexachlorobenzene, anaerobic reductive 
dehalogenation is by far the most effective strategy available for their biodegradation.12  However, 
dehalogenases responsible for anaerobic reductive dehalogenation are typically cobalamin and 
iron-sulfur cluster dependent and are therefore extremely oxygen sensitive. Despite that one oxygen 
tolerant example of this class was recently reported, its application in bioremediation is still 
hindered by the difficulty of cobalamin incorporation during its heterologous expression.23 
Therefore, an oxygen stable and easy-to-express species is still lacking from this class of reductive 
dehalogenase. 
1.3 Iodotyrosine deiodinase (IYD): a promising candidate for 
bioremediation: 
 
IYD is a flavin mononucleotide (FMN) dependent enzyme catalyzing the unusual reductive 
dehalogenation of 3-iodo-L-tyrosine (I-Tyr) and 3,5-diiodo-L-tyrosine (I2-Tyr). These 
iodotyrosines are the byproducts of thyroid hormone biosynthesis in vertebrates and their 
deiodination maintains the iodine homeostasis in these organisms (Scheme 1-3).24 IYD homologs, 
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however, are found in all kingdoms of life except for plants. The iodotyrosine deiodinase activity 
is highly conserved among homologs of IYD from different organisms despite that IYD’s 
physiological function is unknown in organisms that do not require iodine.25 IYD is able to act 
under both aerobic and anaerobic conditions and is well-expressed in Escherichia coli (E. coli). 
Besides deiodination, IYD also debrominates and dechlorinates 3-bromo-L-tyrosine (Br-Tyr) and 
3-chloro-L-tyrosine (Cl-Tyr), respectively.26–28 
 
 
Scheme 1-3 Halotyrosine dehalogenation and proposed halophenol dehalogenation by IYD. 
FMNhq stands for fully reduced FMN. 
 
IYD is proposed to utilize fully reduced FMN (IYD•FMNhq) to support dehalogention 
through a two consecutive one-electron transfer process (Figure 1-1).26 Prior to electron transfer, 
the phenolic substrate tautomerizes to its keto form and the α-carbon where the halogen is attached 
is protonated (Step (1) in Figure 1-1). This tautomerization is believed to facilitate reduction of the 
substrate by switching the electron rich aromatic system to an electrophilic α-haloketone system. 
Evidence for this includes the nanomolar affinity of the reduced enzyme with pyridone-containing 
derivatives of tyrosine that mimics the keto form.29 The α-haloketone intermediate then accepts an 
electron from FMNhq to form an α-haloketyl radical anion intermediate (Step (2) in Figure 1-1) 
which subsequently eliminates halide to form a more stable phenoxy radical (Step (3) in Figure 1-
1). The enzyme is half-oxidized to a transient FMN semiquinone (IYD•FMNsq) intermediate which 
then transfers the second electron to the phenoxy radical to produce Tyr as product and oxidized 
FMN (FMNox) (Step (4) in Figure 1-1). This dehalogenation scheme resembles the reductive 
dehalogenation of α-halomethyl ketones through a ketyl anion radical intermediate in the presence 
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of one electron reductants.30 The proposed mechanism is further supported by the observation of 
the FMNsq intermediate when IYD is slowly reduced in the presence of an unreactive substrate 
analog 3-fluoro-L-tyrosine (F-Tyr).31 
 
Figure 1-1 Proposed mechanism of IYD dehalogenation. 
 
IYD seems to be a promising candidate for the bioremediation of halophenols (Scheme 1-
3), due to the structural similarity between halophenols and its native substrates halotyrosines. 
However, the activity of native IYD towards halophenols is extremely low compared to that 
towards halotyrosines. 2-Iodophenol (2IP), a model compound for halophenols, binds human IYD 
(HsIYD) ~104 times less tightly and is deiodinated ~104 times less efficiently compared to I-Tyr.32 
Active site binding alone is not sufficient to explain IYD’s low activity towards 2IP since an IYD 
homolog from Haliscomenobacter hydrossis (HhIYD) binds 2IP only 8-fold less tightly than it 
binds I-Tyr but still retains the 104 gap in catalytic activity.32 Crystal structure of HhIYD shows 
that HhIYD is a homodimer with one FMN cofactor bound to each active site (Figure 1-2(A)).32 
The electron density for an active site lid of HhIYD is not observed in the crystal structure in the 
absence of I-Tyr, suggesting that the lid is highly flexible without substrate. However, in the co-
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crystal structure of HhIYD and I-Tyr, the zwitterion of I-Tyr interacts with three residues (Glu, Lys, 
and Tyr) and the FMN cofactor, which induces the active site lid to form a helix-turn-helix motif 
that encloses the active site (blue in Figure 1-2(A) and (B)). This conformation is further stabilized 
by polar interactions between the hydroxyl group of I-Tyr and the ribose of FMN as well as a 
backbone amide of Ala 64. These structural features are also shared by HsIYD and IYD from Mus 
musculus (MmIYD).31,33 2IP, lacking a zwitterion, is not able to induce the lid of HhIYD to close 
even as it stacks below the FMN cofactor in the similar fashion as I-Tyr (Figure 1-2(C)).32 However, 
no evidence suggests that the zwitterion of I-Tyr has important roles in the chemical mechanism of 
dehalogenation.26 The zwitterion most likely supports efficient deiodination by stabilizing a 
productive conformation with the active site lid closed. Therefore, to support such a productive 
conformation for 2IP as substrate, the active site lid needs to be engineered to close upon 2IP 




Figure 1-2 Crystal structures of 
HhIYD with I-Tyr and 2IP bound. (A) 
Overall structure of HhIYD with I-
Tyr bound (PDB: 5KO8). The two 
monomers of HhIYD is colored with 
green and cyan respectively. I-Tyr 
and FMN are shown as yellow and 
orange sticks respectively. The active 
site lid is shown in blue. (B) The 
active site of HhIYD with I-Tyr 
bound. Protein residues are shown in 
sticks. Interactions between I-Tyr and 
HhIYD are indicated with dashed 
lines (within 3.5 Å). (C) The active 
site of HhIYD with 2IP bound (PDB: 
5KRD). 2IP is shown as yellow sticks. 
Interactions between 2IP and HhIYD 
are indicated with dashed lines 

















1.4 Engineering the active site lid of IYD: a promising but challenging 
path: 
 
Engineering the active site lid of IYD is a promising strategy to promote halophenol 
dehalogenation since the function of the lid seems to be control of substrate specificity. Furthermore, 
IYD belongs to the nitro-FMN reductase superfamily which catalyzes a wide range of reactions 
from reductive dehalogenation to nitro, quinone, flavin reduction and flavin fragmentation.34 The 
enzymes within different subgroups of this superfamily all share a common core structure with an 
α/β fold (Figure 1-3). However, substantial variability is observed at the regions equivalent to 
IYD’s lid.29 These variable lids and loops surrounding the active site provide the structural basis 
for the great diversity of chemical functions and substrate selectivity of the superfamily. Therefore, 
the active site lid of IYD is likely to be evolvable for expanding its substrate specificity.34 
Engineering flexible loops in proteins has received growing attention as the dynamic nature 
of such loops are often important to substrate binding and catalysis.35 However, the exact role of 
loop dynamics in protein catalysis is still poorly understood and there has yet been a general 
approach to guide such engineering efforts.36 Directed evolution based on error prone PCR and 
iterative site saturation mutagenesis is a powerful strategy to engineer enzymes.37,38 However, the 
cumbersome activity assay for IYD based on radioactivity or high performance liquid 
chromatography (HPLC) cannot support screening of large scale libraries of enzyme variants 
generated by these methods. Shuffling of libraries of natural IYD variants is also not an appealing 
strategy since the zwitterion recognition triad (Glu, Lys, Tyr in Figure 1-2) is highly conserved in 





Figure 1-3 Structural diversity in the active site of the nitro-FMN superfamily.  The α/β dimeric 
core of IYD (PDB 4TTC),31 flavin reductase (FRP, PDB 2BKJ),40 nitroreductase (NfsB, PDB 
1YKI),41 and flavin destructase (BluB, PDB 2ISJ)42 are shown in gray.  The variable active site 
regions are illustrated in green for IYD, cyan for BluB, magenta for FRP and yellow for NfsB.  For 
simplicity, the C-terminal extension (~ 50 residues) of FRP is omitted and the carbon atoms of 
FMN of are shown in gray. This figure was originally published in Sun, Z.; Su, Q.; Rokita, S. E.29 
 
Recently, computational design as an alternative approach to directed evolution for 
engineering enzymes has been rapidly gaining attention. It overcomes the bottleneck of directed 
evolution, the requirement of high-throughput screening, by exploring extremely large sequence 
spaces in silico and exporting small-sized libraries of enzyme variants for experimental 
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characterization.43 Computational design is able to alter multiple amino acids simultaneously44 and 
introduce sequence insertions and loop replacements45 and has demonstrated success in increasing 
native activity,46 altering substrate selectivity,47 and even designing de novo enzymes.48 Therefore, 
computational design offers an attractive approach to engineer IYD towards a halophenol 
dehalogenase. 
However, there are a few potential obstacles for the computational design of IYD. The 
essence of computational design is to optimize the interactions between the enzyme and the 
substrate to achieve stabilization of the transition state. To date, co-crystal structures of IYD with 
substrate bound were only obtained with their FMN cofactor fully oxidized.31–33,49 Therefore, the 
enzyme-substrate interactions from these structures may not be catalytically relevant since the 
FMNhq is required for the dehalogenation. In addition, the rate determining step of IYD catalysis is 
still obscure. Neither the tautomerization step forming the unstable α-haloketone intermediate (step 
(1) in Figure 1-1) nor the first electron transfer step forming the reactive α-haloketyl radical anion 
intermediate (step (2) in Figure 1-1) seems to be the rate-determining step under steady-state 
condition.50 Therefore, how IYD stabilizes the transition state of its rate-determining step remains 
unclear. As a result, a catalytically relevant model for the computational design of IYD to promote 
halophenol dehalogenation is lacking. 
1.5 Specific aims: 
IYD is a promising candidate for a reductive dehalogenase to remediate the widely spread 
and highly toxic halophenols. Its low basal activity towards halophenols needs to be improved by 
enzyme engineering. In this dissertation, such effort was explored by the following four aims. 
Aim (1): Engineering IYD from Homo sapiens (HsIYD) towards a halophenol 
dehalogenase via computational design. To improve halophenol dehalogenation, the active site lid 
of HsIYD was first engineered computationally to stabilize its closed conformation in the presence 
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of 2IP, a model compound for halophenol. Variants of HsIYD generated by this approach were 
screened for tighter binding of 2IP and more efficient 2IP deiodination. 
Aim (2): Engineering IYD from Haliscomenobacter hydrossis (HhIYD) towards a 
halophenol dehalogenase via computational design. After Aim (1) achieved limited success, 
HhIYD, an easy-to-work with alternative to HsIYD, was redesigned by two different strategies-
fixed backbone design and loop replacement to further improve 2IP deiodination. 
Aim (3): Charactering the structure and function of IYD from Thermotoga neapolitana 
(TnIYD). After Aim (2) failed to improve 2IP deiodination, attempts to obtain crystal structures of 
IYD with its FMN cofactor in the semiquinone and fully reduced states were carried out in hope to 
capture catalytically relevant conformations of the active site. TnIYD, a natural IYD homolog from 
a thermophilic bacterium, was functionally analyzed and structurally characterized with its FMN 
in the oxidized and semiquinone states. 
Aim (4): Probing the effect of substrates and their analogs on the reduction of IYD. The 
reduction of HsIYD and TnIYD by sodium dithionite in the presence of substrate was monitored 
under steady-state conditions to reveal the basis for IYD’s substrate inhibition and explore the 


















Chapter 2 Engineering HsIYD towards a halophenol 
dehalogenase via computational design 
 
2.1 Introduction: 
IYD’s potential for bioremediation of halophenols is hindered by its weak activity towards 
substrates lacking a zwitterion. The stringent selectivity of IYD is enforced by its active site lid 
which is only responsive to halotyrosines. Computational design is a promising approach to 
engineer this active site lid to improve its recognition of halophenols and promote dehalogenation. 
Challenges associated with lid redesign are the inherent flexibility of the lid and the lack of 
structural information on catalytically active IYD•FMNhq•substrate complex. However, there are 
several features in the co-crystal structure of IYD•FMNox•I-Tyr that could support a productive 
IYD•2IP complex, despite that the FMNox is catalytically inactive. The closure of the lid shields 
the substrate away from bulk solvent-a strategy that is common for enzymes to promote catalysis.51 
Moreover, the aromatic ring of 2IP stacks below the isoalloxazine ring of FMN, which is likely to 
facilitate electron transfer from reduced FMN to 2IP.52 
As a first attempt to alter the substrate selectivity of IYD, the sequence of the active site 
lid was redesigned to stabilize its closed conformation in the presence of 2IP (Figure 2-1) which is 
analogous to the lid of oxidized native IYD in its co-crystal structure with I-Tyr (Figure 1-2(B)). 
2IP is chosen as a model compound for halophenol due to its structural simplicity and similarity to 
I-Tyr. The sequence redesign was carried out by the program Rosetta which has demonstrated the 
most success in designing enzymes.43 Rosetta is a powerful biomolecular modeling suite capable 
of handling a wide range of biological problems from de novo protein structure prediction to protein 
design and glycoengineering.53–55 Early examples of enzyme design by Rosetta focused on the de 
novo design of novel enzyme activities beyond those of natural enzymes.48,56,57 Recently, Rosetta 
also demonstrated success in engineering existing enzymes for improving activity and altering 
substrate specificity.45,47,58 These examples are all based on template enzymes with structurally 
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well-defined active sites. Therefore, it is interesting to see if Rosetta is able to redesign the lid that 











Figure 2-1 Computational model of the proposed productive complex of HsIYD and 2IP generated 
by PyRosetta.59 The two monomeric polypeptides of HsIYD are colored with green and cyan 
respectively. 2IP and FMN are shown as yellow and orange sticks respectively. The active site lid 
plus three residues extended from both termini (residues 157-182, magenta) were varied by Rosetta. 
Polar interactions between 2IP and HsIYD are shown with dashed lines. A cavity created by the 
absence of the I-Tyr zwitterion is indicated by a dashed circle. For clarity, a loop on top of FMN 
containing residues 238-245 were hided from view. 
 
In this chapter, the initial effort to switch HsIYD’s substrate specificity from I-Tyr to 2IP 
was described.60 Chemical rescue was first attempted to promote 2IP deiodination activity by using 
Gly and Ala as exogenous zwitterions. When such effort failed, Rosetta was used to redesign the 
active site lid of HsIYD to stabilize a HsIYD•2IP complex. To achieve this goal, two parallel design 
strategies-guided Rosetta design (GD) directed by intuitions on secondary-structure stability and 
unguided Rosetta design (UD) were employed. Only unguided Rosetta design generated variants 
that improved both the binding affinity and catalytic efficiency of HsIYD towards 2IP. The effect 
of mutations forming UD08 on the 2IP deiodination of HsIYD revealed the strong epistatic nature 
of active site lid mutations. The unguided Rosetta design further demonstrated the ability to induce 
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a dramatic disorder to order transition of the active site lid in the presence of 2IP as characterized 
by protection against trypsin proteolysis. 
2.2 Materials and methods: 
2.2.1 Computational design: 
All Rosetta simulations were carried out via Pyrosetta 3 (an interactive Python-based 
interface to Rosetta).59 The Rosetta scripts used for preparation of starting structure and lid redesign 
can be found in Appendix A: script A1 and A2. 
(1) Preparation of the starting structure: 
The crystal structure of HsIYD with I-Tyr bound (PDB 4TTC) provided a template for 
building the enzyme•2IP complex with the closed active site lid. The co-crystal structure was first 
optimized by Rosetta to eliminate structural errors in the original PDB file such as atom clashes, 
and unfavorable side chain rotamers.61 A single optimization trajectory contained two stages 
(Appendix Figure A1(A) and Table A1). In the first stage, the side chains were allowed to repack 
with conformations chosen from a backbone-dependent rotamer library.62 Hydrogens were added 
to the protein automatically by Rosetta. In the following minimization stage, the torsion angles of 
backbones and side chains and the positions of FMN and I-Tyr were optimized by gradient based 
minimization. The minimized structure was either accepted for next round of optimization or 
rejected based on the Monte Carlo Metropolis criterion.63 The two stages were performed iteratively 
before the lowest energy structure encountered in the trajectory was recovered as the final output. 
Fifty independent structures were generated by the same protocol and ranked by their Rosetta 
energies. I-Tyr in the best scored structure was then substituted with 2IP by deleting the coordinates 
of the zwitterion and β-carbon to generate the model complex of HsIYD•2IP for lid redesign. Since 
IYD is a homodimer and its two active sites are functionally identical, the substrate substitution 
and subsequent redesign were only applied to one of the two active sites. Parameterization of small 
molecules-I-Tyr, 2IP, and FMN was performed following the PyRosetta user’s guide.64 The 
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geometries of I-Tyr and FMN were adopted from those in the co-crystal structure of HsIYD•I-Tyr 
(PDB 4TTC). Hydrogens and partial charges of the small molecules were added by Chem3D Pro 
13.0 (Cambridgesoft) and DiscoveryStudio 4.1 (Accelrys), respectively. 
(2) Fixed backbone design: 
Similar to structure optimization, a two-stage protocol was used for lid redesign with fixed 
backbones following published procedures (Appendix Figure A1(B) and Table A1).65 In the design 
stage, the side chains of the active site lid and three additional residues from both termini (residues 
157-182, magenta in Figure 2-1) were varied in a random and combinatorial fashion by two 
different approaches. The lid, when closed, forms a helix-turn-helix motif (blue in Figure 1-1(B)). 
Therefore, in the first approach, the “guided Rosetta design”, substitutions in the helix region of 
the lid were restricted to amino acids that favor α-helix formation.66 In the loop regions of the lid, 
Rosetta was directed to choose amino acids frequently observed in natural IYDs at the same 
positions since such amino acids may stabilize the structure more than those found infrequently.67 
A detailed amino acid selection for each position is shown in Appendix Table A2. In contrast, all 
20 common amino acids were allowed at all positions of the lid in the “unguided Rosetta design” 
approach. Sidechain rotamers of residues within 10 Å of the lid were repacked during the design 
stage to accommodate any potential substitutions. To reduce the computation cost, the enzyme’s 
backbone torsion angles and small molecule (FMN and 2IP) positions were all fixed at this stage. 
They were, however, relaxed in the following minimization stage to optimize the structures of the 
variants which were then accepted or rejected by the Monte Carlo Metropolis criterion. After 
iterations of the two-stage algorithm, the lowest energy structure encountered in the trajectory was 
recovered as the final output. One hundred independent designs were calculated for both guided 
Rosetta design and unguided Rosetta design. 
To confirm that the stabilization of the designs over the starting model was a result of 
mutations rather than changes of backbone and side change conformations, the starting model of 
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HsIYD•2IP complex was allowed to go through the same three-stage protocol except that in the 
design stage the active site residues were only allowed to be repacked rather than be mutated. 
(3) Selection of redesigned variants for experimental characterization: 
A series of filters were used to choose potential variants for characterization. A total 
Rosetta energy filter was first applied to select the top 20 designs in total energy. Then the solvent 
accessible area (SASA) of 2IP in these designs was evaluated by Pymol (education version, 
Schrödinger). Designs with a 2IP SASA smaller than that in the control experiment (6.4 Å2) were 
considered for the next filter. Finally, redundant variants with the same sequences were removed 
from all remaining ones to give 11 total variants (2 guided designs and 9 unguided designs) for 
characterization. 
2.2.2 Cloning: 
The cloning of HsIYD was described in a previous report.31 The vector pSMT3 contains 
the gene for HsIYD without the membrane anchor (residue 1-31) plus a N-terminal SUMO tag to 
facilitate expression of soluble proteins.68 The SUMO tag was later removed during purification 
leaving a non-native serine at the N-terminal truncation of HsIYD. The construct also carries a 
(His)6 tag at the C-terminal of IYD gene to facilitate purification. 
Except for GD02 and UD01, all variants of HsIYD were generated by site directed 
mutagenesis.69,70 GD02 and UD01 were constructed by sequence ligation independent cloning.71 
Briefly, the parent plasmid of HsIYD was linearized by inverse PCR. An insert containing all 9 
mutations of UD01 flanked by 18 bases of homologous sequence to each end of the linearized 
plasmid was prepared by PCR-based DNA assembly.72,73 The linearized plasmid and insert were 
digested separately by T4 DNA polymerase (New England Biolabs) at room temperature for 30 
min to create 5’ overhangs. The digestion reaction was stopped by addition of dCTP (Thermo 
Fisher Scientific) and the digestion products were purified by a cleanup kit (Thermo Fisher 
Scientific). The vector and insert were then mixed with a molar ratio of 1:1 and their 
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complementary 5’ overhangs were annealed at 37 ºC for 30 min. The annealed product was 
transformed directly into Genehogs chemically competent cells (Invitrogen) to repair nicks. 
All DNA oligonucleotides used for cloning were synthesized by IDT and are listed in 
Appendix Table A3. PCR was performed with Phusion High-Fidelity DNA polymerase (Thermo 
Fisher Scientific). The DNA sequences of all variants were verified by Sanger sequencing 
(Genewiz). 
2.2.3 Protein expression and purification: 
HsIYD and its variants were heterologously expressed in Rosetta2 chemically competent 
cells (Novagen). After transformation, the cells were grown in 100, 500, or 1000 mL LB media at 
37 ºC with vigorous shaking (220 rpm). The cultures were cooled to 16 ºC after their OD600 nm 
reached ~ 1. Isopropyl thio-β-galactoside (IPTG, Goldbio, 25 μM final) was then added to induce 
expression of IYD at 16 ºC with vigorous shaking (220 rpm) for 15 hr. Cells were harvested by 
centrifugation at 4 ºC and 5000×g for 10 min, flash-frozen in liquid nitrogen and stored at -80 ºC. 
Enzymes with the SUMO tag removed from the prep were obtained as follows: frozen cell 
pellets were thawed at room temperature and resuspended in ~ 25 mL cell lysis buffer (50 mM 
sodium phosphate, 500 mM sodium chloride, 10% glycerol, 25 mM imidazole, 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP), pH 8.0) by vortex. From then on, all procedures were done at 4 
ºC unless otherwise noted. FMN was added to the suspension to a final concentration of ~ 300 μM 
to enhance its occupancy in IYD. Cells were then lysed by an EmulsiFlex-C3 homogenizer (Avestin) 
with 4 passes at ~17000 psi. ULP1 protease (~ 40 μg) was then added to the cell lysate to cleave 
the SUMO tag off the deiodinase. Cell debris was removed by centrifugation at 45000×g for 1 hr. 
The ULP1 digestion was completed during this time. The supernatant was mixed with 5 mL of 
HispurTM nickel-nitrilotriacetic acid (Ni-NTA) resin (Thermo Fisher Scientific, pre-equilibrated 
with 10 column volumes of cell lysis buffer) by a bench top Econo pump (Bio-rad) at a flow rate 
of 1 mL/min. Since the SUMO tag also carries a N-terminal (His)6 tag, both SUMO and the 
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deiodinase bound the resin. The SUMO tag, however, can be removed from the resin by extensive 
washing with 16 column volumes of cell lysis buffer and 16 colum volumes of washing buffer (50 
mM sodium phosphate, 500 mM sodium chloride, 10% glycerol, 60 mM imidazole, 0.5 mM TCEP, 
pH 8.0) using an ÄKTA protein purification system (GE Healthcare) at 1 mL/min. Finally, the 
bound protein was eluted with elution buffer (50 mM sodium phosphate, 500 mM sodium chloride, 
10% glycerol, 250 mM imidazole, 0.5 mM TCEP, pH 8.0). Most SUMOs were removed by one 
Ni-NTA column, but a second Ni-NTA column as described above was generally needed to 
completely remove the tag. The eluted proteins were then supplied with ~300 μM FMN and 
incubated on ice for 1 hr to further increase the FMN occupancy. Finally, the proteins were 
exchanged into storage buffer (50 mM sodium phosphate, 100 mM sodium chloride, 15% glycerol, 
1 mM TCEP, pH 7.4) using a gravity driven PD-10 desalting column (GE healthcare) following 
manufactures’ instructions. The proteins were then concentrated with a 50 kD molecular weight 
cut off centrifugal filter unit (Amicon), aliquoted, flash-frozen with liquid nitrogen and stored in -
80 ºC. 
A partial purification protocol modified from the above protocol was used to purify variants 
used for binding and activity screening. The SUMO tag was removed from the deiodinases after 
purification by the ULP1 protease but not further removed from the prep. All procedures were done 
at 4 ºC unless otherwise noted. Dithiothreitol (DTT) was used as the reductant in all buffers for the 
purification of GD01-02 and UD01-09 but switched to TCEP for all the other purifications for its 
greater oxygen stability. Cell lysate clarified via centrifugation was mixed with 2-3 mL Ni-NTA 
resin by a rotary shaker with mild agitation for 30 min. The subsequent washing (cell lysis buffer, 
10 column volumes) and elution steps were driven by gravity. ULP1 protease (~ 40 μg) was then 
added to eluted proteins to cleave the SUMO tag overnight. The mixture of the SUMO tag and the 
deiodinase was directly exchanged into storage buffer by using either a centrifugal filter unit (50 
kD molecular weight cut off, Amicon) or a Econo-Pac 10DG gravity desalting column (Bio-rad) 
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following manufactures’ instructions. For purification of DM01 variants with substitutions at E157, 
cell pellets from 100 mL cultures were lysed with B-PERTM bacterial cell extraction reagent 
(Thermo Fisher Scientific) following manufacturer’s instructions. Lysozyme (1 mg/mL, Thermo 
Fisher Scientific) and Pierce™ universal nuclease (25 unit, Thermo Fisher Scientific) were also 
added to the lysate to facilitate cell lysis. After elution from the nickel affinity column (200 μL), 
the variants were frozen directly in elution buffer without buffer exchange. 
Enzymes used for limited proteolysis with trypsin required extra purification to avoid 
detectable contaminants on SDS-PAGE. Enzymes used in these experiments had their C-terminal 
(His)6 tag removed by site directed mutagenesis but were still able to bind to the Ni-NTA column 
by (His)6 tag attached to the SUMO. After elution, the SUMO together with its (His)6 tag was 
cleaved by ULP1 protease and the deiodinase-SUMO mixture was loaded onto a second Ni-NTA 
column. At this point the deiodinase was free of (His)6 tag and therefore would flow through the 
column while the SUMO tag and any non-specific Ni-NTA binding proteins were still retained on 
the column. The purified deiodinases were then exchanged into storage buffer and frozen as 
described above. 
The purified enzymes were analyzed by 12% SDS-PAGE with Comassie brilliant blue 
staining. Enzyme concentration was determined by either UV-vis absorption of enzyme-bound 
FMN (ε450 nm=12500 M-1cm-1)74 or quantification of FMN liberated from the enzyme by HPLC at 
445 nm upon denaturation with 4.4% formic acid (see Section 2.2.5 for detailed HPLC methods). 
The discrepancy between the two methods was ≤ 10%. The FMN occupancy of purified deiodinases 
was determined by the ratio of enzyme-bound FMN (determined by UV-vis) over the total protein 
concentration which was calculated from UV absorption at 280 nm (extinction coefficient 
estimated by the ExPASy ProtParam tool)75 after correcting for the contribution from bound FMN 




2.2.4 Binding dissociation constant: 
The affinity (dissociation constant, Kd) of substrates (I-Tyr and 2IP) to HsIYD and its 
variants was determined by measuring the quenching of enzyme-bound FMNox fluorescence upon 
stacking of the substrates’ aromatic ring to FMNox as previously described.27 Briefly, I-Tyr or 2IP 
was titrated into 4 μM enzyme in 200 mM potassium chloride, 100 mM potassium phosphate, pH 
7.4 with mild stirring at 25 ± 1 °C. Quenching of FMN fluorescence upon addition of substrates 
was recorded at 516 nm with an excitation wavelength of 450 nm. Kd was obtained from fitting the 
dependence of fluorescence intensity on substrate concentration to a previously described binding 
isothermal.21 
2.2.5 Deiodination activity assay: 
The deiodination activity was measured by quantifying the rate of product (phenol or Tyr) 
formation via reverse-phase HPLC as previously described.28,32 Briefly, 80 nM to 5 μM enzyme 
was incubated with 0.5-10 mM 2IP in 900 μL of 220 mM potassium chloride, 110 mM potassium 
phosphate, pH 7.4 at 25 ± 1 °C for 5 min. Sodium dithionite (5%, 100 μL) in 5% sodium bicarbonate 
was then added to initiate catalysis. For initial screening of HsIYD variants generated by Rosetta, 
the reactions were quenched after 30 min by 50 μL of 88% formic acid. Resorcinol (30 μM final) 
in the above buffer was then added as an internal standard. For all other activity measurements, the 
reaction was quenched after 5-30 min by addition of 100 μL of a 1:1 mixture of 88% formic acid 
and 0.55 μM (final) Cl-Tyr (as an internal standard) in the above buffer. The reaction was then 
analyzed by an Agilent 1100 series HPLC equipped with a 1200 series multiwavelength detector. 
The product of the reaction, Tyr or phenol, was separated on a C18 reverse phase column (Agilent, 
Microsorb-MV 300 C18, 250 × 4.6 mm) by a gradient of water and acetonitrile both containing 
0.44% formic acid at a flow rate of 1 mL/min and detected at 271 nm. See Appendix Table A4 for 
the detailed solvent gradients. For steady state kinetics measurements, the rate versus substrate 
concentration was fitted with Michaelis-Menton equation to obtain kcat and KM. 
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2.2.6 Limited proteolysis: 
Deiodinases (HsIYD, DM01, GD02, or UD08, 5 μg) and its corresponding substrates (100 
μM I-Tyr or 10 mM 2IP) were incubated in 200 mM NaCl, 100 mM sodium phosphate pH 7.4 at 
25 ± 1 °C for 5 min. When substrate was not present, the above buffer was added to maintain a 
constant volume. Sodium salts were used in this buffer instead of potassium salts used in binding 
and activity experiments to avoid precipitation of SDS involved in the later SDS-PAGE analysis. 
Digestion was initiated by addition of trypsin (fleshly prepared before use, Sigma-Aldrich, TPCK 
treated) in the same buffer. The final deiodinase to trypsin ratio was 50:1 (in μg) in all cases. 
Aliquots of 5 μL was removed from the digestion reaction at indicated time points and mixed 
immediately with an equal volume of standard SDS-PAGE loading buffer. The mixture was then 
heated in a boiled water bath for 5 min to ensure denaturation of all proteins. The reaction aliquots 
were then analyzed by 15% SDS-PAGE. After electrophoresis, the gel was mixed with 100 mL 
Coomassie brilliant blue staining solution, microwaved for 90 s at the highest output and then 
agitated mildly for 30 min. The same procedures were used to destain the gel twice with 10% (v/v) 
acetic acid. During the second time, agitation was reduced to 15 min to avoid over-destaining. Gel 
bands were then scanned and undigested proteins were quantified by densitometry (ImageQuant 
TL 7.0, GE Healthcare) with pre-constructed calibration curves. The consumption of undigested 
proteins overtime followed pseudo first order kinetics from which the digestion rate constant and 
half-life of undigested proteins were calculated. 
2.2.7 Effect of I-Tyr and 2IP on trypsin activity: 
A 1 mg/mL suspension of Nα-Benzoyl-DL-arginine 4-nitroanilide hydrochloride (DL-
BAPNA) in 200 mM sodium chloride, 100 mM sodium phosphate pH 7.4 was strongly vortexed 
for 10 min. The DL-BAPNA did not completely dissolve and the suspension was then centrifuged 
at 14000×g for 5 min. The supernatant was used as the substrate stock solution whose concentration 
was adjusted with the above buffer to give a UV absorbance of 0.45 at 315 nm. To set up the assay, 
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trypsin (8 μM) and deiodinase substrates (100 μM I-Tyr or 10 mM 2IP) in the above buffer were 
mixed to a total volume of 65 μL and incubated at room temperature (25 ± 1°C) for 5 min. In the 
control, buffer was used to substitute substrates. The reaction was initiated by addition of 85 μL of 
DL-BAPNA stock solution and the release of proteolysis product, 4-nitro-aniline, was monitored 
at 405 nm (ε405nm=9920 M-1cm-1)76 every 15 seconds for 5 min. The first eight points were fit into 
a linear line to obtain the initial rate of the reaction. 
2.2.8 Identification of trypsin digestion site on HsIYD: 
The two major trypsin digestion products of HsIYD were extracted separately from the 
SDS-PAGE gel.77 Briefly, the gel bands containing the digestion products were carefully excised 
and placed into a 2 mL centrifuge tube (USA-Scientific, 1620-2700). Destaining solution (a 1:1 
mixture of 50 mM ammonium bicarbonate and acetonitrile, 200 μL) was subsequently added to the 
tube and the gel bands were crushed manually with a glass rod. The resulting gel particles were 
incubated with the destaining solution for 10 min to remove the Coomassie brilliant blue. After 
centrifugation at 14000×g for 5 min, the blue supernatant containing the Coomassie stain was 
discarded and the gel particles were washed once with another 200 μL destaining solution. The 
now colorless gel particles were allowed to dry in air for 10 min before incubated with 100 μL 
extraction solution (a mixture of 88% formic acid, water and isopropanol in 1:3:2 volume ratio). 
The mixture was then vortexed mildly for 7 hr during which time the digestion products were 
extracted into solution from the gel. After centrifuged at 14000×g for 5 min, the supernatant was 
transferred into a 1.5 mL centrifuge tube carefully without disturbing the pelleted gel particles. 
Another 100 μL of the extraction solution was used to wash the gel particles, centrifuged, and 
combined with the previous fraction. The combined solution was then evaporated to ~ 20 μL under 
vacuum (Savant Speed Vac○R, SC100A) and analyzed directly by a Waters Acquity/XevoG2 UPLC-
MS system to detect peptides from the trypsin digestion. Peptides were separated using an Acquity 
UPLC® Protein BEH C4 column (300 Å, 1.7 μm, 2.1 mm×50 mm) and a binary mobile phase of 
23 
 
water and acetonitrile (1% v/v formic acid in each) that remained at 100% water for 1 min and then 
a linear gradient of acetonitrile to 80% for the next 6.5 min and remained at this condition for 
another 0.9 min. The capillary voltage, sampling cone and extraction cone were set to 3 kV, 40 V, 
and 4 V, respectively and the source temperature was 130 ºC. The desolvation gas temperature and 
flow rate were 400 ºC and 400 L/hr, respectively. All data were analyzed by BiopharmaLynx 
(Waters). The mass of HsIYD without SDS-PAGE treatment and undigested HsIYD extracted from 
the gel was also obtained to check any protein modification during SDS-PAGE. 
2.2.9 Rosetta simulation of DM01 variants with E157 substitutions: 
 (1) Preparation of a starting structure of DM01: 
A protocol similar to that in Section 2.2.1 part (2) was used to generate the double mutation 
variant DM01. In the design stage, E158 and M162 of HsIYD were mutated to Y and A, 
respectively. Sidechain rotamers of residues within 10 Å of the two residues were repacked during 
the design stage to accommodate any potential mutations. The enzyme’s backbone torsion angles 
and small molecule (FMN and 2IP) positions were all fixed at this stage but later relaxed in the 
following minimization stage to optimize the variant structure which was then accepted or rejected 
by the Monte Carlo Metropolis criterion. After iterations of the two-stage algorithm, the lowest 
energy structure encountered in the trajectory was recovered as the final output. Five independent 
structures were generated and the one with the lowest energy (the deviations of energy between 
five structures were less than 1 Rosetta energy unit (REU)) was used as the starting structure for 
the site saturation mutagenesis simulation. 
(2) Calculation of DM01 variants with E157 substitutions: 
A protocol similar to that in Section 2.2.1 part (2) was used for site saturation mutagenesis 
simulation calculation. In the design stage, E157 of DM01 was mutated to all other 19 canonical 
amino acids. Sidechain rotamers of residues within 10 Å of E157 were repacked during the design 
stage to accommodate any potential mutations. The enzyme’s backbone torsion angles and small 
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molecule (FMN and 2IP) positions were all fixed at this stage but later relaxed in the following 
minimization stage to optimize the variant structure which was then accepted or rejected by the 
Monte Carlo Metropolis criterion. After iterations of the two-stage algorithm, the lowest energy 
structure encountered in the trajectory was recovered as the final output. Five independent 
structures were generated and the one with the lowest energy (in most case, the deviations of energy 
between 5 structures were less than 1 Rosetta energy unit (REU)) was used for subsequent analysis. 
2.2.10 Additional software: 
Least-square fittings were performed with Origin 2017 (Originlab). All structural 
illustrations were prepared by Pymol (education version, Schrödinger). 
2.3 Results and discussion: 
2.3.1 Exogenous zwitterions failed to rescue 2IP deiodination: 
Since the presence of a zwitterion in the substrate confers the 104-fold higher selectivity of 
HsIYD towards I-Tyr over 2IP,32 efficient deiodination of 2IP can potentially be rescued by an 
exogenous zwitterion. Such chemical rescue has been used to restore the activity of an inactive 
aspartate aminotransferase mutant K258A via exogenous amines.78 More recently, exogenous 
imidazole was shown to rescue the tyrosine kinase Src R388A mutant in vivo.79 The difference 
between I-Tyr and 2IP is a zwitterion and a β-carbon which altogether closely resembles Ala. 
Amino acids bigger than Ala may clash with 2IP in the active site once the lid closes. Therefore, 
Ala and Gly were chosen as the rescue compounds. 
The binding affinity (Kd) and deiodination activity (V/[E]) of HsIYD with 2IP were 
measured in the absence and presence of 10 mM Gly and Ala (2×103 times HsIYD concentration). 
The deiodination activity was measured at two 2IP concentrations: one equal to its KM (4 mM) and 
one smaller than its KM (0.5 mM). As shown in Appendix Table A5, the presence of Gly did not 
affect the Kd but increased the deiodination activity by 1.3-fold at both 2IP concentrations. Ala, in 
contrast to Gly, decreased the Kd by 1.1-fold while left activity unchanged at both 2IP 
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concentrations. Therefore, simple zwitterionic compounds like Gly and Ala have no significant 
effects on the binding and deiodination of 2IP by HsIYD. Chemical rescue with exogenous 
zwitterions is not a practical solution to switch substrate specificity of HsIYD towards 2IP. 
2.3.2 Computational design by Rosetta with fixed backbones stabilized a HsIYD•2IP complex 
with the lid closed: 
 
Once chemical rescue failed to promote 2IP deiodination, Rosetta was used to redesign the 
active site lid of HsIYD to stabilize the proposed productive conformation for 2IP deiodination 
(Figure 2-1). This model complex of HsIYD•2IP was built by first optimizing the co-crystal 
structure of HsIYD•I-Tyr (PDB 4TTC)31 in Rosetta. The zwitterion and β-carbon of I-Tyr were 
then deleted to generate the HsIYD•2IP complex. The Rosetta model of HsIYD•2IP differed from 
the co-crystal structure of HsIYD•I-Tyr only by a 0.5 Å all-atom root mean square deviation 
(RMSD). The sequence of the lid was then redesigned by a protocol consisting of two stages. In 
the design stage, the sidechains of the lid area (residues 157-182, magenta in Figure 2-1) were 
varied via two different strategies. Rosetta was either allowed to choose amino acid variants 
randomly from all 20 canonical amino acids (unguided Rosetta design, or UD) or from a limited 
selection of amino acids that stabilizes the helix-turn-helix motif of the closed lid (guided Rosetta 
design, or GD) (Appendix Table A2). The backbones of the lid were fixed during the design stage 
but were allowed to relax together with the side chains in a subsequent minimization stage to 
accommodate the incorporated substitutions. The design and minimization stages were then 
iteratively alternated before outputting a final design sequence. Any energy change of the 
redesigned enzyme•2IP complex from the starting structure could be from either changes of amino 
acid identity or changes of protein conformation due to the relaxation in the minimization stage. 
Therefore, as a control, the same protocol was used to repack rather than redesign the HsIYD•2IP 
complex to capture the energy change solely from conformational relaxation. Since Rosetta 
sampling is stochastic, multiple independent designs starting from the same starting model were 
needed to avoid trapping of the designs into a local energy minimum.53 Therefore, 100 independent 
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designs were generated for the control as well as guided and unguided design. While 100 
independent designs only explored a small fraction of the possible sequence space, a previous study 
showed that 100 independent designs were enough to reach convergence in sequence variability 
when the backbones were fixed during the design stage.80 Indeed, ~ 85% of the redesigned positions 
on the lid showed less than three amino acid substitutions among all 100 sequences of both the 
guided and unguided design (Appendix Figure A2).  
The averaged total energies of both the 100 guided and unguided Rosetta designs were 
lower than that of the control by 8 and 13 Rosetta energy units (REU), respectively (Table 2-1), 
suggesting that both strategies stabilized the enzyme•2IP complex via redesign of the lid sequence. 
These energy decreases are significant since a previous study showed that even a 0.8 REU decrease 
in Rosetta calculated binding energy was sufficient to result in a 2-fold increased binding affinity 
of the protease calpain to a redesigned peptide.81 As shown in Table 2-1 by the standard deviation 
of Rosetta energies, the control showed the smallest variability in total energy followed by the 
guided design and then unguided design. This trend correlates well with the increased degree of 
freedom from the control to the unguided design (Appendix Table A1). The sequences of guided 
designs also showed less variability and therefore higher degree of convergence than those of 
unguided designs (Appendix Figure A2). 
Table 2-1 Evaluation of designs generated by Rosetta. This table was originally published from 
Sun, Z.; Rokita, S. E.60 






All 100 designs -812.7 ± 0.2 -821 ± 1 -825 ± 2 
Top 20 designs -812.9 ± 0.1 -821.0 ± 0.1 -829 ± 1 
Binding energy of 
2IP[c] 
Top 20 designs -9.4 ± 0.1 -9.6 ± 0.1 -9.8 ± 0.3 
Lid stabilization 
energy[d] 
Top 20 designs -2.4 ± 0.1 -10.4 ± 0.2 -18 ± 1 
SASA of 2IP (Å2) Top 20 designs 6.4 ± 0.3 3.2 ± 1.3 6 ± 3 
aThe energy calculated by Rosetta is expressed in Rosetta energy units (REUs). bThe control is repacking of the native 
HsIYD without varying its sequence. cBinding energy of 2IP is defined as the energy of the enzyme•2IP complex minus 
that of the ligand free enzyme. dLid stabilization energy is defined as the energy of the ligand free design minus that of 




The designs were ranked based on two criteria-total energy and solvent accessible area 
(SASA) of 2IP. The top 20 designs in total energy were selected for further analysis. To understand 
how both guided and unguided design stabilized the enzyme•2IP complex over the control, the 
averaged total energy of the top 20 designs were broke down into two parts: (1) the interaction 
between 2IP and enzyme and (2) the stabilization of the lid structure. The differences in binding 
energy of 2IP between the control and design only accounted for ~2% of the difference in total 
energy (Table 2-1). In contrast, the major stabilization of the enzyme•2IP complex by the design 
over the control was provided by the lid stabilization energy. The control only modestly stabilized 
the lid over the starting model by 2.4 REU as a result of conformational relaxation (all atom RMSD 
< 0.1Å) introduced during the minimization stage. In contrast, both design strategies increased the 
lid stabilization energy by at least 4-fold compared to the control, suggesting much greater 
stabilization of the lid by amino acid substitutions. 
The SASA of 2IP was then calculated by Pymol for the top 20 control and design structures 
to evaluate packing of the active site. A cavity (dashed circle in Figure 2-1) is formed in the active 
site when the zwitterion of I-Tyr is absent. Filling this cavity may lead to tighter packing of the 
active site and thus greater stability of the enzyme•2IP complex.82,83 Although Rosetta does not 
specifically penalize a cavity, the van der Waals attraction energy term in Rosetta’s energy function 
would favor more compacted structures.84 All but one of the top 20 guided Rosetta designs 
decreased SASA compared to the control, indicating a tighter packing around 2IP (Table 2-1). This 
is expected as Rosetta was instructed to put bulky, hydrophobic residues near the void in guided 
Rosetta design (Appendix Table A2). In contrast, only 11 of the top 20 unguided Rosetta designs 
decreased SASA. 
Finally, the top 20 designs with decreased SASA were checked for redundant sequences 
and 17 of 19 GDs and 2 of the 11 UDs were removed from the collection. The higher number of 
redundant sequences for guided design than unguided design is yet another sign of its higher level 
28 
 
of convergence. Both the 2 GDs (GD01-02, ranked by descending order in total energy) carry 9 
substitutions from HsIYD in the 26-residue variable region compared to 14-18 for the 9 UDs 
(UD01-09, ranked by descending order in total energy) (Figure 2-2). It is not a surprise that residues 
of the zwitterion recognition triad (E157, Y161, and K182) were not retained in any final variants, 
except for K182 in GD01 and GD02. 
  
Figure 2-2 Lid sequence of HsIYD and redesigned variants. Conserved residues are labeled with 
dash (-). Residues with their side chains within 5 Å of the zwitterion of I-Tyr are colored in red. 
The ones forming polar interactions with the zwitterion of I-Tyr are indicated by star (*). Total 
number of mutations that each designed enzyme carries are listed in parenthesis following the 
enzyme labels. The lid sequence of HsIYD is flanked by its residue numbers. Secondary structures 
of the lid are shown on top of the alignment (α-helix as gray cylinders and loop as black lines). This 
figure is modified from Sun, Z.; Rokita, S. E.60  
 
2.3.3 Variants generated by Rosetta improved binding, catalytic efficiency and substrate 
selectivity of HsIYD towards 2IP: 
 
The 11 selected variants were constructed from HsIYD by sequence-ligation independent 
cloning and site-directed mutagenesis.69–71 The mutant enzymes were then expressed in E. coli with 
a N-terminal SUMO tag68 and a C-terminal (His)6 tag to facilitate solubility and purification via 
Ni-NTA affinity chromatography, respectively. All 11 variant enzymes were expressed as soluble 
proteins (Appendix Figure A3) despite containing large number of mutations (at least 9) from 
HsIYD. The SUMO tag was released from the variants by ULP1 protease post Ni-NTA 
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chromatography but was not further removed from the enzyme preparation. The presence of the 
SUMO tag did not affect the initial binding and activity screening (data not shown) or measurement 
of enzyme concentration since the enzymes were quantified based on bound FMN rather than total 
protein. 
The binding affinity of variants towards 2IP was measured by a FMN fluorescence 
quenching assay as previously reported.27 While both GDs bound 2IP at least 2-fold weaker than 
HsIYD, the 9 UDs invariably bound 2IP tighter (Figure 2-3(A)). The 2IP deiodination activity of 
the variants was measured with 0.5 mM and 1 mM 2IP (Figure 2-3(B) and Appendix Table A6). 
For all enzymes with detectable activity, the activity at 0.5 mM 2IP was 2-fold smaller than that at 
1 mM 2IP. This indicates that the activity measurements were all performed under conditions where 
the enzyme was not saturated with substrate and there was no significant decrease in KM for any 
variants compared to HsIYD. Three of the nine UDs improved the 2IP deiodination activity by at 
least 1.5-fold where two GDs had no detectable activity. Clearly, variants generated by the guided 
and unguided design provided a sharp contrast even though they share ~ 50% similar or identical 
mutations. Restricting amino acid substitution limited the sequence space relative to that explored 
under unrestricted conditions and in return prevented identification of beneficial mutations. For the 
unguided Rosetta design, there is a discrepancy between the 100% successful rate in binding 
affinity improvement and the 30% successful rate in activity improvement. This is consistent with 







Figure 2-3 Characterization of HsIYD and its variants. (A) Affinity of 2IP to HsIYD and its 
variants. Two independent measurements were fitted as one curve to obtain the Kd and associated 
error from the fitting. (B) Deiodination activity of HsIYD and its variants with 1 mM 2IP. The V/[E] 
represent the average of two independent measurements. The error is either the range of two 
independent measurements or three times the background of the assay (0.004 min-1), whichever is 
larger. This figure was originally published in Sun, Z.; Rokita, S. E.60  
 
The unguided Rosetta design UD08 has both the largest increase in 2IP binding affinity 
(10-fold) and deiodination activity (4.5-fold). Its binding and steady-state kinetics with both I-Tyr 
and 2IP were characterized in detail (Table 2-2). The enzymes used in these studies were purified 
further to remove the SUMO tag from the enzyme preparation by extensive washing of Ni-NTA 
column (Appendix Figure A4). The FMN occupancy of the enzymes was estimated to be at least 
90%. Although UD08 bound 2IP 10-fold tighter than HsIYD, the KM only decreased by 1.3-fold. 
The 4.5-fold increase in kcat/KM, therefore, was mainly a result of a 3.5-fold increased kcat. This is 
comparable or approaching the levels of activity boost in some previously published efforts of 
enzyme engineering by rational or computational design and directed evolution.45,85–88 With I-Tyr 
as substrate, UD08 increased both the Kd and KM by ~103-fold compared to HsIYD while left kcat 
unchanged (Table 2-2). Therefore, UD08 decreased the catalytic efficiency of I-Tyr deiodination 
by three orders of magnitude compared to that of HsIYD. Such an effect can be explained by 
disruption of interactions between the zwitterion of I-Tyr and the zwitterion recognition triad of 
HsIYD with mutations E157S, Y161W, and K182H. Overall, UD08 increased the substrate 
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selectivity towards 2IP by 104-fold compared to that of HsIYD by improving 2IP deiodination and 
suppressing I-Tyr deiodination (Table 2-3). Therefore, the unguided Rosetta design with fixed 
backbones has demonstrated the ability to promote 2IP deiodination with relatively small 
computational and experimental cost. 
Table 2-2 The dissociation constants and steady-state kinetics of HsIYD, UD08, DM01, and TM01 
with 2IP and I-Tyr. This table was originally published in Sun, Z.; Rokita, S. E.60  







(2.4 ± 0.1) 
×103 
0.26 ± 0.01e 
(4.4 ± 0.4) 
×103 e 
(6.0 ± 0.6) 
×10-5 e 
1 
UD08 230 ± 6 0.92 ± 0.05 
(3.4 ± 0.4) 
×103 
(2.7 ± 0.4) 
×10-4 
4.5 ± 0.8 
DM01 
(1.57 ± 0.03) 
×103 
1.03 ± 0.07 
(5.0 ± 0.7) 
×103 
(2.1 ± 0.3) 
×10-4 
3.5 ± 0.7 
TM01 
(1.31 ± 0.04) 
×103 
0.96 ± 0.05 
(2.9 ± 0.4) 
×103 
(3.3 ± 0.5) 
×10-4 
5.5 ± 1.0 
I-Tyr 
HsIYD 0.14 ± 0.03 6.1 ± 0.4b 7.3 ± 0.8b 0.8 ± 0.1b 1 
UD08 470 ± 10 5.7 ± 0.2 
(1.5 ± 0.1) 
×104 
(3.9 ± 0.4) 
×10-4 





4.4 ± 0.2 1.4 ± 0.4 3.1 ± 0.9 4 ± 1 
TM01 10.0 ± 0.3 32 ± 3 130 ± 30 0.25 ± 0.06 0.30 ± 0.08 
aEnzymes used in these studies are purified from SUMO contamination. bThree independent measurements were fitted 
as one curve to obtain the Kd and associated error. cAll the data and error bars were obtained by fitting of three independent 
measurements as one curve. dActivity change is defined as the ratio of the kcat/KM of the variants to that of the HsIYD. 
eData from Ingavat, N.; et, al.32 
 
Table 2-3 The substrate selectivity of HsIYD, UD08, DM01, TM01 towards 2IP. This table was 
originally published in Sun, Z.; Rokita, S. E.60  
Enzyme 2IP selectivitya Relative 2IP selectivityb 
HsIYD (7.14 ± 0.12)×10-5 1 
UD08 0.69 ± 0.11 1×104 
DM01 (7 ± 2)×10-5 1 
TM01 (1.3 ± 0.4)×10-3 18 
a2IP selectivity is defined as the ratio of the kcat/KM for 2IP to that for I-Tyr. bRelative 2IP selectivity is the 2IP selectivity 
of variant enzymes relative to that of HsIYD. 
 
2.3.4 Amino acids responsible for the improved 2IP deiodination by UD08 were highly 
epistatic: 
 
UD08 contains 15 mutations from HsIYD (Figure 2-2) and it is unlikely that all of them 
contribute to promote 2IP deiodination. To identify mutations that can increase 2IP deiodination 
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activity as potential “hot spots” for further activity improvements, 15 separate variants were 
constructed by introducing these mutations individually to HsIYD via site directed mutagenesis. 
Their effects on the 2IP deiodination activity were evaluated by the activity screening assay 
described in the above section (Appendix Figure A5).  As shown in Figure 2-4, the mutational 
effects can be divided into three categories. Two of the 15 mutations (E158Y and M162A) 
increased the activity of HsIYD with 2IP by more than 1.5-fold and are therefore beneficial 
mutations. Seven of the 15 mutations are deleterious as they decreased the activity by more than 
1.5-fold. The remaining 6 changed the activity by less than 50% and thus are classified as neutral. 
The beneficial mutations discovered by computational design in this case occurred in a much higher 
rate (~ 13%) than those typically from directed evolution (0.01-1%).89 
 
Figure 2-4 Effects of individual substitutions on HsIYD that combine to form UD08 mapped onto 
the model complex of HsIYD•2IP. See Appendix Table A7 for details. This figure was modified 
from Sun, Z.; Rokita, S. E.60  
 
Interestingly, summing the effects of all 15 mutations (V/[E] measured with 0.5 and 1 mM 
2IP) would generate a variant that decreased the 2IP deiodination activity of HsIYD by 25-fold. 
Defying this prediction, the activity of UD08 (V/[E] measured with 0.5 and 1 mM 2IP) actually 
increased 4.5-fold experimentally compared to the wildtype enzyme. This non-additivity shows 
that the effects of these mutations are dependent on the specific protein environment-a phenomenon 
known as epistasis.90 Although the exact molecular basis of epistasis is still not fully understood, 
mutations interacting with each other, either directly or indirectly, tend to be epistatic.90,91 The 15 
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mutations of UD08 are all confined locally within the lid and as a result interactions between 
mutations are highly likely. Epistasis could greatly frustrate protein engineering by accumulation 
of single mutations since the fitness landscape becomes rugged and the outcome of combining 
mutations would not be predictable.89 In contrast, Rosetta is able to offer multiple mutations 
simultaneously (as in the case of UD08) and may serve as a more efficient strategy to explore a 
rugged fitness landscape of active site lids like that of HsIYD. 
A variant DM01 combining the two beneficial mutations, E158Y and M162A, was 
generated from HsIYD. These two mutations individually increased the 2IP deiodination activity 
of HsIYD by 3.0- and 2.7-fold, respectively and a simple addition of the two implied an 8-fold 
increase. However, the DM01 just increased the activity by 3.5-fold and again demonstrated 
epistasis. With 2IP as substrate, the kcat of UD08 and DM01 was nearly the same and KM differed 
only by 1.5-fold (Table 2-2). Therefore, the two beneficial mutations together are responsible for 
nearly 80% of the rate increase of 2IP deiodination by UD08 compared to HsIYD. Interestingly, 
DM01 binds I-Tyr even 3-fold tighter and deiodinates I-Tyr 3.7-fold more efficiently than HsIYD, 
resulting in no net change in the substrate selectivity from HsIYD (Table 2-3). Interestingly, these 
two mutations (M162A more frequently) are observed among natural IYD homologs (Appendix 
Figure A2). E158Y could possibly stabilize the α-helix by participating in a π-π interaction with a 
nearby W180 (within 4.5 Å) and M162A could potentially decrease the solvent exposed 
hydrophobic area of the sidechain (Appendix Figure A6(A)). Since the two mutations are surface 
exposed and away from the zwitterion recognition site, their beneficial effects are likely 
independent of the presence of either substrate. 
2.3.5 Extremely low evolvability of E157 in DM01 highlighted the importance of side chain 
interactions: 
 
The two beneficial mutations (E158Y and M162A) in UD08 are both located more than 5 
Å away from 2IP in the model structure. In contrasts, none of the five mutations in UD08 within 5 
Å of 2IP are beneficial on the context of HsIYD. This is surprising since residues near the substrate 
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binding site are intuitively “hot spots” for designing productive enzyme-substrate interactions. 
E157 is one of the three zwitterion recognition triad and is strictly conserved in all IYD homologs 
(Appendix Figure A2).29 Previous study showed that even a similar substitution of Glu to Gln at 
this position in IYD from Drosophila melanogaster (DmIYD) decreased the kcat/KM of I-Tyr 
deiodination by at least three orders of magnitude.28 However, with 2IP as substrate, this position 
is facing hydrophobic aromatic ring of 2IP and should favor hydrophobic substitutions than charged 
residues. Therefore, E157 could potentially be evolvable as a “hot spot” to improve 2IP 
deiodination. To evaluate the evolvability of E157, site saturation mutagenesis was performed at 
this position on the context of DM01. DM01 was chosen as the parent enzyme so that any potential 
activity increase can be made on top of previously identified beneficial mutations. The evolvability 
here is defined as the ability to promote 2IP deiodination via mutagenesis. 
Nineteen common amino acid substitutions at E157 of DM01 were constructed by site 
directed mutagenesis and expressed and purified similarly with the variants generated by Rosetta 
design (Appendix Figure A7). The yield of the E157K variants was 3-4 times less compared to the 
rest variants including the E157R as judges by SDS-PAGE and UV-vis spectroscopy. The activity 
of the site saturation mutations was again assayed with 0.5 mM and 1 mM 2IP as described in 
section 2.3.3 (Figure 2-5 and Table A8). Defying our expectation, E157 in DM01 had extremely 
low evolvability as only E157D slightly increased the activity by 1.3-fold. All the other mutations 
are deleterious with at least 2-fold activity decrease. The importance of a small, negatively charged 
residue at this position to 2IP deiodination is quite counterintuitive. Asp is typically an α-helix 
“breaker”66 and its small size is not expected to facilitate tight packing around 2IP. In addition, a 
negatively charged residue would not promote interactions with the hydrophobic ring of 2IP. 
Further defying expectations, large, hydrophobic substitutions at E157 generally conferred lower 
activity than polar substitutions. This might partly explain the failure of guided design approach in 
which Rosetta was specifically instructed to install large, hydrophobic substitutions at or near E157. 
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To check if Rosetta simulation can reproduce the experimentally observed effects of E157 
mutations, the stability of the DM01•2IP complex with E157 substitutions was evaluated by Rosetta 
(Appendix Figure A8). Although the stability of these variants calculated by Rosetta did not 
precisely agree with the experimental activity profile, Rosetta still favored a negatively charged 
residue at this position over other substitutions and performed far better at predicting the deleterious 
effects of bulky, hydrophobic substitutions than intuition. 
 
Figure 2-5 Deiodination activity of DM01 variants with substitutions at E157. Bars were colored 
by the chemical properties of the amino acid side chains with gray as non-polor, orange as aromatics, 
green as polar, blue as positively charged, and pink as negatively charged. The dashed line 
represents the activity level of HsIYD. The values of V/[E] were measured with 1 mM 2IP and 
represent the average of two independent trials. The error bar represents either the range of two 
independent measurements or three times the background of the assay (0.004 min-1), whichever 
one is larger. This figure was originally published in Sun, Z.; Rokita, S. E.60  
 
The substrate binding and steady state kinetics were then evaluated for a triple mutation 
variant TM01 combining DM01 and the only more beneficial substitution at E157 
(E157D/E158Y/M162A on the context of HsIYD). With 2IP as substrate, TM01 mildly increased 
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the kcat/KM by 1.6-fold compared to that of DM01 (Table 2-2), which was mainly contributed to a 
decrease in KM. The response of TM01 to I-Tyr is more dramatically changed compared to that of 
DM01. TM01 binds I-Tyr 240-fold less tightly and deiodinates I-Tyr 12-fold less efficiently. The 
magnitude of the activity decrease is, however, not as significant as the 103-fold activity drop with 
the Glu to Gln mutation in DmIYD.28 
The extremely constrained evolvability of E157 may originate from its extensive 
interactions with nearby residues. E157 could potentially interact with N160 and K182 as shown 
in the model structure of HsIYD•2IP (Appendix Figure A6(B)). The salt bridge between K182 and 
E157 could shield the charges of both residues facing the hydrophobic ring of 2IP. The hydrogen 
bonding between E157 and N160 could also prevent the Asn from interacting with the helix 
backbone and cause its destabilization.66 The unguided designs preserved these interactions by 
coevolution of E157D/S and K182H (Figure 2-2). In contrast, K182 was fixed in the guided design 
and E157 was restricted to hydrophobic substitutions and thereby disrupting the interactions 
between E157, N169, and K182. Again, the results demonstrated that the effect of single mutations 
on the active site lid is strongly dependent on the context. It has been shown that the rate of amino-
acid substitution though out the evolution of natural enzymes is an order of magnitude slower 
compared to what is expected without epistasis.92 Therefore, epistasis is likely a common feature 
for protein evolution. While it is difficult to bypass the effect of epistasis by rational design, Rosetta 
is able to overcome such limitation by exploring a much bigger sequence space with coordinated 
substitutions. 
2.3.6 Unguided Rosetta design changed the responsiveness of the active site lid towards 2IP: 
 
Rosetta was employed to stabilize the active site lid of HsIYD in its closed conformation 
with 2IP bound in hope to increase its activity towards 2IP. To verify if Rosetta indeed generated 
variants that stabilized the active site lid in response to 2IP, the conformation of the active site lids 
of HsIYD and its variants UD08, GD02, and DM01 was probed by limited proteolysis. The 
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resistance to proteolysis can be used to probe flexible regions of proteins since such regions are 
more accessible to the active site of proteases and thus are preferentially digested over more 
compact and structured regions.93 To prove the principle, if the active site lid of HsIYD is closed 
into a compact and structured conformation by binding of a substrate, the resulting 
enzyme•substrate complex should confer more proteolytic resistance than the substrate free enzyme.  
In the absence of substrates, HsIYD was digested into two major digestion products, a ~16 
kD peptide and a ~13 kD peptide, as separated and shown by SDS-PAGE (Figure 2-6). To identify 
the site of proteolysis, the two digestion products were extracted from the gel and analyzed by mass 
spectrometry. Characterization of the ~13 kD digestion product was not successful due to low 
signal-to-noise ratio. However, the ~16 kD digestion product was identified as three similar but 
distinct peptide fragments whose masses correspond to those produced by alternative cleavage at 
positions K163 and R164 (Appendix Figure A9, Figure A10 and Table A9). These two residues 
are in the middle of the active site lid which is expected to undergo a disorder to order transition 
responding to I-Tyr binding (Figure 2-7). 
 
Figure 2-6 Limited proteolysis of HsIYD and UD08 in the absence and presence of 2IP analyzed 
by SDS-PAGE. (A) substrate-free HsIYD; (B) HsIYD in the presence of 10 mM 2IP; (C) substrate-
free UD08; (D) UD08 in the presence of 10 mM 2IP. This figure was originally published in Sun, 





Figure 2-7 Sites of trypsin proteolysis on HsIYD. The digestion sites K163 and R164 are shown 
in magenta. Green and cyan represent the two identical polypeptides of the homo dimer. The active 
site lid is colored in blue. FMN and 2IP are shown by orange and yellow sticks. This figure was 
modified from Sun, Z.; Rokita, S. E.60  
 
The remaining undigested HsIYD over time was quantified by densitometry and fitted into 
a first-order decay to obtain the half-life of HsIYD in limited proteolysis (Appendix Figure A11). 
In the absence of substrates, 50% of HsIYD was digested in as short as 1.5 min (Figure 2-8). The 
presence of I-Tyr greatly increased the resistance of HsIYD towards trypsin digestion by at least 
160-fold, as expected by the ability to induce the closure of the active site lid (Figure 2-8). In 
contrast, addition of 2IP to the digestion reaction only marginally protected HsIYD by 1.2-fold 
(Figure 2-6 and Figure 2-8). Control experiments showed that 100 μM I-Tyr had no effect on the 
innate proteolytic activity of trypsin while 10 mM 2IP suppressed its activity by only approximately 
1.3-fold (Appendix Figure A12). Therefore, the 1.2-fold protection 2IP afforded to HsIYD is 
merely a result of inhibition of trypsin rather than 2IP induced conformational change of the lid. 
The results are consistent with the previous crystallographic studies showing that binding of I-Tyr 




Figure 2-8 Half-life of HsIYD and its variants in limited proteolysis. These values and error bars 
were obtained from fitting two independent measurements as one curve. This figure was originally 
published in Sun, Z.; Rokita, S. E.60  
 
The accessibility of the active site lids of HsIYD variants was then evaluated similarly as 
the wildtype enzyme. Even in the absence of ligand, UD08, the variant with the largest 
improvement of binding affinity and deiodination efficiency towards 2IP, was already more 
protected against trypsin digestion by 5.6-fold than HsIYD (Figure 2-8). The gain in resistance to 
proteolysis for UD08 is not a result of a shift in the indicated digestion sites since one of the digest 
sites of HsIYD R164 was retained in UD08 while the other one K163 was mutated to an Arg which 
was still a preferred site for trypsin. Moreover, the size of the digestion products of UD08 was 
comparable to that of HsIYD (Figure 2-6). Therefore, the gain in resistance to proteolysis for UD08 
is more likely a gain in structure for the lid of UD08 in the absence of ligand. More importantly, 
the presence of 2IP further increased the resistance of UD08 to trypsin by 9-fold (Figure 2-6 and 
Figure 2-8), which is far greater than the inhibitory effect of 2IP on the trypsin activity. These 
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results are best explained by the ability of the active site lid of UD08 to interact with 2IP and be 
stabilized it into a more structured conformation as predicted by Rosetta. 
The guided design GD02 which had no measurable activity towards 2IP also showed 
similar protection from trypsin direction by 3.7-fold compared to HsIYD in the absence of 2IP 
(Figure 2-8). Both trypsin digestion sites in HsIYD are also present in GD02. Therefore, the lid of 
GD02 likely also gained structure compared to that of HsIYD in the absence of 2IP. However, 
unlike the case of UD08, the presence of 2IP did not increase the trypsin resistance of GD02 to a 
significant extent. This is consistent with the fact that GD02 decreased the binding affinity towards 
2IP by 2-fold compared to that of HsIYD. Therefore, the lid of GD02 is not able to respond to 2IP 
and be stabilized further, despite gaining structure mildly in the absence of 2IP. 
The double mutation variant DM01 accounts for nearly 80% of UD08’s 2IP deiodination 
activity increase. Yet, the trypsin digestion patterns of DM01 were nearly identical to that of HsIYD 
both in the absence and presence of 2IP (Figure 2-8). Therefore, DM01 did not show any protection 
against trypsin despite improved 2IP deiodination relative to HsIYD. In contrast to the 15 
substitutions in UD08 that induced a drastic change in the responsiveness of the lid from I-Tyr to 
2IP, the double mutation in DM01 most likely stabilized the lid in a more subtle fashion which is 
beneficial to both 2IP and I-Tyr deiodination as discussed in Section 2-3-4. 
Overall, only the unguided Rosetta design demonstrated the ability to change substrate 
selectivity of HsIYD and trigger a disorder to order transition of the active site lid responding to 
2IP. Since the protection of UD08 from trypsin digestion by 2IP is already approaching the level 
demonstrated by HsIYD and the native substrate I-Tyr, further stabilization of the lid with 2IP 
bound is unlikely to significantly improve the activity. This might be more successfully approached 
by focusing on subtle optimization of the active site just as the two mutations forming DM01 





To generate an efficient dehalogenase to remediate toxic halophenols, substrate specificity 
of HsIYD was challenged by computational design to accept an unnatural substrate 2IP. The 
intrinsically disordered lid of HsIYD was redesigned by Rosetta’s fixed backbone design to induce 
a disorder-to-order transition of the lid responding to the presence of 2IP rather than the natural 
substrate I-Tyr. While a guided approach based on stabilizing the secondary structures of the closed 
lid failed to improve 2IP deiodination, success was obtained when Rosetta was allowed to sample 
all amino acids without restriction. This unguided approach successfully identified three variants 
promoting 2IP deiodination, the best of which exhibited a kcat/KM that was 4.5-fold than that of 
HsIYD. The native activity of HsIYD on I-Tyr was simultaneously suppressed 104-fold by this 
variant UD08. Furthermore, only the unguided design demonstrated the ability to change the 
responsiveness of the active site lid from I-Tyr to 2IP. When rational based engineering of the lid 
is frustrated by the strong epistasis of lid mutations resulting from extensive side-chain interactions, 














Chapter 3 Engineering IYD from Haliscomenobactor hydrossis 
towards a halophenol dehalogenase via computational design 
 
3.1 Introduction: 
The attempt to engineer HsIYD via computational design to detoxify halophenols was 
mildly successful. Redesigning the active site lid of HsIYD which controls the substrate selectivity 
using Rosetta improved the deiodination efficiency of a model halophenol-2IP by 4.5-fold while 
diminishing the activity towards the native substrate I-Tyr by 2×103-fold. Moreover, Rosetta 
demonstrated the ability to change the responsiveness of the active site lid towards 2IP and induce 
a disorder-to-order transition of the lid in the presence of 2IP. Despite the success, the 2IP 
deiodination activity of the best performing variant is still three orders of magnitude lower than the 
native activity of HsIYD with I-Tyr and is far from practically applicable. Thus, more active 
variants towards halophenols are required. 
As mentioned in Chapter 2, the advantage of Rosetta over rational design or accumulation 
of random mutations is the ability to explore a much larger sequence space by offering many 
coordinated mutations simultaneously. Two different approaches to further enlarge the sequence 
space Rosetta can navigate were described in this chapter. In the first approach, instead of sampling 
every position on the active site lid, the design was focused on a few “hot spots” that are typically 
responsible for catalysis and substrate recognition. Despite that the degree of freedom is narrowed, 
the number of possible variants Rosetta can evaluate with the same computational cost will be 
greatly increased. Rosetta has been used to successfully improve enzyme selectivity towards non-
native substrates by redesigning substrate-enzyme interactions at restricted positions.58,96 In a 
different approach, the sampling space of Rosetta was broaden by relaxing constrains on backbone 
conformation of the lid. When HsIYD was engineered as described in Chapter 2, Rosetta was 
restricted to explore sequences that could stabilize the lid in a closed conformation in the presence 
of 2IP. This conformation, however, is evolutionarily optimized to specifically support 
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haloptyrosine dehalogenation. It is possible that alternative compact conformations of the lid are 
able to or even better to support halophenol dehalogenation. Rosetta has also demonstrated success 
with such a loop remodeling approach to switch substrate selectivity of human guanine deaminase 
or improve activity of a de novo designed Diels-Alderase.45,47  
In this chapter, both approaches described above were utilized to engineering a new parent 
sequence HhIYD in collaboration with Prof. Jeffrey Gray (Johns Hopkins University). HhIYD is 
from the bacterium Haliscomenobacter hydrossis, a species commonly found in water after sewage 
treatment and possibly involved in the degradation of water pollutants.97 The structural and 
functional analysis of HhIYD recently became available.32 Similar to HsIYD, HhIYD also favors 
I-Tyr as a substrate over 2IP by 104-fold. However, HhIYD is much easier to express and purify as 
it does not need a SUMO tag to be expressed in soluble form. Although 2IP still cannot induce the 
lid of HhIYD to close, it binds HhIYD ~ 20-fold tighter than it binds to HsIYD. As a result, it might 
be easier to improve the interactions between HhIYD and 2IP. HhIYD was first redesigned at nine 
residues near the hydrophobic edge of 2IP to improve enzyme-2IP interaction. This approach 
obtained limited success by increasing the 2IP deiodination activity of HhIYD by only 2-fold. To 
further improve 2IP deiodination, the lid of HhIYD was substituted by shorter loops from PDB that 
can potentially form a more structured lid with 2IP bound. Remodeled lids of 15 and 16 amino 
acids long all failed to support 2IP deiodination. Despite such failure, Rosetta again demonstrated 
its ability to stabilize more structured lids of alternative backbone conformations from the native 
lid in the presence of 2IP as shown by limited proteolysis. 
3.2 Materials and methods: 
3.2.1 Computational design: 
All Rosetta simulations were carried out via Rosetta 3 with REF15 as the default energy 
function by the lab of Prof. Gray.53,84 
(1) Preparation of the starting structure: 
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The starting structure of HhIYD•2IP was prepared with the Fastrelax method by Morgan 
Nance of the Gray lab.98 Briefly, the coordinates of the β-carbon and zwitterion of I-Tyr in the co-
crystal structure of HhIYD and I-Tyr (PDB 5KO8) were deleted to generate an initial model of the 
HhIYD•2IP complex.32 This initial model was then optimized by Rosetta’s Fastrelax protocol with 
rounds of sidechain repacking and minimization. The final output (see Figure 3-1) was used as the 
starting structure of HhIYD•2IP for lid redesign. Parameterization of I-Tyr, 2IP, and FMN was 
performed following the Rosetta user’s guide as described in Section 2.2.1.99 The geometries of 
these small molecules were calculated by Gaussian 09 with the basis set 6-311+g(d).100 The iodine 
atom was calculated by a separate basis set-LanL2DZ aug-cc-pVTZ-PP. Population analysis of 
geometry optimized small molecules was performed in Gaussian 09 with the CM05 method to 
obtain partial charges.101 
(2) Redesign of HhIYD at selected positions with limited backbone freedom: 
Briefly, nine residues in HhIYD within 5 Å of the zwitterion of I-Tyr in the co-crystal 
structure of HhIYD and I-Tyr (PDB 5KO8)32 were varied by Rosetta with a protocol modified from 
the Fastrelax used to prepare the starting structure (Figure 3-1) by Morgan Nance of the Gray lab. 
In the original Fastrelax protocol, side chains were repacked while the backbones were minimized. 
For redesigning HhIYD, the nine residues were allowed to mutate while all other side chains were 
repacked and the backbones were minimized. This protocol offered some backbone freedom during 
design. However, the backbone movement provided by minimization was very subtle. The RMSD 
between the starting model and the designs was generally less than 0.5 Å which was very similar 
to those of the previous fixed backbone designs. A total of 10,000 independent designs were 
generated by this protocol. These designs were first evaluated by two in silico analyses: forward 
folding and ligand docking. The forward folding experiment checks the ability of the new 
sequences to refold to the desired structure by Rosetta’s de novo loop-modeling methods when the 
constraints of backbone conformation are removed.47,102 Ligand docking predicts the ability of the 
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redesigned active site to bind 2IP in the desired conformation.103 Variants succeeded in both 
experiments were ranked by total Rosetta energy and Fpocket score which is an algorithm detecting 
cavities in the active site to evaluate atom packing around 2IP.104 Finally, the top five designs by 
total Rosetta energy and by Fpocket score were manually evaluated for sequence redundancy. 
Seven designs with the most sequence diversity were selected for experimental characterization. 
(3) Loop remodeling of the lid: 
Loop remodeling of the lid was performed by a loop hash method by Drew Morley and Dr. 
Shourya Burman of Gray lab.98 Briefly, a library of loop segments containing 15 amino acids was 
derived from PDB. This libraries was queried to find loops with terminal coordinates matching 
those of the N- and C-terminal of HhIYD’s lid in the HhIYD•2IP complex (20 amino acid, S94-
D113). The backbone of the lid was then substituted by those of the matching loops identified. 
Kinematic closure (KIC) protocol was used to ensure the closure of the loop termini onto the rest 
of the protein.105 The sequences of the new lids were subsequently redesigned using the Fastrelax 
protocol described in the part (2) to optimize interactions with 2IP and the rest of the protein. Finally, 
50000 independent structures generated by this approach were filtered by SASA of the protein and 
2IP, forward folding and ligand docking as described before. Only 1 variant passed all tests and 
was selected for experimental characterization.  
Variants containing 16 amino acid lids were remodeled in a similar fashion. However, one 
residue in the middle of the newly substituted loops was mistakenly fixed during the design and 
therefore still retained the amino acid from the wildtype sequences. Moreover, a residue from the 
native enzyme immediately after the C-terminus of the loop was subjected to the sequence redesign 
even through it was not a part of the new loop. As a result, 17 amino acids in total were actually 






The sequences encoding the active site lid (residues 161-177) and a nearby flexible loop 
(residues 200-208) of HsIYD were deleted via sequence ligation independent cloning and the 
termini from both deletions were linked together respectively to generate the HsIYD_Δlid/loop 
variant.71 The plasmid pET24a carrying HhIYD with a C-terminal (His)6 tag was described 
previously.32 All variants of HhIYD redesigned at selected positions were generated by site directed 
mutagenesis.69,70 The 15-mer loop remodeling design J3736 was constructed by sequence ligation 
independent cloning as described in 2.2.2.71 The 16-mer loop remodeling designs were generated 
by site directed mutagenesis,69,70 overlap extension PCR,106 and Q5® site-directed mutagenesis 
(New England Biolabs). 
All DNA oligonucleotides used for cloning were synthesized by IDT and Sigma (see 
Appendix Table B1 for a list of oligonucleotides). PCR was performed with Phusion High-Fidelity 
DNA polymerase (Thermo Fisher Scientific). The DNA sequences of all variants were verified by 
Sanger sequencing (Genewiz). 
3.2.3 Protein expression and purification: 
All variants were heterologously expressed as described in 2.2.3. The HsIYD_Δlid/loop 
variant was purified as follows. Frozen cell pellets (from 500 mL culture, ~ 4 g) were thawed at 
room temperature and resuspended in ~ 25 mL cell lysis buffer (50 mM sodium phosphate, 500 
mM sodium chloride, 10% glycerol, 25 mM imidazole, 0.5 mM TCEP, pH 8.0) by vortex. From 
then on, all procedures were done at 4 ºC unless otherwise noted. Cells were lysed by an 
EmulsiFlex-C3 homogenizer (Avestin) with 4 passes at ~17000 psi. FMN was added to the lysate 
to a final concentration of ~ 300 µM to enhance the occupancy of the cofactor in the protein. Cell 
debris was removed by centrifugation at 45000×g for 1 hour. The supernatant was mixed with 3 
mL Ni-NTA resin (Thermo Fisher Scientific, pre-washed with 5 volumes of cell lysis buffer) on a 
rotary shaker for 30 min. The resin with His-tagged protein bound was loaded onto a column and 
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cell lysate was allowed to flow through. The column was then washed with 10 column volumes of 
cell lysis buffer and 5 column volumes of washing buffer (50 mM sodium phosphate, 500 mM 
sodium chloride, 10% glycerol, 60 mM imidazole, 0.5 mM TCEP, pH 8.0). Proteins were finally 
eluted from the column with 4 column volumes of elution buffer (500 mM sodium chloride, 50 
mM sodium phosphate, pH 8.0, 10% glycerol, 250 mM imidazole, 0.5 mM TCEP). ULP1 protease 
(40 μg) was then added to eluted proteins to cleave the SUMO tag overnight. The next day proteins 
were concentrated with a 50 kD molecular weight cut off spin filter (Amicon) and passed through 
a gel filtration column (Sephacryl S-200HR, GE Healthcare) equilibrated with 100 mM sodium 
chloride, 50 mM sodium phosphate, pH 7.4, 1 mM TCEP, and 10% glycerol to remove the cleaved 
SUMO tag. The purified enzymes were then concentrated, aliquoted, flash-frozen with liquid 
nitrogen, and stored at -80 °C. 
Variants redesigned at selected positions and the 16-mer loop remodeling designs were 
purified similarly as the DM01 variants with substitutions at E157 as described in Section 2.2.3. 
The 15-mer loop remodeling design J3736 and enzymes used for limited proteolysis studies were 
purified to homogenous similarly as the HsIYD_Δlid/loop variant with the following modification. 
Proteins eluted from the Ni-NTA column were supplied with ~300 µM FMN and incubated on ice 
for 1 hour to further increase the FMN occupancy in the enzyme. The proteins were subsequently 
exchanged into storage buffer (50 mM sodium phosphate, 100 mM sodium chloride, 15% glycerol, 
1 mM TCEP, pH 7.4) using a gravity driven PD-10 desalting column (GE healthcare) following 
manufactures’ instructions. The proteins were then concentrated, aliquoted, stored in -80 ºC as 
described in the previous protocol. 
Purified enzymes were analyzed by 12% SDS-PAGE with Comassie brilliant blue staining. 
Enzyme concentration was determined by either UV-vis absorption of enzyme-bound FMN (ε450 
nm=12500 M-1cm-1)74 or quantification of FMN liberated from the enzyme by HPLC (see 
deiodination activity assay for details) at 445 nm upon denaturation with 4.4% formic acid. The 
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discrepancy between the two methods was ≤ 10%. The FMN occupancy of highly purified variants 
was determined by the ratio of enzyme-bond FMN over the total protein concentration as calculated 
from UV absorption at 280 nm (extinction coefficient estimated by the ExPASy ProtParam tool)75 
after correcting the contribution of A280 from bound FMN (A280/A450 = 1.57).31 
3.2.4 Binding dissociation constant: 
The affinity (dissociation constant) of 2IP to HhIYD and its variants was determined as 
described in Section 2.2.4. 
3.2.5 Deiodination activity assay: 
The deiodination activity was measured as described in Section 2.2.5 by quantifying phenol 
formation by HPLC with Cl-Tyr as an internal strandard. 
3.2.6 Limited proteolysis: 
Trypsin proteolysis of HhIYD and its variants was performed as described in Section 2.2.6. 
3.2.7 Additional software: 
Least-square fittings were performed with Origin 2017 (Originlab). All structural 
illustrations were prepared by Pymol (education version, Schrödinger). 
3.3 Results and discussion: 
3.3.1 Redesign of HhIYD at selected positions with limited backbone freedom only marginally 
improved 2IP deiodination: 
 
When HsIYD was engineered, the sequence of the entire active site lid, regardless of active 
site residues or surface residues, was sampled to stabilize the desired structure. While mutations on 
the enzyme surface can promote catalysis like the two beneficial mutations in UD08, active site 
mutations are more likely to support the binding of 2IP by directly interacting with the substrate. 
Since 2IP and I-Tyr differ by a zwitterion, active site residues around the zwitterion are the potential 
“hot spots” for switching substrate selectivity. Therefore, nine residues within 5 Å of the zwitterion 
of I-Tyr in its co-crystal structure with HhIYD (PDB: 5KO8)32 were redesigned to stabilize a target 
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model of HhIYD•2IP (Figure 3-1). The number of independent designs was increased from 100 
used in HsIYD redesign to 10000 for HhIYD redesign as an attempt to further enlarge the sequence 
space for Rosetta to sample. 
 
Figure 3-1 Computational model of HhIYD and 2IP with the active site lid closed generated by 
Rosetta.53 The two monomers of HhIYD is colored with green and cyan respectively. 2IP and FMN 
are shown as yellow and orange sticks respectively. Residues (gray) within 5 Å of the zwitterion 
of I-Tyr in its co-crystal structure with HhIYD were varied by Rosetta.  
 
Such effort, however, did not seem to greatly increase the variability in the designed 
sequences. Except for M99 and W103, sequences at other seven positions of the total 10000 
independent designs converged into one or two amino acid substitutions (Appendix Figure B1). 
Such high level of convergence still holds when the 10000 designs were narrowed down to ten after 
applying filters based on the ability of the lid to refold into the desired structure and to stabilize 2IP 
binding (forward folding and ligand docking simulations, see Materials and Methods for details), 
total Rosetta energy and packing around 2IP (Figure 3-2). Interestingly, bulky, hydrophobic 
substitutions were overwhelmingly favored in both top five designs with the highest total energy 
(BS1-5, ranked by descending order in total energy) and the top five designs with the tightest 
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packing around 2IP (BF1-5, ranked by descending order in total energy). Such a bias towards large 
hydrophobic amino acids is expected as they can favorably interact with 2IP’s hydrophobic edge 
and fill the cavity in the active site created by the absence of the zwitterion of I-Tyr (Figure 3-1). 
However, this contradicts the results of the previous redesign of HsIYD (Section 2.3.5). 
Hydrophobic substitutions were exclusively disfavored at position E157 (E91 in HhIYD) of the 
HsIYD variant DM01 due to the disruption of polar interactions between E157 and nearby N160 
and K180 (N94 and K116 in HhIYD).60 While N94 in HhIYD was not subject to redesign, E94 and 
K116 were always co-mutated in HhIYD variants. Therefore, the polar interaction network in the 
active site of wildtype enzyme could be substituted with a hydrophobic interaction network in the 
variants to achieve stabilization of the lid structure and favor the binding of substrates more 
hydrophobic than I-Tyr. Three of the top five designs in total energy and four of the top five designs 
in active site packing represented the greatest sequence variability among each group and were 
selected for experimental characterization. 
 
Figure 3-2 Sequence of HhIYD and its variants generated by redesigning selected positions. 
Conserved residues within the subgroup of best total energy (BS1-5) and best packing around 2IP 
(BF1-5) are labeled with dash (-).Designs selected for experimental characterization are highlighted 




The seven selected variants were all successfully expressed and purified as soluble proteins 
with a yield ~2-fold less than that of HhIYD (~15 mg/L culture) (Appendix Figure B2). The 
enzymes were partially purified for the purpose of initial activity screening and the presence of 
contaminating proteins would not interfere with quantification of IYD since its concentration was 
determined by enzyme-bound FMN. Deiodination of 2IP was measured by the same HPLC assay 
described in Section2.2.5 with 25 µM and 250 µM 2IP. Neither the variants nor HhIYD had 
measurable activity with 25 µM 2IP (no larger than 0.004 min-1-the detection limit which is three 
time the background of the assay). With 250 µM 2IP, only BF4 showed 2-fold higher deiodination 
activity compared to that of HhIYD while all the other designs failed to improve the activity (Figure 
3-3). The largest activity increase with these variants is still ~2.5-fold smaller than that of the most 
activity HsIYD variants (UD08 and TM01).60 Therefore, redesign of HhIYD residues near the 
hydrophobic edge of 2IP is not a robust approach to enhance the 2IP deiodination of HhIYD. 
 
Figure 3-3 2IP deiodination activity of HhIYD and its variants generated by redesign at 9 selected 
positions. The activity was measured with 250 µM 2IP. The V/[E] represent the average of two 
independent measurements. The error is either the range of two independent measurements or three 




The result of fixed backbone design of HhIYD again contradicted our intuition of 
promoting enzyme•2IP interactions and stabilizing the closed lid with hydrophobic force. Without 
I-Tyr, the lid of HhIYD is highly flexible as indicated by the lack of electron density for the lid in 
the crystal structure.32 The closed conformation of the lid, despite being highly structured, is 
actually not a thermodynamically favorable conformation in the absence of ligand. The interactions 
between the zwitterion and the recognition triad (Glu, Tyr, Lys) likely overcome the 
thermodynamic barrier of the open-to-close transition of the lid. Hydrophobic interactions, on the 
other hand, may not be strong enough to support such transition. Since the intrinsic disorder of the 
wildtype lid is difficult to maneuver, it might be easier to redesign sequences stabilizing a shorter 
and more rigid loop that can also hold 2IP in the desired conformation in the active site. 
3.3.2 HhIYD variants with remodeled lids failed to support 2IP deiodination:1 
Removing restrictions on backbone conformation allows Rosetta to sample a substantially 
larger sequence and conformation space and generate alternative loops that may confer the desired 
non-native activity.45,47 On the other hand, such an approach is more risky than fixed backbone 
design since it might induce large conformational changes of the protein and as a result destabilize 
the enzyme as a whole. Remodeling the lid of HhIYD seems promising since members of the nitro-
FMN reductase superfamily including IYD all share a structurally similar dimeric core but have 
different loops around their active sites to confer diverse catalytic activity and substrate selectivity 
(Section 1.4 and Figure 1-2).29,34 In addition, a variant of HsIYD with the active site lid and a nearby 
flexible loop truncated was successfully expressed as soluble protein (Appendix Figure B3). The 
yield of this variant was ~ 4-fold less than that of the wildtype enzyme (typically ~ 9 mg/L culture) 
and its FMN occupancy was only ~ 50% (typically ~ 100% for the wildtype enzyme). The variant 
showed no quenching of its fluorescence with up to 10 mM 2IP and no deiodination activity with 
                                                          
1 The cloning and characterization of the 15-mer loop remodeling design J3736 were performed by Shaun Spisak 
(Johns Hopkins University) and Zuodong Sun. 
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2IP between 20 µM and 5 mM (no larger than 0.004 min-1-the detection limit which is three time 
the background of the assay). Despite that this variant is a totally inactive 2IP deiodinase, it 
demonstrated the stability of the dimeric core of IYD on its own without the presence of the active 
site lid. Therefore, the active site lid of structurally similar HhIYD is likely to be remodeled without 
necessarily impairing the overall stability of the enzyme. 
The remodeling of the lid started with substituting the entire lid with loop segments of 
different sizes from PDB via a loophash method.98 Only loops shorter than the original lid (20 
amino acids) were considered since a shorter loop is likely to be more rigid and generally easier to 
be modeled accurately.102 However, the loop must be long enough to form a lid which can position 
2IP in the active site and exclude bulk solvent. Therefore, loops of 15 and 16 amino acids were 
chosen as initial attempts to balance these factors. The sequence of the remodeled lid was then 
optimized by the standard Rosetta Design protocol.65 The final outputs were filtered by the ability 
of the lid to refold into the desired structure and to stabilize 2IP binding (forward folding and ligand 
docking simulations) and by the solvent accessible area of the overall protein and 2IP to assess 
packing of the lid. Of the 50,000 independent 15-mer loop remodeling variants generated, only one 
survived all the filtering criteria. Therefore, more non-optimized solutions than the fixed backbone 
approach might be sampled by the loop remodeling approach, despite that it allows Rosetta to 
sample a much larger sequence and conformational space. 
The new lid of this sole 15-mer variant J3736 is predicted to have a helix-loop structure as 
shown in Figure 3-4 (see Appendix Figure B4 for sequences). The residues of J3736 near the non-
polar edge of 2IP are more hydrophobic compared to those in HsIYD. Such a preference for 
hydrophobic residues again makes intuitive sense but failed to promote 2IP deiodination when 
applied on the backbone of the native lid. The variant expressed and generated soluble proteins 
with a yield (~ 10 mg/L culture) comparable to that of the HhIYD and a FMN occupancy of ~ 96%, 
which demonstrated that the lid remodeling did not affect the global stability of the enzyme nor the 
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binding of FMN. The binding affinity of 2IP to J3736 was measured by the same fluorescence 
quenching assay. The dissociation constant Kd of 2IP to J3736 was estimated to be 149 ± 9 µM and 
represented a 2.2-fold increase compared to that to HhIYD (67 ± 2 µM).32 Despite that J3736 is 
able to bind 2IP tighter than any of the previously studied HsIYD variants in Chapter 2, it did not 
exhibit any deiodination activity (no larger than the detection limit of the assay, 0.004 min-1) with 
2IP concentrations from 25 µM to 5 mM. The result again echoes the previous finding that binding 







































Figure 3-4 Computational models of 
HhIYD•2IP and the 15-mer loop 
remodeling variant J3736•2IP generated 
by Rosetta. (A) Overlay of the two 
models. The monomeric units of the 
enzyme were colored with green and 
cyan. FMN and 2IP are shown in orange 
and yellow, respectively. The active site 
lid of HhIYD and the remodeled lid of 
J3736 were shown in blue and magenta, 
respectively. (B) Residues (gray) 
surrounding 2IP’s hydrophobic aromatic 
ring in J3736. (C) Residues (gray) 
surrounding 2IP’s hydrophobic aromatic 




















Six 16-mer loop remodeling designs were subsequently selected from 50,000 independent 
designs by criteria similar to those for the 15-mer designs. The six designs can be categorized into 
three groups based on their predicted structures. Designs 0609, 0479, and 4354 are all predicted to 
fold into the same conformation (Figure 3-5(A)). Design 0039 has a unique structure that packs 
most tightly around 2IP by visual inspection (Figure 3-5(B), also Appendix Figure B6). Designs 
1719 and 3654 are structurally very similar to the 15-mer design J3736 (Figure 3-5(C) and (D)). 
All six variants were expressed well as soluble proteins with yields between 10 and 20 mg/L culture. 
FMN was invariably incorporated into the variants but the occupancy could not be determined since 
the variants were only partially purified and their 280 nm absorption would be biased by 
contaminating proteins. Unfortunately no measurable deiodination activity (no larger than 0.004 
min-1, the detection limit) was found for any of the 16-mer variants with both 250 μM and 2.5 mM 





Figure 3-5 Computational models of HhIYD•2IP and the 16-mer loop remodeling variants 
generated by Rosetta.53 (A) Overlay of HhIYD•2IP and designs 0609, 0479, and 4354 with 2IP. 
The monomeric units of the enzyme were colored with green and cyan. FMN and 2IP are shown in 
orange and yellow, respectively. The active site lid of HhIYD and the remodeled lids of 0609, 0479, 
and 4354 were shown in blue and magenta, respectively. (B) Overlay of HhIYD•2IP and design 
0039•2IP. The active site lid of HhIYD and the remodeled lids of 0039 were shown in blue and 
pink, respectively. (C) Overlay of HhIYD•2IP and designs 1719 and 3654 with 2IP. The active site 
lid of HhIYD and the remodeled lids of 1719 and 3654 were shown in blue, red, and gray, 
respectively. (D) Overlay of designs 1719, 3654, and J3736 with 2IP. The remodeled lids of 1719, 
3654, and J3736 were shown in red, gray, and black, respectively.  
3.3.3 The remodeled lids of HhIYD variants were more structured than the native lid in the 
absence or presence of 2IP: 
 
As shown in Section 2.3.6, the lid of UD08, a successful design of HsIYD improved 2IP 
deiodination, demonstrated a disorder-to-order transition upon 2IP binding.60 In contrast, the lid of 
a failed design GD02 was not responsive to 2IP. The lids of selected loop remodeling variants were 
analyzed similarly to probe whether or not the conformations of their remodeled lids are responsible 
for the impaired activity of the variants. In the absence of 2IP, more than 90% of HhIYD (5 μg) 
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was digested within 30 min by 50 ng of trypsin (Figure 3-6(A)) into two major and many minor 
peptides (shown as two discrete bands in a smear less than 15 kD on SDS-PAGE). However, even 
ten times more trypsin failed to cleave 5 μg J3736 after 1 hour of digestion (Figure 3-6(B)). 
Increasing trypsin concentration further by 100 and 1000 times only resulted in minor digestion of 
J3736. HhIYD and J3736 only differ by their lids and both of their lids have one trypsin digestion 
site (an Arg, Appendix Figure B5(A) and (B)). Therefore, the ultra-stability of J3736 over HhIYD 
cannot be explained by a lack of trypsin digestion site. The lid of J3736 most likely has a very rigid 
conformation that resists trypsin digestion even in the absence of 2IP.60,93 
 
Figure 3-6 Trypsin digestion of HhIYD and J3736 in the absence of 2IP analyzed by SDS-PAGE. 
(A) Trypsin digestion of HhIYD overtime. The mass ratio of HhIYD to trypsin was 50:1. (B) J3736 
digested by different amounts of trypsin. The digestion time in all cases were 1 hour.  
Design 0039, the 16-mer loop remodeling variant with the tightest packing around 2IP by 
visual inspection (Appendix Figure B6), was then digested by trypsin with HhIYD as a control in 
the absence and presence of 2IP (Appendix Figure B7). The remaining parent protein overtime was 
fit into a first-order decay from which the half-life of the parent protein was derived (Figure 3-7). 
The half-life of ligand free 0039 was ~ 2-fold smaller than that of HhIYD, which suggested that the 
new lid in 0039 was actually more accessible to trypsin than the native lid in HhIYD. This could 
be a result of greater conformational flexibility of the new lid in the absence of 2IP. However, the 
greater accessibility of 0039 to trypsin can also be explained by the increased number of digestion 
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sites from 1 in the lid of HhIYD to 3 in the lid of 0039 (Appendix Figure B5(C)). The presence of 
2IP slowed the trypsin digestion of HhIYD by ~ 2-fold (Figure 3-7). This decrease in digestion rate 
is just a bit more than the inhibitory effect of 2IP on the innate proteolytic activity of trypsin (1.3-
fold, Appendix Figure A12). Therefore, 2IP did not significantly increased the trypsin resistance 
of HhIYD by inducing its active site lid to be more structured. This is also consistent with the lack 
of electron density for the lid of HhIYD in the co-crystal structure with 2IP.32 The new lid of 0039, 
however, gained 5-fold more protection in the presence of 2IP (Figure 3-7), which is significant 
compared to the simple inhibitory effect of 2IP on trypsin. Therefore, such a gain in protection for 
0039 indicates that its lid is induced by 2IP to gain more structure and as a result is less accessible 
to trypsin. 
 
Figure 3-7 The first order decay of the undigested protein in limited proteolysis. The solid lines 
represent the fitting of remaining HhIYD over time by first order decay kinetics. The dashed lines 
represent the fitting of remaining 0039 over time by first order decay kinetics. Each data point is a 




In the lid remodeling approach, Rosetta was instructed to replace the native lid of HhIYD 
with a shorter loop in hope to gain more structure to support 2IP binding. The remodeled lid of the 
15-mer design J3736 is indeed much more rigid even in the absence of 2IP. Such structural rigidity, 
however, did not block the entrance of 2IP to the active site since 2IP can still bind to J3736, albeit 
~3-fold less tightly than to HhIYD. Moreover, the remodeled lid of the 16-mer design 0039 is able 
to gain structure in response to 2IP, resembling the lid of native HsIYD responding to I-Tyr and 
the redesigned lid of HsIYD variant UD08 responding to 2IP.60 The gain in trypsin protection of 
0039’s lid with 2IP is only 2-fold less than that of UD08’s lid with 2IP. Yet 0039 has no measurable 
activity with 2IP while UD08 improved 2IP deiodination of HsIYD by 4.5-fold. Therefore, the 
result again highlight the ability of Rosetta to create a lid that undergoes a disorder-to-order 
transition in the presence of 2IP even when the conformation of the new lid is completely different 
from that of the native lid. The failure of the loop remodeling designs to promote 2IP deiodination 
is likely not due to a lack of responsiveness to 2IP for the remodeled lids. When the 15-mer loop 
remodeling variant J3736 was analyzed by ligand docking for its ability to bind 2IP in the target 
conformation expected for catalysis, multiple alternative conformations of 2IP which deviated from 
the target conformation were stabilized in low energy enzyme•2IP complexes (Figure 3-8). The 
result might suggest that the remodeled lid was able to stabilize 2IP conformations that were not 
productive. This phenomenon is not specific to this one variant but is ubiquitous to all variants 
generated by fixed backbone design and loop remodeling of HhIYD, which may again explain the 
low activity of HhIYD variants towards 2IP. It is possible to promote the dehalogenation of 
halophenols by creating specific enzyme-substrate interactions to stabilize the productive 
conformation. Since the results of HsIYD and HhIYD engineering demonstrated ineffectiveness of 
hydrophobic interactions to promote enzyme•2IP interactions, future design should focus on 
designing polar enzyme-substrate interactions to stabilize the productive conformation. This is 
difficult for 2IP which does not have many functional groups to support polar interactions. 
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Bromohydroquinone, the brominated analog of 2IP with a hydroxyl group at the para-position, is 
potentially a better model compound than 2IP to facilitate the design of more efficient substrate 
recognition via its additional hydroxyl group. 
 
Figure 3-8 Deviation of alternative conformations of 2IP from the target conformation detected in 
ligand docking of the 15-mer loop remodeling variant J3736. (A) Conformation of 2IP in J3736 
and target conformation of 2IP in the starting HhIYD•2IP complex superimposes with each other. 
(B) Alternative conformations of 2IP in J3736 deviates from the target conformation of 2IP in the 
starting HhIYD•2IP complex. The carbons in 2IP in the target conformation is colored blue while 
those in the alternative conformations are colored green. Oxygen and iodine atoms were colored 
red and purple, respectively. 
 
3.4 Summary: 
In this chapter, HhIYD was redesigned to support 2IP deiodination by two computational 
approaches. These approaches aimed at enlarging the sequence and conformational space compared 
to that used in the redesign HsIYD described in Chapter 2. The first approach focused on just 9 
residues around the zwitterion of I-Tyr in its co-crystal structure with HhIYD. The number of 
independent designs were also increased by 100-fold compared to that in the fixed backbone design 
of HsIYD to further increase sampling of the sequence space. The most active variant towards 2IP 
generated by this approach, however, was only 2-fold faster than the HhIYD. The second design 
approach was subsequently explored to replace the native lid with shorter loops from the PDB that 
can potentially form a more structured lid upon binding of 2IP. Variants with remodeled lids of 15 
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and 16 amino acids rather than the native length of 20 showed many desired properties such as the 
ability to bind 2IP (despite weaker than the wildtype), to form a much more rigid lid than that of 
the native enzyme in the absence of 2IP, and to form a lid that can gain structure upon 2IP binding. 
However, none of the loop remodeling variants exhibited measurable activity towards 2IP. 
Similarly as in engineering of HsIYD (Section 2.3.6), Rosetta once again demonstrated success in 
altering the responsiveness of the active site lid of IYD from I-Tyr to 2IP via the lid remodeling 
approach. However, the target model of IYD•2IP stabilized by Rosetta was derived from the crystal 
structure of catalytically inactive oxidized IYD and might not lead to productive deiodination as 
expected. Better guidance for designing a halophenol dehalogenase from IYD might be obtained 


















Chapter 4 Structural and functional analysis of IYD from 




The efforts of engineering IYD towards a halophenol dehalogenase via computational 
design so far produced limited success in improving IYD’s activity with the model compound 2IP. 
However, computational design via Rosetta did demonstrated the ability to stabilize a compact 
conformation of IYD’s active site lid with 2IP bound. This active site conformation is derived from 
the co-crystal structure of IYD with fully oxidized FMN and I-Tyr and is the best model available. 
However, it is the fully reduced, not the oxidized, FMN cofactor that supports deiodination. 
Therefore, the model used previously for IYD•2IP complex might not be productive. The structural 
information of the fully reduced IYD is needed to uncover possible enzyme-substrate interactions 
that support active deiodination. 
Obtaining such structural information is challenging since the fully reduced FMN is very 
sensitive to oxygen. As a result, crystals containing fully reduced FMN need to be generated and 
handled under absolutely anaerobic environments. Previous efforts using sodium dithionite to 
reduce the pre-grown co-crystals of HsIYD or HhIYD containing the oxidized FMN and an inactive 
substrate analog F-Tyr failed as the crystals quickly melted.50 One additional disadvantage of using 
previously crystallized IYDs to obtain the reduced structure is that all structures of oxidized IYD 
obtained so far are mid-resolution (2-3 Å). Although pronounced conformational differences have 
been observed between oxidized flavoproteins and their fully reduced counterparts,107,108 in many 
other cases reduction of the flavin cofactor does not change the conformation of the flavoprotein to 
a significant extent.109,110 If the differences between the oxidized and reduced structures of IYD are 
subtle, mid-resolution structures will likely not be able to capture them. 
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One way to potentially improve the quality of protein crystals is to increase the 
thermostability of the protein being crystallized.111 Certain thermophilic bacteria and archaea were 
found to contain IYD homologs in their genome.29 Representatives from the themophilic bacteria 
Thermotoga neapolitana (TnIYD) and archaea Pyrococcus furiosus (PfIYD) were characterized 
preliminarily and the results suggested that they could indeed deiodinate I2-Tyr at 25 °C and, with 
a higher activity, at 60 °C.112,113 While most signature residues conserved in mesophilic IYDs are 
also present in thermophilic IYDs such as the zwitterion recognition triad and a threonine hydrogen 
bonding to the N5 of FMN modulating its one-electron chemistry, there are marked differences 
between the two groups (Figure 4-1(A)).29 First, the active site lid of thermophilic IYDs is one 
amino acid short than that of mesophilic IYDs, suggesting that the conformation of the lid might 
be slightly different in thermophilic IYDs. In addition, a loop near the active site (Appendix Figure 
B3(A)) where the halogen atom of the substrate is positioned in all mesophilic IYDs are completely 
missing for thermophilic IYDs. This loop is unstructured in ligand free HsIYD and MmIYD but 
folds into a hairpin like structure when I-Tyr is bound.31,33 In HhIYD, the loop is structured even in 
the absence of ligand.32 Finally, all mesophilic IYDs have N- or C-terminal extensions of various 
lengths (Figure 4-1(B)) compared to thermophilic IYDs. These N-terminal extensions typically 
include a membrane association domain (not present in certain invertebrates and lower organisms) 
and an intermediate domain.29 Although the functions of the loop near the active site and the 
intermediate domain are still not clear, they are not absolute requirements for catalysis as 
thermophilic IYDs can still function as deiodinases without them. Therefore, thermophilic IYDs 





Figure 4-1 Sequence comparison of IYD homologs. (A) Sequence alignment of the catalytic 
domains of IYD homologs. The percent amino acid identical to human IYD is indicated in 
parenthesis following the name of the organism. Sequence numbers of each homologs are given on 
both sides of the alignment. Secondary structure elements (on top of the sequences) are derived 
from the co-crystal structure of HsIYD and I-Tyr bound (PDB ID: 4TTC).31 The active site lid and 
the nearby flexible loop are enclosed by solid squares. Conserved residues are colored red. IYD’s 
signature sequence elements, Glu157, Y161, K182, and T239, are indicated by red sharing and a 
star on top of the sequence. (B) The domain representation of IYD homologs. The membrane 
association of lancelet IYDs is species dependent as a homolog from Branchiostoma belcheri is 
predicted to have a membrane anchor but one from Branchiostoma floridae is not. Both figures are 
originally published in Sun, Z,; Su, Q.; Rokita, S. E.29  
 
Thermophilic IYDs are also good starting points for engineering IYD towards a halophenol 
dehalogenase. The thermostability of thermophilic IYDs may tolerate more structurally deleterious 
but functionally beneficial mutations than their mesophilic counterparts.114 In addition, 
thermophilic enzymes are typically more stable to proteolysis and organic solvents, which may 
allow thermophilic IYDs to better tolerant the harsh environment at contaminated sites of 
halophenols when used as extra-celluar enzymes.115 Detailed structural and functional analysis of 
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thermophilic IYDs was the first step towards utilization of their potentials for the bioremediation 
of halophenols. 
In this chapter, the characterization of TnIYD as a representative of thermophilic IYDs was 
described. Overexpressed TnIYD was purified from E. coli cells in its semiquinone form. Free Tyr 
was discovered to bind TnIYD tightly and stabilize its semiquinone form. The activity of TnIYD 
at 25 °C already rivaled that of mesophilic IYDs and increased further at 60 ºC as expected. Co-
crystal structures of oxidized and semiquinone TnIYD with I-Tyr, F-Tyr, and Tyr were determined 
and the results suggested overall similarity in the enzyme architecture and the active site binding 
of the ligands between TnIYD and mesophilic IYDs. An additional binding site for I-Tyr besides 
the two active sites was observed on the surface of TnIYD. This additional binding of I-Tyr to the 
enzyme-substrate complex is likely to be the molecular basis for its severe substrate inhibition of 
activity. 
4.2 Materials and methods: 
4.2.1 Cloning: 
The original plasmid pET28 encoding TnIYD was a generous gift from Dr. Janine Copp 
(University of British Columbia, Vancouver). TnIYD from this plasmid was then subcloned into a 
pET24(a) vector (Novagen) via restriction sites NdeI and XhoI introduced by PCR. Both restriction 
enzymes were purchased from New England Biolabs. A C-terminal (His)6 tag was then added to 
the TnIYD sequence by site directed mutagenesis to facilitate purification.69,70 The resulting 
construct encoding TnIYD with the C-terminal (His)6 tag was used for all subsequent studies. The 
TnIYD variant Y112A was constructed via site directed mutagenesis.69,70 The flavin reductase Fre 
from E. coli was amplified from E. coli genome (Genehogs, Invitrogen) with a C-terminal (His)6 
tag and cloned into pET24a vector via overlap extension PCR.106 
All DNA oligonucleotides used for cloning were synthesized by IDT and Sigma (see 
Appendix Table C1 for a list of oligonucleotides). PCR was performed with Phusion High-Fidelity 
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DNA polymerase (Thermo Fisher Scientific). The DNA sequences of all variants were verified by 
Sanger sequencing (Genewiz). 
4.2.2 Protein expression and purification: 
TnIYD, its variant Y112A, and flavin reductase Fre from E. coli were heterologously 
expressed as described in 2.2.3. TnIYD with Tyr bound (greenish yellow TnIYD) was purified as 
follows. Frozen cell pellets from 500 mL culture (~ 4g) were thawed at room temperature and 
resuspended in ~ 25 mL cell lysis buffer (50 mM sodium phosphate, 500 mM sodium chloride, 10% 
glycerol, 25 mM imidazole, 0.5 mM TCEP, pH 8.0) by vortex. From then on, all procedures were 
done at 4 ºC unless otherwise noted. FMN was added to the suspension to a final concentration of 
~ 300 µM to enhance the occupancy of the cofactor. Cells were then lysed by an EmulsiFlex-C3 
homogenizer (Avestin) with 3 passes at ~17000 psi. Cell debris was removed by centrifugation at 
45000×g for 30 min. The supernatant was mixed with 3 mL of Ni-NTA resin (Thermo Fisher 
Scientific, pre-equilibrated with 10 column volumes of cell lysis buffer) in a gravity column by a 
rotary shaker for 30 min. The column was then washed with 10 column volume of cell lysis buffer. 
Finally, the His-tagged protein was eluted with 4 column volumes of elution buffer (50 mM sodium 
phosphate, 500 mM sodium chloride, 10% glycerol, 250 mM imidazole, 0.5 mM TCEP, pH 8.0). 
The eluted proteins were then supplied with ~300 µM FMN and incubated on ice overnight to 
further increase the FMN occupancy. The proteins were further purified by a gel filtration column 
(Sephacryl S-200HR, GE Healthcare) equilibrated with storage buffer (100 mM sodium chloride, 
50 mM sodium phosphate, pH 7.4, 1mM TCEP, and 10% glycerol). The purified enzymes were 
then concentrated with a 30 kD molecular weight cut off centrifugal filter unit (Amicon), aliquoted, 
flash-frozen with liquid nitrogen, and stored at -80 °C. 
TnIYD and the Y112A variant free of bound Tyr were purified similarly as Tyr bound 
proteins except for the following modifications. After centrifugation of cell lysate, the supernatant 
was mixed with 5 mL of Ni-NTA resin (Thermo Fisher Scientific, pre-equilibrated with 10 column 
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volumes of cell lysis buffer) by a bench top Econo pump (Bio-rad) at a flow rate of 1 mL/min. The 
column was then washed with 1 column volume of cell lysis buffer followed by 4 column volumes 
of cell lysis buffer supplemented with sodium dithionite (2% final, technical grade, Sigma-Aldrich) 
with the same Econo pump and flow rate. The column was then washed extensively with 16 column 
volumes of air saturated washing buffer (50 mM sodium phosphate, 500 mM sodium chloride, 10% 
glycerol, 60 mM imidazole, 0.5 mM TCEP, pH 8.0) using an ÄKTA protein purification system 
(GE Healthcare) at 1 mL/min before elution. After supplemented with ~300 µM FMN on ice for 1 
hr, the proteins were exchanged into storage buffer using a gravity driven PD-10 desalting column 
(GE healthcare) following manufactures’ instructions. 
TnIYD used for crystallography was purified similarly as the Tyr free enzyme except for 
the following modifications. Once the cell lysate were loaded onto the Ni-NTA column, no 
dithionite treatment was applied. Instead, the column was directly washed with 16 column volumes 
of cell lysis buffer and 16 column volumes of washing buffer by the same ÄKTA protein 
purification system at 1 mL/min. The proteins eluted from the Ni-NTA column was concentrated 
to 1 mL and incubated with ~300 µM FMN on ice overnight before further purified by a gel 
filtration column similarly as above. The proteins eluted from the gel filtration column were then 
supplemented with ~300 µM FMN on ice for 1 hr before exchanged into crystallization buffer (10 
mM Tris, 100 mM sodium chloride, pH 7.4). This protein was then concentrated to ~ 20 mg/mL 
and stored on ice without freezing. 
The flavin reductase Fre was purified similarly as TnIYD used for crystallography. 
However, no FMN was added to the lysate since Fre does not use flavin as a cofactor. In addition, 
a gel filtration column was not performed for Fre purification and Fre eluted from Ni-NTA column 
was directly buffer exchanged into storage buffer via a gravity driven PD-10 desalting column (GE 
healthcare) following manufactures’ instructions. 
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The purified enzymes were analyzed by 12% SDS-PAGE with Comassie brilliant blue 
staining. Protein concentration and FMN occupancy were determined similarly via UV-vis as 
described in Section 3.2.3. 
4.2.3 Identification of the ligand in TnIYD expressed and purified from E. coli: 
The greenish yellow form of TnIYD (40 μM) was prepared in a 1:1 solution of water and 
storage buffer (as mentioned above) supplemented with 4.4% formic acid. This solution was 
incubated at room temperature for 5 min before centrifugation at 14000×g for 5 min. The 
supernatant (200 μL) was analyzed by a Jasco HPLC system with two PU-980 Intelligent pumps 
and a MD-1510 photo-diode array detector. The solvent gradient used was listed in Appendix Table 
C2. The same HPLC protocol was used to analyze the ligand free enzyme as well. A hydrophilic 
species identified from the analysis of the greenish yellow form of TnIYD was collected from 
HPLC and evaporated to dryness under vacuum (Savant Speed Vac, SC100A). The residues were 
reconstituted with 120 μL water and the sample was analyzed by a Waters Acquity/XevoG2 
UHPLC-MS system. Small molecules were separated using an Acquity UPLC® HSS T3 column 
(100 Å, 1.8 μm, 2.1 mm×100 mm) and a binary mobile phase of water (A) and acetonitrile (B) with 
0.1% v/v formic acid in each at a flow rate of 0.3 mL/min. The 10 min separation gradient started 
with mobile phase B at 0% (0 min) which was then increased to 5% B (0-1 min), then 60% B (1-7 
min), then 95% B (7-7.1 min), then held at 95% (7.1-9 min), then decreased to 0% (9-9.1 min), and 
finally re-equilibrated with system at 0% (9.1-10 min). The column was held at 35 ºC. The positive 
electrospray ionization mode was used for the MS detection of small molecules. The capillary 
voltage, sampling cone and extraction cone were set to 3 kV, 40 V, and 4 V, respectively and the 
source temperature was 130 ºC. The desolvation gas tempearature and flow rate were 400 ºC and 





4.2.4 Reduction of TnIYD and air re-oxidation monitored by UV-vis spectroscopy: 
All reduction and re-oxidation assays were performed under aerobic conditions and room 
temperature (25 ± 1 °C) unless otherwise stated. Ligand free TnIYD (40 μM) and Tyr (68 μM) 
were incubated in 110 mM potassium phosphate, 220 mM potassium chloride, pH 7.4 for 5 min in 
an UV-vis cuvette at room temperature. Sodium dithionite (1%) in 5% sodium bicarbonate was 
then added to the cuvette to reach a final concentration of 3.3 mM (estimated from the weighed 
mass). The subsequent air re-oxidation was performed by pipetting the solution in the cuvette up 
and down until the colorless solution turned purple (in the presence of Tyr) or yellow (in the 
absence of Tyr). Reduction and re-oxidation of TnIYD in the absence of Tyr was performed 
similarly. The UV-vis spectra of the oxidized, fully reduced, and the re-oxidized TnIYD were 
recorded by a Hewlett Packard 8453 Diode-Array Spectrophotometer. 
Reduction of TnIYD by free reduced FMN generated by E. coli flavin reductase Fre was 
carried out by adding 10 μM Fre to a mixture of 25 μM TnIYD, 60 μM Tyr, 300 μM FMN, and 1 
mM NADH in 100 mM potassium phosphate, 200 mM potassium chloride, pH 7.4. The reduction 
of TnIYD was monitored by following the absorbance increase at 590 nm for TnIYD semiquinone. 
Anaerobic reduction of TnIYD by free reduced FMN generated by dithionite was carried 
out in a gas tight cuvette sealed with a septum. A solution of 90 μM FMN and 60 μM Tyr in 100 
mM potassium phosphate, 200 mM potassium chloride, pH 7.4 was deoxygenated by bubbling Ar 
for 20 min. The FMN was then quantitatively reduced by 5% dithionite in 5% sodium bicarbonate 
introduced with a gas tight syringe. The reduction of FMN was monitored by the decrease of 
absorbance of oxidized FMN at 450 nm. To ensure that there was no excess dithionite, oxygenated 
buffer was added to the cuvette to oxidize ~ 20 μM FMN. TnIYD (30 μM, oxygenated) was then 





4.2.5 Deiodination activity assay: 
The deiodination activity of E. coli cell lysate containing overexpressed TnIYD was 
measured as follows. A cell pellet from 500 mL culture was resuspended in ~ 25 mL cell lysis 
buffer (50 mM sodium phosphate, 500 mM sodium chloride, 10% glycerol, 25 mM imidazole, 0.5 
mM TCEP, pH 8.0) by vortex. Cells were then lysed by an EmulsiFlex-C3 homogenizer (Avestin) 
with 3 passes at ~17000 psi. Cell debris was removed by centrifugation at 45000×g for 30 min. 100 
μL of the supernatant was added to 900 μL 220 mM potassium chloride, 110 mM potassium 
phosphate, pH 7.4 containing 20 μM I-Tyr and 300 μM FMN (not included when dithionite was 
used as the reductant). The concentration of TnIYD in the final mixture was estimated to be ~ 1 
μM based on the typical yield of TnIYD after purification. The reaction was incubated at 25ºC for 
5 min and subsequently initiated by 100 μL of 1 mM NADH or 100 μL of 5% sodium dithionite in 
5% sodium bicarbonate. After 1 hour, the reaction was quenched by 100 uL of a 1:1 mixture of 88% 
formic acid and 0.55 µM Cl-Tyr (as an internal standard) in the above pH 7.4 buffer. The reaction 
was heated at 60 ºC for 2 min and centrifuged at 14000×g for 5 min to pellet precipitated proteins. 
The supernatant was then analyzed by HPLC with the same protocol described in Section 2.2.5. 
Instead of the formation of Tyr, however, the activity was monitored by the consumption of the 
substrate I-Tyr since unknown species derived from NADH co-elutes with Tyr. 
The deiodination activity of purified TnIYD with I-Tyr and Cl-Tyr at 25 ºC was performed 
as follows: I-Tyr or Cl-Tyr (0.5-100 μM) in 900 μL of 220 mM potassium chloride, 110 mM 
potassium phosphate, pH 7.4 was incubated at 25 ± 1 °C for 5 min. Sodium dithionite (5%, 100 μL) 
in 5% sodium bicarbonate containing TnIYD (25 to 200 nM in 1 mL final reaction) was then added 
to the I-Tyr solution to initiate catalysis. The reaction was quenched by 50 μL 0.44% formic acid 
and then incubated at 60 ºC for 2 min to ensure the decomposition of dithionite (white precipitations 
were generated from the decomposition which is likely elemental sulfur).116 Cl-Tyr (when I-Tyr as 
substrate) or I-Tyr (when Cl-Tyr as substrate) as an internal standard (50 μL of 0.1 mM in 10 M 
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sodium hydroxide) was added to the reaction to neutralize the formic acid. The neutralized reaction 
was then centrifuged at 14000×g for 5 min and the supernatant was analyzed by a Jasco HPLC 
system with two PU-980 Intelligent pumps and a multiwavelength detector. The product of the 
reaction-Tyr was separated on a C18 reverse phase column (Agilent, Microsorb-MV 300 C18, 250 
× 4.6 mm) by a gradient of 10 mM potassium phosphate pH 6.6 and acetonitrile at a flow rate of 1 
mL/min and detected at 275 nm. See Appendix Table C3 for the detailed solvent gradients. Rates 
with ≤ 2 μM I-Tyr were measured via following substrate consumption at 280 nm which was ~5 
fold more sensitive than following product formation at 275 nm. The deiodination activity of 
purified TnIYD with I-Tyr at 60 ºC was measured with the same protocol above with the following 
modifications. The formation of Tyr was detected via fluorescence on an Agilent 1100 series HPLC 
equipped with a 1200 series fluorescence detector (λex = 275 nm and λem = 312 nm). Since TnIYD 
exhibited severe substrate inhibition with I-Tyr and Cl-Tyr, the trace of activity verses substrate 
concentration was fitted into Equation 4-1 for substrate inhibition kinetics to obtain kcat, KM, and 
Ki.117 
 
2IP deiodination at both 25 and 60 ºC was measured with the same protocol in Section 
2.2.5. V/[E] versus substrate concentration was fitted with Michaelis-Menton equation to obtain 
kcat and KM. 
4.2.6 Crystallization and structure determination: 
Crystallization and structure determination of TnIYD with various ligands were performed 
in collaboration with Prof. Jennifer Kavran (Johns Hopkins University). Crystallization conditions 
were determined using commercially available screens with a Phoenix robot. CrystalMation Intelli-
Plate 96-3 low-profile plates (Hampton research) were used for initial screening and EasyXtal 15-
Well Tool X-Seal plates were used for optimization. Complexes between TnIYD and ligands 
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were formed by incubating approximately 10 mg/mL of purified TnIYD with 2-3-fold molar excess 
of either I-Tyr, Tyr, or F-Tyr in 10 mM Tris, 100 mM sodium chloride, pH 7.4 for three hours at 
4 °C. Crystals were grown by hanging-drop vapor diffusion by mixing a 1:1 or 2:1 ratio of complex 
to well solution containing 100 mM sodium citrate, 3 M NaCl, pH 4.5 at 20 °C.  Bright yellow 
plate shaped crystals appeared after 1 day and grown to their maximum sizes in a week with 
approximate dimensions 400×150×40 m. For the oxidized form, crystals were transferred directly 
from the drop into a cryo-stabilization buffer containing 100 mM citric acid, ~2 mM of ligand, 3 
M sodium chloride, pH 4.5 and 30% PEG400 and flash frozen in liquid nitrogen. For the 
semiquinone form, the drop containing the crystals was exchanged into well solution supplemented 
with 0.5% sodium dithionite and incubated for ~5 minutes until the crystals visibly changed from 
yellow to purple, indicating the presence of the flavin semiquinone. Crystals were then transferred 
to cryo-stabilization buffer and flash frozen in liquid nitrogen. 
Diffraction data were collected at beamline 12-2 at the Stanford Synchrotron Radiation 
Lightsource (SSRL) and processed with XDS/Aimless.118 For the initial structure, phases were 
determined by iterative rounds of molecular replacement with a search model corresponding to a 
ligand free, trimmed, poly-alanine monomeric model of HhIYD (PDB ID: 5KO8)32 in Phaser.119 
Initial electron-density maps were improved by Prime-and-switch density modification.120 
Subsequent structures were determined by difference Fourier. Models were built by iterative rounds 
of manual-building in Coot121 and refinement in Phenix122. 
4.3 Results and discussion: 
4.3.1 TnIYD was purified in its semiquinone form stabilized by bound Tyr: 
Mesophilic IYDs, when released from E. coli cells during purification and bound to the Ni-
NTA column, were bright yellow due to the color of their oxidized FMN cofactors. The cell lysate 
and Ni-NTA column containing TnIYD, however, were dark purple. When directed eluted from a 
gravity Ni-NTA column without extensive washing, the resulting protein carried the purple color 
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for at least a few hours before turning into greenish-yellow after overnight incubation on ice under 
aerobic conditions (Appendix Figure C1). The UV-vis spectrum of the purple protein showed a 
broad peak between 500 nm and 700 nm (Figure 4-2(A)). The intensity of this peak gradually 
decreased over the course of 30 min under aerobic conditions while the absorbance at 450 nm 
increased concomitantly to restore the signature absorption band at 450 nm for oxidized flavin. The 
result suggested that the purple color and its corresponding absorption at 500-700 nm belong to a 
neutral blue FMN semiquinone species which overtime oxidized by air to generate the fully 
oxidized FMN. It is unprecedented that IYD was purified in its semiquinone form. TnIYD must 
somehow be reduced to at least the semiquinone within the E. coli cells or upon the cell lysis. This 
is very interesting since to date an in vivo reducing system for IYD has never been characterized. 
Activity assays for IYD mostly were powered either by the artificial reducing reagent sodium 
dithionite or by NADPH and unidentified electron transfer systems in thyroid or human embryonic 
kidney (HEK) 293 cells.8,123 TnIYD must also be able to stabilize the usually highly oxygen 
sensitive semiquinone sufficiently for it to be observed on the time scale of the purification. 
 
Figure 4-2 UV-vis spectrum of TnIYD at various stages of purification. (A) Spectrum of purple 
TnIYD eluted from a gravity Ni-NTA column. Spectrum was recorded every 10 min for 30 min. 
(B) Spectrum of the greenish yellow form of TnIYD obtained from overnight incubation of the 
purple TnIYD on ice under aerobic conditions. The insert is an enlarged view of the spectrum 




Once the purple TnIYD was oxidized to greenish yellow, no further change was observed 
towards the bright yellow color of a typical oxidized mesophilic IYD. The UV-vis spectrum of this 
greenish yellow TnIYD was very similar to that of oxidized mesophilic IYDs except for the 
presence of a broad band of absorbance between 500 nm and 700 nm (Figure 4-2). This band was 
not observed for mesophilic IYDs and might be responsible for the greenish yellow color of TnIYD. 
A similar greenish yellow color and spectroscopic feature were reported for the old yellow enzyme 
isolated from Saccharomyces cerevisiae124 and attributed to a charge transfer complex between the 
oxidized enzyme bound FMN and 4-hydroxybenzaldehyde.125 It is then possible that the greenish 
yellow color of TnIYD was also a result of a charge transfer interaction between its oxidized FMN 
and an aromatic small molecule. Previous studies showed that a FMN semiquinone species was 
observed during the slow anaerobic reduction of HsIYD and HhIYD by a reducing system of 
xanthine/xanthine oxidase/methyl viologen in the presence of the substrate analog F-Tyr.31,32 This 
substrate analog stabilized the FMN semiquinone of mesophilic IYDs by inducing the closure of 
the active site lid and the concomitant formation of a hydrogen bond between the side chain of a 
threonine and the N5 of FMN. It is then likely that the semiquinone of TnIYD observed during its 
purification is also stabilized by the binding of the same small molecule that possibly forms the 
charge transfer band to create the greenish yellow TnIYD. 
4.3.2 Identification of Tyr as the ligand in TnIYD expressed and purified from E. coli: 
A sample of the greenish yellow TnIYD was first denatured by formic acid and then 
analyzed by HPLC in attempt to identify the small molecule bound to the enzyme isolated from E. 
coli. Besides FMN and the polypeptide of TnIYD, a hydrophilic species with an absorption maxima 
around 275 nm was also identified from this sample (Figure 4-3(A)). The retention time of this 
species is very close to that of Tyr analyzed as the product of the deiodination assay of I-Tyr. 
Comparison of HPLC retention time (Figure 4-3(A)) and mass spectra (Figure 4-3(B)) between a 
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Tyr standard and the hydrophilic species suggested that Tyr was the ligand in TnIYD expressed 
and purified from E. coli. 
 
Figure 4-3 Identification of Tyr as the ligand in the greenish yellow form of TnIYD. (A) HPLC 
chromatograms of 40 μM greenish yellow form of TnIYD (black), 40 μM of FMN and Tyr each 
(blue), and a buffer black (red). (B) Comparison of mass spectra of a Tyr standard (black) and the 
ligand in the greenish yellow form of TnIYD isolated by HPLC. The mass fragments of the Tyr 
standard is assigned based on a published report.126 The calculated exact mass for each fragment is 
shown in parenthesis following the assignment.  
 
Binding of Tyr to TnIYD is surprising since none of the previously characterized 
mesophilic IYDs were co-purified with Tyr bound and the Kd of Tyr with mesophilic IYDs is at 
least 100 μM.27,31 The Tyr that co-purified with the enzyme first needed to be removed in order to 
evaluate the ability of Tyr to form a charge transfer complex with oxidized TnIYD and to stabilize 
the semiquinone form of TnIYD. The previously mentioned 4-hydroxybenzaldehyde co-purified 
with old yellow enzyme from Saccharomyces cerevisiae was removed by anaerobic dialysis of the 
reduced enzyme since 4-hydroxybenzaldehyde only binds to the oxidized, not the reduced 
enzyme.124 Therefore, TnIYD was reduced and washed with 2% dithionite supplemented buffer 
during Ni-NTA purification to learn if this treatment can remove Tyr from TnIYD as well. When 
washed with dithionite supplemented buffer, the purple TnIYD semiquinone quickly disappeared, 
indicating reduction of the purple FMN semiquinone to the colorless hydroquinone (Appendix 
Figure C2). The 2% dithionite in the buffer is enough to keep the system oxygen free as TnIYD 
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stayed colorless throughout the washing procedure under aerobic conditions. Once the column was 
washed with air saturated buffer, the colorless TnIYD quickly turned to bright yellow (Appendix 
Figure C2). Tyr was no longer detected in the HPLC analysis of this bright yellow form of TnIYD 
after formic acid denaturation (Appendix Figure C3). Therefore, Tyr does not seem to bind the 
reduced TnIYD and can be removed from oxidized TnIYD via dithionite treatment. 
As expected, the charge transfer band between 500 nm and 700 nm was not observed for 
the ligand free TnIYD (Figure 4-4). However, this band was restored after addition of Tyr to the 
ligand free TnIYD. In addition, a TnIYD semiquinone species mimicking that isolated directly 
from E. coli was generated by reducing TnIYD by dithionite and then re-oxidizing by air in the 
presence of Tyr and was stable for at least 15 min as indicated by UV-vis spectra (Figure 4-4(A)) 
under aerobic conditions. In contrast, the semiquinone was not observed for the ligand free TnIYD 
that was similarly reduced by dithionite and re-oxidized by air (Figure 4-4(B)). The fully oxidized 
TnIYD was instead obtained in the absence of Tyr. These results demonstrated the ability of Tyr to 
stabilize TnIYD semiquione and form a charge transfer complex with fully oxidized TnIYD. The 
stabilization of the semiquinone by Tyr explains the persistence of the purple color of TnIYD 
during purification. However, a physiological reducing source must have presented in E. coli cells 




Figure 4-4 Reduction and re-oxidation of TnIYD with and without Tyr. (A) In the presence of Tyr, 
TnIYD forms a charge transfer band and stabilizes its semiquinone form upon reduction with 
dithionite followed by air re-oxidation. (B) In the absence of Tyr, no charge transfer band 
wasbserved for TnIYD and fully oxidized TnIYD instead of its semiquinone form was obtained 
upon reduction with dithionite followed by air re-oxidation. The inserts in both (A) and (B) are 
enlarged views of the corresponding spectrum between 500 nm and 900 nm. 
 
4.3.3 TnIYD can be reduced by free reduced flavins generated by a flavin reductase from E. 
coli: 
 
A reducing source for IYD from E. coli has never been reported. Its identification is of 
great interest since it will allow the bioremediation of halophenols with TnIYD or its variants in 
intact cells. In the standard purification of TnIYD, free FMN (~ 300 μM) is always added to the 
cell lysate to increase the FMN occupancy in the enzyme. However, when exogenous FMN was 
omitted, the Ni-NTA column was mostly greenish yellow instead of purple after loading of the cell 
lysate. This seems to suggest that free FMN is required for the in vivo reduction of TnIYD. The 
role of free FMN is most likely an electron shuttle that passes electrons to TnIYD from other 
reducing sources. In E. coli, reduced FMN can be generated by multiple NAD(P)H dependent flavin 
reductases.127,128 
E. coli cell lysate containing overexpressed TnIYD was first tested for I-Tyr deiodination 
in the presence of FMN and NADH to see if the endogenous E. coli reducing system can support 
the catalysis of TnIYD. Since species derived from NADH co-eluted with Tyr on HPLC, the 
deiodination reaction was followed by the consumption of I-Tyr. As a control, when dithionite was 
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used as reductant, all 20 μM I-Tyr in the reaction was consumed within 1 hr. When 1 mM NADH 
and 300 μM exogenous FMN were used as reductant, about 10 μM I-Tyr was depleted in 1 hr. The 
result suggested that the endogenous reducing system in E. coli is capable of supporting the 
deiodination acitivity of TnIYD. Without FMN, NADH alone with the cell lysate containing 
TnIYD was not reactive towards I-Tyr, again demonstrated the requirement of free FMN in the 
reducing system. 
The well-studied Flavin:NAD(P)H reductase Fre from E. coli was then overexpressed and 
purified to reconstitute this reducing system in vitro. Fre utilizes both NADH and NADPH to 
reduce FMN, FAD, and riboflavin and has been suggested to provide reducing equivalence to 
ribonucleotide reductase in E. coli.127 When Fre was added to a mixture of TnIYD, Tyr, FMN, and 
NADH under aerobic conditions, a flavin semiquinone was formed as monitored by UV-vis (Figure 
4-5(A)). This semiquinone species is most likely formed from reduction of TnIYD by reduced 
FMN since Fre reduces free FMN directly to its hydroquinone state. The full reduction of TnIYD 
to the hydroquinone was not observed under aerobic conditions since the fully reduced TnIYD 
could rapidly react with oxygen and re-oxidized to the semiquinone state which in the presence of 
Tyr was much slower oxidized (Figure 4-4(A)). 
 
Figure 4-5 Reduction of TnIYD with free FMN. (A) TnIYD was reduced to the semiquinone form 
by free reduced FMN generated with a NADH/flavin reductase Fre system. (B) TnIYD was reduced 




The role of Fre in this system could either be providing a source of reduced flavin that then 
diffuses to the proximity of TnIYD129 or delivering reduced flavin to TnIYD via a transient complex 
between the two enzymes.130 When TnIYD was added to a solution of excess Tyr and free reduced 
FMN generated by dithionite under anaerobic conditions, the TnIYD semiquinone was formed 
without Fre (Figure 4-5(B)). The absorbance of the semiquinone at ~ 590 nm reached its maximum 
in ~ 5 min and stayed unchanged for another 5 min. This result suggested that reduced flavin alone 
is capable of reducing TnIYD to its semiquinone form. It is still not clear whether the failure to 
observe the fully reduced TnIYD is a result of its rapid re-oxidation to the semiquinone by residual 
oxygen since the system was not absolutely anaerobic (the TnIYD was not deoxygenated when 
introduced into the Ar purged cuvette and the cuvette itself slowly leaked air into the cuvette as 
slow increase in 450 nm absorbance was observed overtime). However, this does not necessarily 
conflict with the ability of free FMN dependent endogenous reducing system in E. coli to support 
deiodination of TnIYD which requires the fully reduced enzyme bound FMN. In the presence of 
substrate, the re-oxidation of the fully reduced TnIYD may compete by oxygen and the substrate. 
Closure of the active site lid induced by substrate binding may hinder the re-oxidation by oxygen 
and favor catalytic deiodination. 
The ability of TnIYD to bind Tyr and be reduced by free flavin may not be specific to 
TnIYD but rather a common feature of thermophilic IYDs since another thermophilic IYD-PfIYD 
was also purified from E. coli as a purple semiquinone.112 It is possible that free flavins can also 
reduce mesophilic IYDs. More detailed spectroscopic and kinetic studies are needed to see if such 
a system has a physiological relevance and can power the bioremediation of halophenols. 
4.3.4 TnIYD is a functional thermophilic iodotyrosine deiodinase with severe substrate 
inhibition: 
 
TnIYD demonstrated its uniqueness compared to mesophilic IYDs with the ability to bind 
Tyr in a redox dependent manner and stabilize its semiquinone state during purification. Its ligand 
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binding and catalytic properties were subsequently evaluated to reveal the functional similarities 
and differences between meso- and thermophilic IYDs. Tyr free TnIYDs used in these studies were 
purified with a yield of ~ 15 mg/L culture and a FMN occupancy of ~90-95% (Appendix Figure 
C4). The binding of various ligands to TnIYD was measured via the previously described FMN 
fluorescence quenching assay (Section 2.2.4).  At 25 ºC, halotyrosines (I-Tyr and F-Tyr) bound 
TnIYD tightly with sub-micromolar dissociation constants, which is consistent with the 
conservation of the zwitterion recognition triad (E68, Y72, and K92) in TnIYD (Table 4-1). The 
50 nM Kd of TnIYD with I-Tyr is the smallest of all IYDs with halotyrosines measured to date. The 
Kd of F-Tyr with TnIYD is only ~2-fold larger than I-Tyr, while Kd of F-Tyr with mesophilic IYDs 
were at least 5-fold larger than that of I-Tyr.27,28,31,32 Results described in Section 4.3.2 already 
showed that oxidized TnIYD bound Tyr and formed a charge transfer complex. The Kd of 0.5 μM 
for Tyr at 25 ºC is consistent the ability of Tyr to co-purify with TnIYD (Table 4-1). The affinity 
between Tyr and oxidized TnIYD was similar or even tighter than that between I-Tyr and DmIYD 
(Kd 0.62 μM) and HhIYD (Kd 8.2 μM).28,32 The 10-fold difference in Kd between Tyr and I-Tyr with 
TnIYD was surprisingly small given that such a difference in mesophilic IYDs are at least 1000-
fold.27,31 The affinity of halotyrosines and Tyr with HsIYD has been correlated with the pKa of the 
hydroxyl group in the ligands. HsIYD preferred to bind the phenolate form of halotyrosines 
presumably due to its strong interactions with the 2`-hydroxyl group of FMN’s ribose tail and a 
backbone amide of Ala 130.31 The pKa of the hydroxyl group in Tyr (pKa 10.05) is more than one 
pH unit higher than halotyrosines and nearly three pH unit above the pH of the buffer (pH 7.4) used 
in affinity determination.131 Tyr in the affinity assays is overwhelmingly in its phenol form and as 
a result does not bind mesophilic IYDs tightly. The tight binding of Tyr to TnIYD suggested that 
pKa of the hydroxyl group might not be a dominate factor contributing to the affinity of Tyr and 
halotyrosines with TnIYD. This was further demonstrated by tight binding of 3-methoxy-L-
Tyrosine (MeO-Tyr) to TnIYD at 25 ºC (Kd 0.54 μM, Table 4-1) despite a high pKa of the hydroxyl 
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group for MeO-Tyr (pKa 10.01).131 On the other hand, the presence of a zwitterion has a bigger 
effect on ligand binding than pKa of the hydroxyl group. 2IP bound to oxidized TnIYD at least 
300-fold less tightly than halotyrosines and 50-fold less tightly than Tyr (Table 4-1). However, 
compared to mesophilic IYDs, the 26.4 μM Kd is already the smallest measured to date and is only 
~ 3-fold larger than the Kd of I-Tyr with HhIYD.32 Therefore, high affinity with TnIYD likely 
dependents on many factors and TnIYD may have structural features different from mesophilic 
IYDs to support binding of phenolic compounds. 
Table 4-1 Affinity and steady-state kinetics of TnIYD with various ligands and substrates.2  
Substrate/Ligand Kd (μM)[a] kcat (min-1)[b] KM (μM)[b] 
kcat/KM 
(min-1× μM -1) 
Ki (μM) 
 TnIYD (25 ºC) 
I-Tyr 0.05 ± 0.02 5.4 ± 0.9 0.02 ± 0.10 270 ± 1000 5 ± 2 
Cl-Tyr N. D. 0.9 ± 0.1 1.3 ± 0.4 0.7 ± 0.3 18 ± 6 
F-Tyr 0.08 ± 0.03 - - - - 
Tyr 0.49 ± 0.04 - - - - 
MeO-Tyr 0.54 ± 0.07 - - - - 
2IP 26.4 ± 0.5 0.84 ± 0.06 
(4.2 ± 0.7) 
× 103 
(2.0 ± 0.4) 
 × 10-4 
N. D. 
 TnIYD (60 ºC) 
I-Tyr ≤ 0.05 29 ± 4 0.8 ± 0.2 36 ± 10 9 ± 2 
Cl-Tyr N. D. N. D. N. D. N. D. N. D. 
F-Tyr N. D. - - - - 
Tyr 0.74 ± 0.05 - - - - 
MeO-Tyr N. D. - - - - 
2IP N. D. 6.5 ± 0.3 
(6.6 ± 0.5) 
× 103 
(9.8 ± 0.9) 
 × 10-4 
N. D. 
[a] The Kd and associated were obtained from nonlinear fitting of one determination to the previously published equation.21 
[b] All the data and error bars were obtained by fitting of two independent measurements as one curve to substrate 
inhibition kinetics. 
 
The activity of TnIYD with I-Tyr at 25 ºC was then measured by the previously described 
HPLC assay (Section 2.2.5). Substrate inhibition kinetics (Equation 4-1 in section 4.2.5) was used 
to describe the severe substrate inhibition of TnIYD with I-Tyr and Cl-Tyr (Appendix Figure 
C5).117 Thermophilic enzymes typically have little to no activity near room temperature.132 
                                                          
2 The kinetic parameters of TnIYD with 2IP were measured by Shaun Spisak (Johns Hopkins University). 
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However, TnIYD is a noticeable exception. At 25 ºC, the kcat of TnIYD with I-Tyr was well within 
the same magnitude with the range of kcat measured for mesophilic IYDs with I-Tyr.28,31,32 Its KM 
with I-Tyr, though, was 100-fold smaller than that of mesophilic IYDs. However, this KM was 
subject to high error due to the lack of a sensitive enough method to measure rates with less than 
0.5 μM I-Tyr. Overall, the kcat/KM of I-Tyr suggested that TnIYD catalyzed I-Tyr deiodination at 
least one order of magnitude more efficiently (assuming KM is actually 0.5 μM) than mesophilic 
IYDs even at 25 ºC.28,31,32 However, TnIYD exhibited severe substrate inhibition starting with I-
Tyr concentration as low as 0.5 μM. Substrate inhibition is not specific to TnIYD but commonly 
observed for IYDs in general. The Ki of I-Tyr for TnIYD was estimated to be 5 μM which is similar 
in magnitude to the KM of mesophilic IYDs with I-Tyr. Therefore, the substrate inhibition seemed 
to be more severe in TnIYD than mesophilic IYDs. The kcat/KM of TnIYD with 2IP was ~ 4-fold 
higher than mesophilic IYDs at 25 °C.32,60 However, this is mainly a contribution of increased kcat 
but not decreased KM, consistent with previous findings that tight binding with the oxidized enzyme 
does not guarantee efficient deiodination.32 TnIYD does not defluorinate F-Tyr even at 77 ºC (the 
optimum growth temperature of Thermotoga neapolitana) despite binds F-Tyr only 2-fold less 
tightly than I-Tyr. 
The ligand binding and kinetic properties of TnIYD were then measured under higher 
temperature to evaluate the thermoadaptation of TnIYD. The optimum temperature of TnIYD 
should be close to the optimum growth temperature of Thermotoga neapolitana (77 ºC).133 
However, at 77 ºC the initial rate of TnIYD with I-Tyr was too fast to be measured accurately by 
the standard HPLC assay. Therefore, the binding and activity of TnIYD was instead measured at 
60 ºC. An accurate dissociation constant of I-Tyr to TnIYD could not be obtained since fitting of 
the measurement generated a negative value for Kd. However, the traces of fluorescence quenching 
of TnIYD upon addition of I-Tyr measured under 25 ºC and 60 ºC overlapped with each other well 
(Appendix Figure C6). Therefore, the Kd of I-Tyr to TnIYD at 60 ºC was estimated to be close to 
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that at 25 ºC (Table 4-1). For Tyr, the Kd with TnIYD at 60 ºC was only 1.5-fold larger than that 
measured at 25 ºC (Table 4-1). The increased temperature did not drastically affect the binding of 
Tyr to TnIYD. The activity of TnIYD with I-Tyr at 60 ºC was measured by quantifying the 
fluorescence of the product Tyr with HPLC. The fluorescence detection of Tyr on HPLC was 100-
fold more sensitive than the corresponding UV detection and therefore permits rate measurement 
with sub-micromolar I-Tyr. The kcat of TnIYD with I-Tyr was 5.4-fold more active at 60 ºC than at 
25 ºC, consistent with its thermophilic nature (Table 4-1). The KM, though, was also 40-fold larger, 
although this could again be an artifact due to the high uncertainty of KM at 25 ºC. The kcat/KM of I-
Tyr with TnIYD at 60 ºC was at least 30-fold higher than mesophilic IYDs at 25 ºC.28,31,32 This may 
suggest a partial loss of activity when IYD was adopted to a cold environment. However, the 
substrate inhibition of TnIYD with I-Tyr was still severe at 60 ºC with a Ki only 2-fold higher than 
that at 25 °C (Table 4-1). Mesophilic IYDs likely sacrificed some activity compared to thermophilic 
IYDs to partially relieve substrate inhibition. The kcat and KM of TnIYD with 2IP at 60 ºC was 8-
fold and 1.5-fold higher than at 25 ºC, respectively (Table 4-1). The kcat/KM of TnIYD with 2IP at 
60 ºC is at least 3-fold higher than any mesophilic IYDs and their variants, which might make 
TnIYD a better parent enzyme for engineering a halophenol dehalogenase. 
4.3.5 Crystal structures of oxidized TnIYD in complex with I-Tyr, F-Tyr, and Tyr are similar 
to those of mesophilic IYDs:3 
 
Crystallographic studies of TnIYD are of great interest since the structure of TnIYD 
represents a minimal scaffold required for reductive dehalogenation (Section 4.1). Comparison of 
structures of TnIYD with mesophilic IYDs may also reveal the structural basis for the tight binding 
of Tyr with thermophilic but not mesophilic IYDs. In addition, the presumably decreased flexibility 
of TnIYD at room temperature may result in crystals with better quality than mesophilic IYDs and 
                                                          
3 Looping and freezing of the crystals, data collection, and structure determination were performed by Prof. Jennifer 
Kavran (Johns Hopkins University).  
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may in return yield high-resolution structures which are potentially useful in revealing subtle 
differences between the oxidized and reduced structures.111 
Indeed, co-crystals of oxidized TnIYD with I-Tyr, F-Tyr, and Tyr all yielded high-
resolution structures (1.8 Å, 1.6Å, 1.6Å, respectively). The data collection and structure refinement 
statistics are listed in Table 4-2. In the co-crystal structure of TnIYD and I-Tyr, the two subunits of 
TnIYD form a homodimer contains the same α/β core with other members of the nitro-FMN 
reductase superfamily (Figure 1-2 and Figure 4-6(A)). The two active sites at the dimer interface 
are identical and each active site contains a FMN cofactor. Despite sharing only 37% identity (based 
on the length of TnIYD, 186 amino acids), there is no major conformational changes between 
HsIYD and TnIYD as evident from an RMSD of 1.48 Å for 269 Cα atoms (Figure 4-6(B)). The 
active site lid of TnIYD shares the helix-turn-helix motif of the lids in mesophilic IYDs (Figure 4-
6(C)).31–33 The lid of TnIYD is one amino acid shorter than HsIYD and only minor conformational 
differences between the lids of two enzymes were observed at the “turn” region between two 
helixes of the lid (Figure 4-6(C) and (D)). Consistent with prediction by sequence alignment, a loop 
near the active site of mesophilic IYDs is truncated in TnIYD (Figure 4-6(C)). This loop interacts 
with the lid in mesophilic IYDs via π-π interaction between a Tyr on the loop and a Trp on the lid 
(Figure 4-6(D)). However, in TnIYD these residues were substituted with a Pro and a Leu 
respectively and are not in apparent contact distance (≥ 3.5 Å, Figure 4-6(C)). Since TnIYD is even 
more active than all mesophilic IYDs characterized at 25 ºC, this loop is not absolutely needed for 





Figure 4-6 Crystal structures of I-Tyr bound to TnIYD and HsIYD.Co-crystal structure of TnIYD 
with I-Tyr (PDB 6Q1L). The monomeric units of the enzyme are colored with green and cyan. 
FMN and 2IP are shown in orange and yellow, respectively. (B) Co-crystal structure of HsIYD 
with I-Tyr (PDB 4TTC).31 (C) Active site of TnIYD with I-Tyr bound. The active site lid and the 
truncated loop relative to HsIYD are shown in blue and magenta, respectively. Shortest distance 
between P111 and L79 is indicated by a dashed line. (D) Active site of HsIYD with I-Tyr bound. 
The active site lid and the loop are shown in blue and magenta, respectively. Shortest distance 


















Table 4-2 Data Collection and Refinement Statistics of the oxidized TnIYD structures.4  
PDB ID  6PZ0 6Q1L 6Q1B 
     Protein TnIYD TnIYD TnIYD 
     Ligand Tyr I-Tyr F-Tyr 
     Oxidation state oxidized oxidized oxidized 
Data Collection    
     Space group P212121 P212121 P212121 
     Unit Cell    






          == (°) 90 90 90 
     Number of unique 
reflectionsa 
34678 (1965) 47126 (2264) 47253 (2162) 
     Number of observed 
reflectionsa 
225230 (11584) 211852 (9484) 1234895 (49162) 






     Rpim (%)a,b  4.3(13.8) 3.9 (38.0) 2.6 (33.2) 
     I/a  15.1(5.1) 10.7 (2.1) 17.0 (2.1) 
     Completeness (%)a 99.8 (97.7) 96.9 (95.5) 99.6 (93.2) 
     Redundancya 6.5 (5.9) 4.5 (4.2) 26.1 (22.7) 
Refinement    
     Rcryst(%)a,c  15.83 (16.63) 16.51 (22.82) 16.57 (40.12) 
     Rfree(%)a,c 20.10 (21.59) 19.60 (26.28) 20.32 (45.43) 
     Ramachandran analysis    
           Favored (%) 97.85 98.65 98.11 
           Allowed (%) 2.15 1.35 1.89 
     rmsd bonds  0.007 0.011 0.015 
     rmsd angles 1.051 1.286 1.393 
     Average B-factor for 
protein (Å2) 
23.55 25.49 26.35 
     Average B-factor for 
water (Å2) 
31.15  31.15 13.59 
     Average B-factor for 
ligands (Å2) 
 15.21  16.35 14.00  
aThe values in parentheses are for the highest resolution shell. bRpim =Σhkl√((1/(n-1)) Σi |Ii - <I>| / ΣhklΣiIi, where Ii is 
the intensity of an individual reflection and <I> is the mean intensity obtained from multiple observations of symmetry 
related reflections. cRcryst is Σ||Fo – Fc||/Σ Fo, where Fo is an observed amplitude and Fc a calculated amplitude; Rfree is the 
same statistic calculated over a subset of the data that has not been used for refinement. 
 
 
The binding of I-Tyr to TnIYD is stabilized by multiple interactions between I-Tyr, FMN, 
and the protein that are well conserved in mesophilic IYDs (Figure 4-7(A) and (B)).31–33 The 
                                                          
4 This table was compiled by Prof. Jennifer Kavran (Johns Hopkins University). 
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zwitterion of I-Tyr forms contacts with the zwitterion recognition triad (E68, Y72, and K92) and 
the isoalloxazine ring of FMN (Figure 4-7(A)). The enzyme-substrate interactions are also 
stabilized by: (1) hydrogen bonding interactions between the hydroxyl group of I-Tyr and the 
backbone amide of Met 41 (Ala in mesophilic IYDs) as well as the 2`-hydroxyl group of FMN’s 
ribose tail, and (2) π-π interaction between the aromatic ring of I-Tyr and the isoalloxazine ring of 
FMN. F-Tyr binds TnIYD similarly as I-Tyr which is expected from the similar structures of both 
ligands with HsIYD. 31,134 Interestly, Tyr binds TnIYD in an almost identical fashion to I-Tyr with 
both TnIYD and HsIYD (Figure 4-7(C)). Therefore, the much tighter binding of Tyr to TnIYD than 
HsIYD is not a result of an alternative binding mode in the active site. The only noticeable 
difference between the structures of TnIYD with I-Tyr and Tyr is the conformation of a Tyr (Y112) 
near the iodine of I-Tyr. When Tyr binds the active site, the ring of Y112 points towards the ring 
of Tyr (the “in” conformation of Y112) and the two may potentially engage in hydrophobic 
interactions (closest distance 3.8 Å) to stabilize Tyr binding. The ring of Y112 points away from I-
Tyr (the “out” conformation of Y112A) in the structure of TnIYD and I-Tyr possibly due to 
repulsion between the two (closest distance 2.2Å if the “in” conformation is retained). The affinity 
of Tyr was, therefore, measured with the TnIYD Y112A variant. The Kd of Tyr with TnIYD Y112A 
(0.9 μM) was only 2-fold greater than that of the wildtype enzyme and is still at least two orders of 
magnitude smaller than mesophilic IYDs. Therefore, Y112 is not a major contributor to the tight 







Figure 4-7 Active sites of TnIYD and HsIYD. (A) Active site structure of TnIYD with I-Tyr (PDB: 
6Q1L). The monomeric units of the enzyme were colored with green and cyan. FMN and I-Tyr are 
shown in orange and yellow, respectively. Interactions between the substrate and TnIYD are shown 
in dashes (≤ 3.5 Å). (B) Active site structure of HsIYD with I-Tyr (PDB 4TTC).31 (C) Active site 
structure of TnIYD with Tyr (PDB 6PZ0). M41 displays two conformations in this structure. (D) 
Overlay of active site of TnIYD with I-Tyr amd Tyr bound. For clarity, only Tyr (yellow) is shown 
as ligand and I-Tyr is omitted from the view. Y112 is colored magenta (the “out” conformation) 
and gray (the “in” conformation) in the structures with I-Tyr and Tyr bound, respectively.  
 
4.3.6 Co-crystal structures of TnIYD in its semiquinone form and I-Tyr, F-Tyr, and Tyr are 
similar to those of oxidized TnIYD:5 
 
The co-crystals of oxidized TnIYD with I-Tyr, F-Tyr, and Tyr were soaked into 
crystallization buffer supplemented with 0.5% dithionite in hope to obtain crystals of fully reduce 
TnIYD with ligand bound. The co-crystals of TnIYD with ligands upon dithionite treatment 
changed color from bright yellow to purple in ~ 10 s for F-Tyr and Tyr as ligand and in ~ 5 min for 
                                                          
5 Looping and freezing of the crystals, data collection, and structure determination were performed by Prof. Jennifer 
Kavran (Johns Hopkins University).  
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I-Tyr as ligand. The purple color of the crystal indicating formation of TnIYD semiquinone (Figure 
4-2(A)) and prolonged incubation with dithionite did not reduce the crystals of TnIYD semiquinone 
further to the fully reduced TnIYD which is expected to have a light yellow color or be colorless. 
The structure of the TnIYD semiquinone is still very interesting as very few crystal structures of 
flavoproteins in the semiquine form are available due to the difficulty in its formation and 
stabilization.135–137 In addition, the co-crystal structures of I-Tyr and Tyr with TnIYD semiquinone 
can mimic the complexes between TnIYD semiquinone and the proposed halotyroxyl radical anion 
intermediate (Intermediate 2 in Figure 1-1) and tyroxyl radical intermediate (Intermediate 3 in 
Figure 1-1), respectively. Therefore, these structures may reveal the molecular basis by which 
TnIYD stabilizes these highly reactive intermediates during catalysis. The co-crystal structures of 
the semiquinone form of TnIYD with I-Tyr, F-Tyr, and Tyr were solved to 1.35 Å, 1.5 Å, and 1.5 
Å, respectively. The data collection and structure refinement statistics are listed in Table 4-3. There 
is no visible conformational changes for TnIYD when these structures were compared to each other 
and to the corresponding oxidized co-crystal structures (Figure 4-8(A)). Previous studies reported 
subtle changes in the conformation of the isoalloxazine ring (2-5 ° bending) and the ribityl chain 
of protein bound flavin semiquinone compared to its oxidized counterpart.135,137 However, no 
changes in FMN conformation were observed in the co-crystal structures of oxidized TnIYD and 
semiquinone TnIYD with I-Tyr bound (Figure 4-8(B)). The results seemed to suggest that the active 
site arrangement in the oxidized structures are sufficient to stabilize the proposed radical 
intermediates and the semiquinone of the FMN cofactor during catalysis. The formation of the 
active site lid in particular excludes bulk solvents from the active site (although there are specific 
water molecules in the active site whose roles are not clear) and creates a relative hydrophobic 
environment around I-Tyr which is a general strategy used by enzymes to stabilize highly reactive 
radical species.138 Finally, it has been shown that flavoproteins can be reduced by X-ray.135,139 It is 
always possible that the crystal of oxidized TnIYD was reduced by the X-ray beam to semiquinone 
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TnIYD or both the oxidized and semiquinone TnIYD were reduced to fully reduced TnIYD. 
Therefore, the fact that no structural differences were observed between the oxidized and 
semiquinone TnIYD could be an artifact. 
 
Figure 4-8 Crystal structures of TnIYD in its semiquinone form. (A) Overlay of co-crystal 
structures of TnIYD semiquinone and I-Tyr (magenta), F-Tyr (cyan), Tyr (green) with co-crystal 
structure of oxidized TnIYD and I-Tyr (blue). FMN and I-Tyr are shown in orange and yellow, 
respectively. (B) Overlay of oxidized FMN (blue) and FMN semiquinone (purple) in the 















Table 4-3 Data Collection and Refinement Statistics of the TnIYD semiquinone structures.6  
PDB ID  n/a 6Q1L n/a 
     Protein TnIYD TnIYD TnIYD 
     Ligand Tyr I-Tyr F-Tyr 
     Oxidation state semiquinone semiquinone semiquinone 
Data Collection    
     Space group P212121 P212121 P212121 
     Unit Cell    






          == (°) 90 90 90 
     Number of unique 
reflectionsa 
86499 (3948) 47126 (2264) 46581 (2076) 
     Number of observed 
reflectionsa 
1173112 (48215) 211852 (9484) 1219785 (48821) 






     Rpim (%)a,b  4.5  (191.7) 3.9 (38.0) 4.8 (81.6) 
     I/a  10.5 (1.2) 10.7 (2.1) 16.8 (2.9) 
     Completeness (%)a 95.2 (88.7) 96.9 (95.5) 99.2 (89.2) 
     Redundancya 13.6 (12.2) 4.5 (4.2) 26.2 (23.5) 
Refinement    
     Rcryst(%)a,c  19.08 (31.17) 16.51 (22.82) 16.46 (32.89) 
     Rfree(%)a,c 20.87 (32.85) 19.60 (26.28) 19.77 (35.56 
     Ramachandran analysis    
           Favored (%) 98.10 98.65 97.58 
           Allowed (%) 1.9 1.35 2.15 
     rmsd bonds  0.006 0.011 0.016 
     rmsd angles 1.053 1.286 1.441 
     Average B-factor for 
protein (Å2) 
16.48 25.49 14.90 
     Average B-factor for 
water (Å2) 
 31.15  
     Average B-factor for 
ligands (Å2) 
 16.35  
aThe values in parentheses are for the highest resolution shell. bRpim =Σhkl√((1/(n-1)) Σi |Ii - <I>| / ΣhklΣiIi, where Ii is 
the intensity of an individual reflection and <I> is the mean intensity obtained from multiple observations of symmetry 
related reflections. cRcryst is Σ||Fo – Fc||/Σ Fo, where Fo is an observed amplitude and Fc a calculated amplitude; Rfree is the 
same statistic calculated over a subset of the data that has not been used for refinement. 
4.3.7 An additional binding mode of I-Tyr in the structures with oxidized and semiquinone 
TnIYD is possibly the structural basis for the severe substrate inhibition of TnIYD: 
 
As described in the last section, no major changes of TnIYD were induced by reduction of 
its oxidized FMN to the semiquinone form. However, an alternative binding site for I-Tyr besides 
                                                          
6 This table was compiled by Prof. Jennifer Kavran (Johns Hopkins University). 
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the two active sites was discovered in the structure of TnIYD semiquinone with I-Tyr (Figure 4-
9(A)). Full electron density for the iodine and phenol ring of I-Tyr can be detected at this alternative 
binding site. Careful inspections of the electron density map of the oxidized TnIYD with I-Tyr also 
revealed extra electron density corresponding to the iodine atom of I-Tyr. However, no extra 
electron density at this site was displayed for the structures with F-Tyr and Tyr, regardless of the 
oxidization state of FMN. This alternative binding of I-Tyr is most likely mediated by van der 
Walls interactions between the iodine and the backbone and Cα atoms of R114 and E115 (between 
4.0 Å and 4.5 Å, Figure 4-9(B)). The smaller fluoride and hydrogen atoms provide much weaker 
van der Walls interactions compared to iodine and therefore F-Tyr and Tyr are not seen at this 
alternative binding site. 
 
Figure 4-9 Additional binding site of I-Tyr in the structure of TnIYD semiquinone with I-Tyr. (A) 
An overall view of the alternative binding site on the context of the whole protein. The monomeric 
units of the enzyme are colored with green and cyan. FMN and I-Tyr in the active sites are shown 
in orange and yellow, respectively. I-Tyr occupies the alternative site is colored in pink. (B) 
Interactions (yellow dashes, 4.0-4.5 Å) between the iodine of I-Tyr and R114 and E115.  
 
The biophysical basis of substrate inhibition on enzyme kinetics is proposed to involve the 
binding and subsequent inhibition of the enzyme-substrate complex by a second molecule of 
substrate.117 Therefore, the alternative binding observed for TnIYD with I-Tyr might be the 
molecular basis for its severe substrate inhibition. As stated above, the van der Walls interactions 
likely responsible for the binding of I-Tyr will be weaker once iodine is substituted with smaller 
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atoms and potentially result in weaker substrate inhibition. The 4-fold larger Ki of Cl-Tyr TnIYD 
relative to that of I-Tyr is consistent with this hypothesis (Table 4-1). The substrate inhibition is 
generally weaker in mesophilic IYDs which likely explains the absence of I-Tyr occupying similar 
alternative binding sites in the structures of oxidized mesophilic IYDs. 
4.4 Summary: 
In this chapter, the structural and functional analysis of a thermophilic IYD-TnIYD was 
described. TnIYD was purified from E. coli cells in its semiquinone form. This semiquinone species 
was formed via reduction of the oxidized enzyme by free flavin generated by E. coli flavin 
reductases. Binding of Tyr further stabilized the TnIYD semiquinone. TnIYD is a functional 
thermophilic deiodinase that exhibits higher activity with increased temperature. Even at 25 °C the 
activity of TnIYD was already higher than mesophilic IYDs, albeit with more severe substrate 
inhibition. TnIYD represents the minimal structural requirement for reductive dehalogenation as it 
lacks the N-terminal extensions and a flexible loop near the active site typically in mesophilic IYDs. 
The binding mode of I-Tyr and Tyr to the active site of oxidized TnIYD is identical to oxidized 
HsIYD, even though TnIYD binds Tyr at least two orders of magnitude tigher than mesophilic 
IYDs. Tyr, however, does not bind to fully reduced TnIYD and therefore avoids inducing severe 
product inhibition. The co-crystals of oxidized TnIYD with I-Tyr, Tyr, F-Tyr were readily reduced 
to the semiquinone form by dithionite but were not able to undergo further reduction to the 
hydroquinone. Reduction of the FMN cofactor from oxidized to semiquinone did not change the 
overall structure of TnIYD, the conformation of FMN, and the active site binding of ligands, 
suggesting that the active site conformation and binding mode of the substrate observed with the 
oxidized structures are sufficient to stabilize intermediates involving TnIYD semiquinone during 
catalysis. An alternative binding mode for I-Tyr was observed with both oxidized and the 
semiquinone TnIYD. This binding is mainly mediated by the van der Walls interaction between 
the halogen atom of the ligand and protein atoms surrounding the binding site and is likely the 
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molecular basis for the severe substrate inhibition of TnIYD. The results established that TnIYD is 
a functional thermophilic dehalogenase but represents a unique subgroup of IYDs as it exhibits 
many differences from previously characterized mesophilic IYDs. Further structural and 
mechanistic studies are needed to reveal the productive substrate-enzyme interactions with fully 
reduced TnIYD and the rate-determining step of its catalysis to facilitate the engineering of TnIYD 
towards the bioremediation of halophenols. Since the reduction of the crystals of TnIYD•FMNox 
by dithionite only resulted in crystals of TnIYD•FMNsq but not TnIYD•FMNhq, two parallel 
alternative approaches to obtain the crystals of TnIYD•FMNhq are currently under investigation. In 
the first approach, TnIYD•FMNhq will be generated by dithionite reduction of TnIYD•FMNox prior 
to crystallization. TnIYD•FMNhq will then be mixed with F-Tyr and crystallized in an anaerobic 
glovebox. Access to the glovebox is kindly provided by Prof. Squire Booker (Pennsylvania State 
University). Alternatively, the crystal of ligand free TnIYD•FMNox might be reduced to 
TnIYD•FMNhq by dithionite. F-Tyr can then be soaked into crystal of ligand free TnIYD•FMNhq 














Chapter 5 Effect of substrates and substrate analogs on the 
reduction of iodotyrosine deiodinase: cofactor regeneration as 
a possible rate-determining step for dehalogenation 
 
5.1 Introduction: 
Over the years, IYD enzymology has been advanced via identification of IYD’s sequence 
in mammals, its heterologous expression and purification, discovery of its wide distribution in all 
domains of life, and determination of its crystal structures.24,29 However, one important question 
still remains unanswered: what is the rate-determining step for the reductive dehalogenation 
catalyzed by IYD? 
As mentioned in Chapter 1, the proposed mechanism for the reductive dehalogenation of 
IYD proceeds by two sequential one electron transfer steps from the reduced FMN cofactor of IYD 
(IYD•FMNhq) to the halogenated substrates.29 Redox titration and mutational analysis have 
demonstrated the likely involvement of a FMN semiquinone intermediate (IYD•FMNsq) in IYD 
catalysis under steady-state conditions.31 However, the IYD•FMNsq intermediate was not observed 
in a significant quantity during the re-oxidation of HsIYD•FMNhq by I-Tyr under pre-steady state 
conditions.26 Therefore, any steps that may involve accumulation of the FMN semiquinone such as 
halide release and the second electron transfer (Figure 1-1, step (3) and (4), respectively) are not 
likely to be rate-determining. Other possible slow steps along the reaction coordinate are the 
tautomerization of substrate and the first electron transfer (Figure 1-1, step (1) and (2), respectively) 
since they both involve formation of unstable substrate and/or FMN intermediates. However, the 
lack of a solvent isotope effect suggested that protonation of the carbon with iodine attached during 
the tautomerizaiton of I-Tyr is not the rate-determining step for HhIYD.50,140 In addition, 
reconstitution of FMN by analogs with varied redox potentials did not significantly affect the 
activity of I-Tyr deiodination of HhIYD, which then suggested that electron transfer was also not 
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rate-determining.50,141 There seems to be no other steps from the oxidative half reaction of 
IYD•FMNhq that can be rate-determining. 
The first order rate constants for the re-oxidation of HsIYD•FMNhq measured under pre-
steady state conditions showed a linear response to I-Tyr concentration up to 25-fold higher than 
the enzyme concentration (8 μM) (Figure 5-1).26 In addition, the second order rate constant of 
HsIYD•FMNhq re-oxidation by I-Tyr correlates well with the kcat/KM value obtained under steady-
state condition. This implies that the re-oxidation is rate-determining when HsIYD is not saturated 
with I-Tyr. However, the first order rate constants of HsIYD•FMNhq re-oxidation observed at all I-
Tyr concentrations were invariably higher (up to 17-fold) than the kcat value measured under steady-
state conditions. Thus, the first order rate constant of HsIYD•FMNhq re-oxidation with saturation 
levels of I-Tyr is higher than the kcat. This suggests that the dehalogenation reaction will no longer 
be rate-determining as the concentration of I-Tyr increases towards saturation level. Therefore, the 








Figure 5-1 Oxidation of HsIYD•FMNhq (8 μM) by halotyrosines as a function of concentration 
under pre-steady state conditions. Oxidation of HsIYD•FMNhq was monitored by absorbance at 
446 nm. Values and error bars were the average and standard deviation of three independent 
measurements. The solid lines were generated by linear best fits to the data. The red dashed line 
represented the kcat value of HsIYD with I-Tyr under steady-state conditions. This figure was 
modified from Bobyk, K. D.; Ballou, D. P., Rokita, S. E.26 
 
The reductive half reaction for IYD is the reduction of its oxidized FMN cofactor 
(IYD•FMNox) to HsIYD•FMNhq. As mentioned in Chapter 4, the physiological reducing equivalent 
for IYD is NADPH but sodium dithionite is used instead in most enzymological studies since the 
electron transfer system proposed to shuttle electrons between NADPH and IYD has not yet been 
identified.29 Dithionite reduction of IYD was not expected to be rate-determining since dithionite 
is strongly reducing (E0.5 = -660 mV, pH 7) and is the most versatile and widely used reducing 
agent in biochemistry.142,143 Flavin reduction by NAD(P)H can be rate-determining in some 
reductases and monooxygenases.144,145 However, these past investigations have not determined if 
reduction by dithionite can be rate-determining in these systems. In one example where the 
dithionite reduction and the NADH reduction of the FMN dependent type 2 isopentenyl 
diphosphate:dimethylallyl diphosphate isomerase was compared, dithionite was able to reduce the 
enzyme at least 50-fold faster than NADH.146,147 
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In this chapter, the effect of substrates and substrate analogs on the reduction of HsIYD 
and TnIYD by excess dithionite was studied to determine its contribution to the rate-determining 
step of steady-state catalysis. The reduction of HsIYD and TnIYD was monitored by the decrease 
in 450 nm absorbance in the presence of I-Tyr, Cl-Tyr, F-Tyr, and Tyr at 25 °C. While all four 
ligands were found to inhibit the reduction of TnIYD as described below, only I-Tyr and Cl-Tyr 
inhibited HsIYD. The inhibition of enzyme reduction by substrates was more pronounced at higher 
substrate concentrations. As a result, reduction of enzyme under such conditions can be rate-
limiting for the turnover of both enzymes. The inhibition of TnIYD reduction by I-Tyr and F-Tyr 
was partially relieved by an Y112A mutation. At 60 °C, the rate of TnIYD reduction in the presence 
of I-Tyr was much faster than that at 25 °C, which is consistent to the thermophilic nature of 
Thermotoga neapolitana. 
5.2 Materials and methods: 
5.2.1 Protein expression and purification: 
HsIYD, TnIYD, TnIYD Y112A were expressed in E. coli as previously described (Section 
2.2.3). HsIYD was purified with the same protocol in Section 2.2.3 in which the SUMO tag was 
removed from the preparation after cleaved off from HsIYD by ULP1 protease. TnIYD and TnIYD 
Y112A free of Tyr were purified as described in Section 4.2.2. 
5.2.2 Reduction of IYD in the absence and presence of Tyr and halotyrosines: 
 Reduction of IYD in the absence and presence of substrates and substrate analogs were 
monitored by UV-vis spectroscopy aerobic conditions. TnIYD, TnIYD Y112A and HsIYD (15 μM) 
was alternatively incubated with 1 to 100 equivalent of I-Tyr, Cl-Tyr, F-Tyr, or Tyr relative to 
enzyme in 180 μL of 110 mM potassium phosphate, 220 mM potassium chloride, pH 7.4 in a 
cuvette at room temperature (25 ± 1 ºC with a thermometer) for 5 min. Sodium dithionite (20 μL 
of 0.5% in 5% sodium bicarbonate) was then added to the cuvette and vigorously mixed by 
pipetting for 6 s to initiate the reduction. The spectrum from 200 to 900 nm was monitored with a 
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Hewlett Packard 8453 Diode-Array Spectrophotometer every 5 s for 15 min. Reduction of TnIYD 
in the presence of 1 and 100 equivalent of I-Tyr was repeated at 60 ± 2 ºC (the actual temperature 
in the cuvette holder was measured by a thermometer and maintained by a circulating bath). 
In cases when I-Tyr were added after the reduction of IYD, the enzyme was first incubated 
with sodium dithionite at room temperature for 5 min. The reaction was initiated by addition of I-
Tyr (1 equivalent to enzyme), mixed and monitored similarly as described above. 
5.2.3 HPLC analysis of the dithionite reduction of IYD in the presence of I-Tyr: 
Reduction of HsIYD and TnIYD in the presence of I-Tyr described in the last section was 
quenched by 10 μL 44% formic acid. The cuvette was then incubated at 60 ºC for 2 min to ensure 
the decomposition of dithionite (white precipitations were generated from the decomposition which 
is likely elemental sulfur).116 Phenol as an internal standard (10 μL of 0.1 mM in 10 M sodium 
hydroxide) was added to the reaction to neutralize the formic acid. The neutralized reaction was 
then transferred to a microcentrifuge tube and centrifuged at 14000×g for 5 min. The supernatant 
(10-100 μL) was diluted by 110 mM potassium phosphate, 220 mM potassium chloride, pH 7.4 to 
a final volume of 1100 μL. This sample (900 μL) was then analyzed by HPLC and the deiodination 
product Tyr was detected via fluorescence as described in Section 4.2.5. 
5.2.4 Deiodination assay with different methods of reaction initiation: 
Deiodination by TnIYD with I-Tyr was measured after two alternative methods of reaction 
initiation. The TnIYD•FMNhq initiation method (reaction initiated by adding TnIYD reduced by 
excess dithionite to a solution of I-Tyr) is same as the deiodination assay with I-Tyr described in 
Section 4.2.5 in which Tyr was detected by HPLC by monitoring fluorescence. The dithionite 
initiation method (reaction initiated by adding dithionite to a solution of TnIYD pre-incubated I-
Tyr) is same as the deiodination assay with 2IP as substrate described in Section 4.2.5. 
5.3 Results and discussion: 
5.3.1 Reduction of HsIYD by dithionite is inhibited by I-Tyr: 
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Dithionite reduction of HsIYD•FMNox was monitored by the decrease of 450 nm 
absorbance in the absence and presence of I-Tyr to investigate the effect of substrate on the 
reduction of HsIYD•FMNox. In the absence of I-Tyr, 0.05% dithionite (~ 24 mM) fully reduced 
HsIYD•FMNox (15 μM) within the mixing time of the assay (≤ 6 s) (Figure 5-2(A), red). However, 
when the same experiment was repeated in the presence of 15 μM I-Tyr, the reduction of 
HsIYD•FMNox slowed by at least 5-fold as reduction required 30 s to complete (Figure 5-2(A), 
blue). The observed change in absorbance at 450 nm is a combined effect of HsIYD•FMNox 
reduction by dithionite (decreased 450 nm absorbance) and HsIYD•FMNhq oxidation by I-Tyr 
(increased 450 nm absorbance). The delay in full reduction observed in the presence of I-Tyr is not 
solely a result of the re-oxidation of HsIYD•FMNhq. When 15 μM I-Tyr was added to 
HsIYD•FMNhq in the presence of excess dithionite (0.05%), re-oxidation (up to 10% of total 
HsIYD•FMNox) was observed within the first 10 s (Figure 5-2(A), black). However, within the 
same time period ~ 40% of total HsIYD•FMNox remained in the oxidized form when reduced in 
the presence of I-Tyr. The slower reduction is also not caused by the accumulation of Tyr-the 
deiodination product of I-Tyr since the presence of up to 100 equivalent of Tyr to enzyme had no 
effect on the reduction of HsIYD•FMNox (Figure 5-2(B)), consistent with the weak binding of Tyr 
to HsIYD (Kd > 1 mM).31 Therefore, the binding of I-Tyr inhibits the reduction of HsIYD. It is 
possibly that the closure of the active site lid induced by I-Tyr blocks entrance of dithionite into 




Figure 5-2 Reduction of HsIYD•FMNox in the absence and presence of I-Tyr and Tyr. (A) 
Solutions (180 μL) of HsIYD•FMNox (15 μM final) and I-Tyr (0 μM (red) and 15 μM final (blue)) 
in 220 mM potassium chloride, 110 mM potassium phosphate, pH 7.4 were mixed with 20 μL 0.5% 
sodium dithionite in 5% sodium bicarbonate at t = 0 s. Reduction of HsIYD•FMNox was monitored 
by decrease of absorbance at 450 nm. For the re-oxidation of HsIYD•FMNhq by I-Tyr (black), 
solutions (160 μL) of HsIYD•FMNox (15 μM final) in the above buffer was mixed with 20 μL 0.5% 
sodium dithionite in 5% sodium bicarbonate prior to addition of 20 μL I-Tyr (15 μM final) at t = 0 
s. Re-oxidation of HsIYD•FMNhq was monitored by increase of absorbance at 450 nm. (B) 
Reduction of HsIYD•FMNox in the presence of 100 equivalent of Tyr to enzyme was performed 
similarly as described in (A).  
 
Dithionite reduction of HsIYD in the presence of 5-100 equivalent of I-Tyr was 
subsequently investigated to study the effect of I-Tyr concentration on the reduction of HsIYD. 
The decrease of absorbance at 450 nm slowed as the concentration of I-Tyr increased (Figure 5-3). 
With I-Tyr concentrations between 7.5 and 20 equivalent to HsIYD, the decrease of 450 nm 
absorbance with a slow phase followed by a fast phase (Figure 5-3, green, purple, yellow). The 
slow phase is most likely a steady-state during which the reduction of HsIYD•FMNox by excess 
dithionite was inhibited by the rapid re-oxidation of HsIYD•FMNhq by I-Tyr. As I-Tyr was 
consumed overtime, the rate of reduction began to outcompete the rate of re-oxidation and the 450 
nm absorbance started to decrease rapidly due to the fast buildup of HsIYD•FMNhq. Such 
hypothesis was confirmed by HPLC analysis of the reduction reaction in the presence of 20 
equivalent I-Tyr to HsIYD. At this I-Tyr concentration, the phase where reduction of 
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HsIYD•FMNox was slower than the re-oxidation of HsIYD•FMNhq lasted about 370 s (Figure 5-3, 
yellow). Roughly 210 μM deiodination product Tyr (70% of total I-Tyr) was produced during this 
phase. The remaining I-Tyr represented approximately 6 equivalent to HsIYD at the beginning of 
the next phase where reduction outcompetes re-oxidation. This is in good agreement with the fact 
that the first phase was not observed with I-Tyr less than 7.5 equivalent to HsIYD (Figure 5-3, 
green) likely due to much slower re-oxidation of HsIYD•FMNhq compared to the reduction of 
HsIYD•FMNhq at low I-Tyr concentrations (Figure 5-2 (B)). The results suggested that the 
reduction of HsIYD•FMNox was inhibited by I-Tyr in a concentration dependent manner and was 
slower than the re-oxidation of HsIYD•FMNhq at high I-Tyr concentrations. 
 
Figure 5-3 Effect of I-Tyr concentration on reduction of HsIYD•FMNox. (A) Solutions (180 μL) 
of HsIYD•FMNox (15 μM final) and I-Tyr (5-100 equivalent to HsIYD) in 220 mM potassium 
chloride, 110 mM potassium phosphate, pH 7.4 were mixed with 20 μL 0.5% sodium dithionite in 
5% sodium bicarbonate at t = 0 s. Reduction of HsIYD•FMNox was monitored by decrease of 
absorbance at 450 nm. The data with 0 and 1 equivalent were the same with those shown in Figure 
5-2(A). (B) The same data in (A) within the first 60 s of reduction. The conditions are color-code 
as described in (A).  
 
5.3.2 A HsIYD semiquinone species is detected during the reduction of HsIYD: 
During the reduction of HsIYD in the presence of high concentrations of I-Tyr (10-100 
equivalents), an absorption band around 590 nm corresponding to a FMN semiquinone (FMNsq) 
species was observed during the phase where reduction is slower than re-oxidation (Figure 5-4).148 
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A similar HsIYD•FMNsq species was also observed during the re-oxidation of HsIYD•FMNhq by 
I-Tyr under pre-steady-state conditions at a very low level that did not correlate to an on-pathway 
intermediate.26 A FMNsq species was also observed with MmIYD during its re-oxidation with I-
Tyr under single turnover conditions and was stable under aerobic conditions for days (post 
turnover).27 Therefore, the HsIYD•FMNsq species observed during the reduction is most likely an 
off pathway species different from the catalytically active HsIYD•FMNsq during catalysis. This 
species is most likely stabilized by the binding of substrates since the ligand free enzyme is readily 
reduced. The formation of this HsIYD•FMNsq species might be an additional source for the overall 
decrease of 450 nm absorbance besides the slowly increasing population of HsIYD•FMNhq.  
 
Figure 5-4 Formation and decay of a HsIYD•FMNsq species during the dithionite reduction of 
HsIYD in the presence of I-Tyr (20 equivalent to enzyme). The data shown in this figure were from 
the same reduction assay of HsIYD in the presence of I-Tyr (20 equivalent to enzyme) as shown in 




5.3.3 Reduction of HsIYD by dithionite is inhibited by Cl-Tyr in addition to I-Tyr: 
The effect of Cl-Tyr on the ditionite reduction of HsIYD was studied similarly as I-Tyr 
(Figure 5-5(A)). The reduction of HsIYD•FMNox in the presence of 1 equivalent of Cl-Tyr occurred 
similarly to that observed with 1 equivalent I-Tyr. Therefore, both Cl-Tyr and I-Tyr inhibit the 
reduction of HsIYD•FMNox relative to the ligand free enzyme under single turnover conditions. 
Interestingly, no significant inhibition of HsIYD•FMNox reduction in the presence of as much as 
100 equivalent of F-Tyr to enzyme was observed despite that F-Tyr binds to HsIYD•FMNox only 
10-fold less tightly than I-Tyr and Cl-Tyr.31 In the presence of more than 5 equivalent of I-Tyr, the 
reduction of HsIYD started with a slow phase where the rate of re-oxidation outcompetes the rate 
of reduction followed by a fast phase where the re-oxidation becomes rate-limiting due to depletion 
of substrates. However, the decrease in 450 nm absorbance with high concentrations of Cl-Tyr 
started with a fast phase for a few seconds before entering a slow steady phase (Figure 5-5(B)). The 
re-oxidation rate of HsIYD•FMNhq by Cl-Tyr was much slower than I-Tyr (Figure 5-1).26 Therefore, 
if the slow phase is where the re-oxidation and reduction reaches an equilibrium, the fast phase 
proceeding this equilibrium is probably the pre-steady-state phase before the slow re-oxidation of 
HsIYD•FMNhq started competing with the reduction. However, when the concentration of Cl-Tyr 
is smaller than 100 equivalent to enzyme, the re-oxidation is still rate-determining so that the 
accumulation of HsIYD•FMNhq dominates. The HsIYD•FMNsq species also formed during 
turnover of HsIYD•FMNox in the presence of more than 5 equivalent of Cl-Tyr to enzyme) in a 
higher concentration than that was observed in the presence of I-Tyr at similar concentrations. 
Higher concentrations of HsIYD•FMNsq were similarly observed during the re-oxidation of 
HsIYD•FMNhq by Cl-Tyr than by I-Tyr under previous pre-steady-state investigations.26 Based on 
results obtained here, the rate-determining step for Cl-Tyr turnover is likely the re-oxidation of 
HsIYD•FMNhq under low Cl-Tyr concentrations since the reduction of HsIYD•FMNhq was much 
less inhibited by re-oxidation for Cl-Tyr compared to I-Tyr. Under high Cl-Tyr concentrations, the 
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rates of re-oxidation are comparable to the kcat of I-Tyr deiodination (Figure 5-1). The steady-state 
kinetics of HsIYD with Cl-Tyr has not been reported. However, the kcat for Cl-Tyr was 3-fold and 
6-fold less than I-Tyr for DmIYD and TnIYD (25 °C, Table 4-1), respectively.28 The re-oxidation 
rates of HsIYD under high Cl-Tyr concentrations are likely to be higher than its steady-state kcat 
and therefore the reduction of HsIYD could still be at least partially rate-determining at high Cl-
Tyr concentrations. 
 
Figure 5-5 Effect of Cl-Tyr concentration on reduction of HsIYD•FMNox. (A) Solutions of 
HsIYD•FMNox (15 μM final) and Cl-Tyr (1-100 equivalent to HsIYD) were mixed with dithionite 
same as decribed in Figure 5-2(A). Reduction of HsIYD•FMNox was monitored by decrease of 
absorbance at 450 nm. (B) Comparison of reduction of HsIYD•FMNox in the presence of 1, 5, and 
10 equivalent of I-Tyr and Cl-Tyr. The data for I-Tyr were the same with those shown in Figure 5-
2(A).  
 
5.3.4 Reduction of TnIYD by dithionite is severely inhibited by I-Tyr: 
The effect of I-Tyr on the dithionite reduction of oxidized TnIYD (TnIYD•FMNox) was 
then studied similarly to that with HsIYD by monitoring the decrease of 450 nm absorbance. In the 
absence of I-Tyr, TnIYD•FMNox (15 μM) was fully reduced by dithionite (0.05%) within the 
mixing time of the assay (≤ 6 s) similar to HsIYD (Figure 5-6(A), black). Strikingly, even just 1 
equivalent of I-Tyr to TnIYD severely slowed the decrease of 450 nm absorbance by at least 500-
fold (~ 4.2 μM reduced in 15 min) compared to ligand free TnIYD (Figure 5-6(A), red). This 
inhibition is 100-fold more severe than that observed for HsIYD with 1 equivalent of I-Tyr. The 
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inhibition is not a result of rapid re-oxidation since re-oxidation of pre-reduced TnIYD•FMNhq by 
1 equivalent I-Tyr in the presence of excess dithionite was only observed during the first 60 s 
(Figure 5-6(B), red). The inhibition is also not caused by accumulation of Tyr since 1 equivalent 
of Tyr only marginally inhibited the reduction for less than 60 s (Figure 5-6(B), green). However, 
Tyr inhibited TnIYD reduction much more efficient than HsIYD reduction since no inhibition of 
HsIYD reduction was observed in the presence of up to 100 equivalent of Tyr to enzyme (Figure 
5-2(B)). This is consistent with 104-fold tighter binding of Tyr to TnIYD•FMNox than to 
HsIYD•FMNox. The results demonstrated that the reduction of TnIYD was severely inhibited by 
binding of 1 equivalent of I-Tyr. Similarily as for HsIYD, such inhibition is likely due to the closure 
of TnIYD’s active site lid induced by I-Tyr. 
 
Figure 5-6 Effect of I-Tyr and Tyr on reduction of TnIYD•FMNox.(A) Solutions of TnIYD•FMNox 
(15 μM final) and I-Tyr (1-100 equvalent to enzyme) were mixed with dithionite similarly as 
described in Figure 5-2(A). Reduction of TnIYD•FMNox was monitored by decrease of absorbance 
at 450 nm. (B) For reduction of TnIYD in the presence of Tyr, a solution of TnIYD•FMNox (15 μM 
final) and Tyr (1 equvalent to enzyme, green) was mixed with dithionite similarly as described in 
Figure 5-2(A). For the re-oxidation of TnIYD•FMNhq by I-Tyr (dark red), a solution of 
TnIYD•FMNox (15 μM final) was mixed with sodium dithionite prior to addition of I-Tyr (15 μM 
final) as described in Figure 5-2(A). Re-oxidation of TnIYD•FMNhq was monitored by increase of 
absorbance at 450 nm.  
 
Inhibition of TnIYD reduction was even more pronounced as I-Tyr concentration increased 
(Figure 5-6(A)). With more than 5 equivalent of I-Tyr, the decrease of 450 nm absorbance in the 
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presence of excess dithionite nearly stalled (only 1.3 μM TnIYD•FMNox (less than 10%) reduced 
in 15 min). Detection of Tyr after15 min of TnIYD reduction reaction with 10, 20, 100 equivalent 
of I-Tyr showed that TnIYD in these reactions were still actively producing Tyr with V/[E]s of 
0.17, 0.21, and 0.08 min-1, respectively. The results suggested that at high I-Tyr concentrations, the 
reduction of TnIYD was also slower than re-oxidation of TnIYD•FMNhq by I-Tyr in addition to the 
already severe inhibition by binding of I-Tyr as demonstrated under single turnover conditions. The 
magnitude of V/[E]s of Tyr formation described above were about 10-fold smaller than the kcat of 
TnIYD with I-Tyr at 25 °C (Table 4-1). This discrepancy is a result of different reaction initiation 
method being used. The reactions for steady-state kinetics of TnIYD with I-Tyr described in 
Section 4.3.4 were initiated by adding TnIYD•FMNhq pre-reduced with dithionite to a solution of 
I-Tyr (TnIYD•FMNhq initiation). However, when the reactions were initiated by adding dithionite 
to pre-incubated TnIYD and I-Tyr like in the reduction assays (dithionite initiation), the measured 
kcat (0.42 ± 0.07 min-1) was 10-fold smaller than that obtained by the TnIYD•FMNhq initiation 
method and is within the same order of magnitude with the V/[E]s measured in the reduction assay 
(Appendix Table D1).7 Two initiation methods only have different impacts on the first turnover 
after which the next turnover starts with the TnIYD•Tyr complex for both methods. Therefore, the 
much slower activity measured by the dithionite initiation method compared to the TnIYD•FMNhq 
initiation method was most likely due to inhibition of TnIYD reduction by pre-incubation with I-
Tyr in the first turnover. A TnIYD semiquinone species (TnIYD•FMNsq) was also detected during 
the reduction of TnIYD in the presence of I-Tyr, but in much smaller quantity compared to HsIYD. 
5.3.5 Reduction of TnIYD by dithionite was inhibited by Cl-Tyr and F-Tyr as well: 
The effect of Cl-Tyr on the reduction of TnIYD•FMNox by dithionite was studied similarly 
as that described above with I-Tyr (Figure 5-7). Cl-Tyr also inhibited the reduction of TnIYD at 
both low (1 equivalence) and high (100 equivalence) concentrations. TnIYD reduction inhibited by 
                                                          
7 This measurement were performed by Shaun Spisak (Johns Hopkins University). 
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Cl-Tyr was somewhat less compared to that produced by I-Tyr. This might be a result of slower re-
oxidation of TnIYD•FMNhq by Cl-Tyr (Table 4-1). However, unlike in the case of HsIYD for which 
100 equivalent of F-Tyr did not show any inhibition of reduction, F-Tyr significantly slowed 
reduction of TnIYD with just 1 equivalent (Figure 5-7). Increase the concentration of F-Tyr to 100 
equivalence to TnIYD further inhibited its reduction by 2-fold. Since F-Tyr was not able to re-
oxidize TnIYD•FMNhq (Section 4.3.4), this provided direct evidence that reduction of 
TnIYD•FMNox is inhibited by binding of halotyrosines alone. Inhibition of the reduction of TnIYD 
by F-Tyr was still much less compared to I-Tyr and Cl-Tyr as 100 equivalent of F-Tyr to TnIYD 
inhibits the reduction to a similar degree as observed with 1 equivalent of I-Tyr and Cl-Tyr. This 
is inconsistent with similar affinity of I-Tyr and F-Tyr to TnIYD (Table 4-1). 
 
Figure 5-7 Effect of F-Tyr and Cl-Tyr on reduction of TnIYD•FMNox. Solutions of TnIYD•FMNox 
(15 μM final) and F-Tyr or Cl-Tyr (1 and 100 equvalent to enzyme) were mixed with dithionite as 
described in Figure 5-2(A). Reduction of TnIYD•FMNox was monitored by decrease of absorbance 
at 450 nm. The data for reduction of TnIYD in the presence of 1 and 100 equivalent of I-Tyr were 
the same as shown in Figure 5-6.  
 
5.3.6 A TnIYD variant partially relieved the inhibition of TnIYD reduction by I-Tyr and F-
Tyr: 
 
As described in Section 4.3.5, residue Y112 of TnIYD is the only residue near the active 
site that exhibited a conformational difference between the co-crystal structures of 
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TnIYD•FMNox•I-Tyr and TnIYD•FMNox•Tyr (Figure 4-7(D)). This residue was suspected to be 
responsible for the tight binding of Tyr to TnIYD•FMNox but later proven not to be the case by an 
Y112A mutation. Since Y112 is also close to the FMN cofactor, substitutions of this residue may 
affect the reduction of TnIYD. Therefore, the reduction of TnIYD Y112A (Section 4.3.5) was 
studied similarly to the wildtype enzyme in the presence of I-Tyr and F-Tyr (Figure 5-8). The 
reduction of TnIYD Y112A in the presence of I-Tyr (1 and 100 equivalents) was only mildly faster 
than TnIYD with I-Tyr (Figure 5-8(A)). However, 1 equivalent of F-Tyr inhibited the reduction of 
the mutant much more weakly than that with TnIYD (Figure 5-8(B)). This effect was even more 
pronounced with 100 equivalent F-Tyr so that the reduction rate difference between with 1 and 100 
equivalent of F-Tyr was smaller for the Y112A variant (1.2-fold) than for TnIYD (2-fold). A 
possible explanation for this observation is that Y112A could create a path for dithionite to access 
the FMN cofactor (Appendix Figure D1) when the lid is closed in the presence of I-Tyr and F-Tyr. 
The reason why the inhibition of reduction was relieved to a greater degree for F-Tyr than for I-
Tyr might be a result of stronger repulsion of negatively charged dithionite ion by the much bigger 








Figure 5-8 Effect of Y112A mutation on the inhibition of reduction of TnIYD•FMNox by I-Tyr and 
F-Tyr. (A) Solutions of TnIYD Y112A•FMNox (15 μM final) and I-Tyr (1 and 100 equvalent to 
enzyme) were mixed with dithionite as described in Figure 5-2(A). Reduction of TnIYD•FMNox 
was monitored by decrease of absorbance at 450 nm. The data for reduction of TnIYD in the 
presence of 1 and 100 equivalent of I-Tyr were the same as shown in Figure 5-6. (B) Solutions of 
TnIYD Y112A•FMNox (15 μM final) and F-Tyr (1 and 100 equvalent to enzyme) were mixed with 
dithionite as described in Figure 5-2(A). The data for reduction of TnIYD in the presence of 1 and 
100 equivalent of F-Tyr were the same as shown in Figure 5-7.  
 
5.3.7 The reduction of TnIYD in the presence of I-Tyr was significantly faster at 60 °C: 
Since TnIYD is a thermophilic enzyme, its reduction in the presence of substrate is 
expected to be faster at elevated temperatures. If the reduction is rate-determining at 25 °C, the 
higher activity of TnIYD measured at 60 °C compared to at 25 °C would also suggest faster 
reduction rates at 60°C. Therefore, the reduction of TnIYD in the presence of I-Tyr was studied at 
60 °C similarly to that as 25 °C. Indeed, the reduction of TnIYD in the presence of 1 equivalent of 
I-Tyr was much faster at 60 °C compared to that at 25 °C (Figure 5-9). Almost full reduction was 
achieved within the first 120 s after which the 450 nm absorption started to increase. Since there is 
no excess I-Tyr, this increase cannot be attributed to the re-oxidation of TnIYD•FMNhq by I-Tyr. 
Re-oxidation of TnIYD•FMNhq by oxygen was also not likely because the system was essentially 
anaerobic in the presence of excess dithionite. Instead, it is likely an effect of evaporation despite 
that the cuvette was capped with a stopper. This hypothesis is supported by the higher initial 
absorbance at 450 nm before addition of dithionite at 60 °C compared to that at 25 °C despite 
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having the same amount of enzyme in each case. About 7% of the solvent was evaporated during 
the 5 min incubation time of TnIYD and I-Tyr before introducing dithionite. Therefore, 21% of the 
solvent should be evaporated in the 15 min of the assay. This agrees well with the observed 22% 
increase in 450 nm absorbance during the same period. The faster reduction at 60 °C could be a 
thermodynamics effect as dithionite is more reducing at higher temperatures142 or a simple kinetic 
effect. However, TnIYD could also exhibit greater conformational flexibility at higher temperatures 
which might provide an easier access to the FMN cofactor for dithionite. 
 
Figure 5-9 Effect of temperature on the reduction of TnIYD•FMNox in the presence of I-Tyr. 
Solutions of TnIYD•FMNox (15 μM final) and I-Tyr (1 and 100 equvalent to enzyme) were mixed 
with dithionite as described in Figure 5-2(A) under 60 °C. Reduction of TnIYD•FMNox was 
monitored by decrease of absorbance at 450 nm. The data for reduction of TnIYD in the presence 
of 1 and 100 equivalent of I-Tyr at 25 °C were the same as shown in Figure 5-6.  
 
The reduction of TnIYD was still much faster in the presence of 100 equivalent of I-Tyr at 
60 °C compared to at 25 °C as indicated by the ~ 20% decrease in 450 nm absorbance in the first 
120 s °C compared to ~ 1.3% at 25 °C. After this initial reduction period the absorbance started to 
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increase again in a rate similarly as in the presence of 1 equivalent I-Tyr. Therefore, this increase 
is again an effect of solvent evaporation overtime. The maximum 20% reduction with 100 
equivalent I-Tyr compared to almost full reduction with 1 equivalent I-Tyr is likely again due to 
the rapid re-oxidation of TnIYD•FMNhq being rate-determining. 
5.3.8 A note on the biological implication of the slow reduction of IYD by dithionite in the 
presence of substrate: 
 
Inhibition on reduction of IYD by dithionite in the presence of substrates and substrate 
analogs suggested that reduction of the enzyme (regeneration of IYD•FMNhq) could be rate-
determining when substrate concentration is high. However, does this effect observed with an 
artificial reductant applies to the physiological reduction of IYD as well? It is beneficial for IYD 
to be reduced after the substrate is bound and the active site lid is closed so that the reduced FMN 
will transfer electrons to substrates rather than to oxygen that would generate reactive oxygen 
species. However, the closure of the active site lid also shields FMN from solvent and therefore 
potentially hinders the reduction of the enzyme. Some flavoenzymes evolved mechanisms using 
substrate binding to greatly increase the rate of reduction by NAD(P)H.147,149,150 In some of these 
cases conformational changes induced by substrate binding have been suggested to expose the N5 
of FMN to the NAD(P)H binding site and facilitate the reduction of the cofactor.151,152 Therefore, 
it is possible that the physiological reducing system of IYD which shuttles electrons between 
NADPH and IYD can induce a conformational change of substrate-bound IYD to facilitate 
reduction. However, there are no conserved residues on the surface of IYD homologs from bacterial 
to mammalian near the N5 of FMN to support the recognition of an electron transfer protein. In 
addition, no conserved reductases have been found to cluster with the gene of IYD in genomes of 
bacteria and archaea that containing IYD homologs. An IYD reductase was also never co-purified 
with IYD isolated from thyroid issues.123 Therefore, the physiological reducing partner of IYD 
might not be a reductase that specifically recognizes IYD but may act as a general reducing system 
that non-specifically interacts with IYD. The NADPH responsive activity of IYD has been 
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supported by the following reducing systems: (1) thyroid issue homogenates containing the 
physiological IYD reducing sytem;123 (2) a HEK 293 cell homogenate;153 (3) and reducing systems 
such as spinach ferredoxin reductase/ferredoxin from Clostridium pasteurianum, bovine 
ferredoxin/ferredoxin reductase, and cytochrome c reductase/methyl viologen.154,155 However, in 
none of these cases did the NADPH responsive activity of IYD support faster deiodination than the 
dithionite responsive activity measured under similar conditions. It is possible that the NADPH 
responsive activity can be increase by increasing concentrations of NADPH and the reducing 
system. However, at least in the thyroid tissue homogenate the ratio of IYD versus its physiological 
reducing system should be similar to that in vivo. The reduction of IYD could potentially be rate-
determining for I-Tyr deiodination in vivo as well. Such a hypothesis might be tested once the 
physiological reducing system is identified. 
5.4 Summary: 
In this chapter, the reduction of HsIYD and TnIYD by excess dithionite was studied by 
monitoring the decrease in 450 nm absorbance in the absence and presence of substrates and 
substrate analogs. A single equivalent of I-Tyr and Cl-Tyr inhibited reduction of HsIYD•FMNox by 
~ 5-fold while F-Tyr and Tyr did not. In the presence of excess I-Tyr, reduction of HsIYD•FMNox 
was slow compared to re-oxidation of HsIYD•FMNhq and therefore might be rate-determining for 
IYD turnover. In the presence of Cl-Tyr, the reduction of HsIYD was faster than the re-oxidation 
of HsIYD•FMNhq and therefore the reduction of HsIYD might not be rate-determinging except at 
high Cl-Tyr concentrations. A likely off pathway HsIYD•FMNsq species was also detected during 
the enzyme turnover. A single equivalent of I-Tyr, Cl-Tyr, and F-Tyr all severely inhibited 
reduction of TnIYD•FMNox by at least 250-fold while Tyr more mildly inhibited the reduction by 
10-fold at 25 °C. Higher concentrations of I-Tyr, Cl-Tyr, and F-Tyr further inhibited reduction of 
TnIYD at 25 °C. For F-Tyr, this inhibition was simply due to binding of F-Tyr to the enzyme while 
with I-Tyr and Cl-Tyr rapid re-oxidation also slowed reduction.. Reduction of TnIYD inhibited by 
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I-Tyr and F-Tyr can be partially relieved by an Y112A mutation. The mutation likely created a path 
for dithionite to access the FMN cofactor more readily. At 60 °C, the reduction of TnIYD in the 
presence of 1 and 100 equivalent of I-Tyr was much faster than that at 25 °C. Despite the faster 
reduction, TnIYD•FMNhq regeneration could still be rate-determining at 60 °C since the reduction 
of TnIYD•FMNhq in the presence of 100 equivalent of I-Tyr was still slower than re-oxidation 
TnIYD•FMNox. The reduction of IYD monitored in the UV-vis assay with substrate concentrations 
higher than 1 equivalence to enzyme was complicated by the intertwining of reduction and re-
oxidation. Therefore, to obtain the true reduction rates of IYD in the presence of higher 
concentrations of substrate, rapid kinetics will be used to capture the pre-steady-state phase of the 
reduction reaction before re-oxidation in collaboration with Prof. Giovanni Gadda (Georgia State 
University). The rate constants obtained will then determine whether or not reduction of the enzyme 
















Chapter 6 Conclusion 
IYD provides a rare aerobic strategy for the bioremediation of halophenols by reductive 
dehalogenation. However, its weak native activity towards halophenols needs to be first improved 
before its full potential can be utilized for this application. To generate an efficient halophenol 
dehalogenase, HsIYD was first redesigned by Rosetta to accept 2IP, a model for halophenols, as 
an efficient substrate. The sequence of the active site lid of HsIYD was varied by Rosetta’s fixed 
backbone design protocol to stabilize the closed lid in the presence of 2IP. This approach 
successfully improved 2IP deiodination of HsIYD by 4.5-fold only when Rosetta was allowed to 
sample all amino acids without restrictions. In contrast, a parallel approach guiding Rosetta via 
intuition to stabilize secondary structures of the lid failed to generate active variants towards 2IP. 
Attempts to further improve 2IP deiodination by accumulation of single mutations were frustrated 
by the strong epistatic nature of lid mutations possibly resulting from extensive side-chain 
interactions. Rosetta can overcame such epistasis with coordinated mutations introduced 
simultaneously. While as little as 2 mutations were able to improve 2IP deiodination, only a sum 
of 15 mutations generated by the unguided Rosetta design demonstrated success in changing the 
responsiveness of the active site lid from I-Tyr to 2IP with. 
Further attempts to improve the computational design were focused on enlarging the 
sequence space for Rosetta to explore. First, fixed backbone design was performed on nine residues 
around the zwitterion of I-Tyr in its co-crystal structure with HhIYD, an easy-to-work with 
alternative to HsIYD. Focusing the design effort on these nine residues near the substrate over the 
entire lid increased sampling of mutations that could potentially interact with the substrate. 
However, this approach only improved 2IP deiodination by 2-fold compared to HhIYD. 
Subsequently, the native lid of HhIYD was remodeled by replacing the lid with shorter loops (15 
and 16 amino acid long) from the PDB that can potentially form a more structured lid upon binding 
of 2IP. This approach again failed to generate active variants towards 2IP. Nevertheless, Rosetta 
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once again demonstrated the ability to alter the stability and responsiveness of an active site lid 
with the loop replacement protocol. The results demonstrated Rosetta as a great tool for stabilizing 
the targeted enzyme•2IP complex. But the failure to obtain an efficient 2IP deiodinase might 
suggest the incorrectness of the target model which was proposed from the crystal structures of 
catalytically inactive oxidized IYD. The crystal structure of the catalytically active reduced IYD 
might instead reveal productive enzyme-substrate interactions for catalysis to guide future designs. 
IYD from a thermophilic bacteria Thermotoga neapolitana (TnIYD) was characterized for 
its potential to gain a high resolution crystal structure of the fully reduced IYD. Previously, the 
crystals of oxidized mesophilic IYDs were unstable to reduction by dithionite. The possibly low 
conformational flexibility of a thermophilic IYD at room temperature might improve the quality of 
crystals. In addition, its thermostability might also facilitate IYD engineering by the ability to 
incorporate more structurally deleterious but functionally beneficial mutations than mesophilic 
IYDs. Surprisingly, TnIYD was purified containing an FMN semiquinone species which was 
generated via reduction of TnIYD•FMNox in the presence of Tyr. This reduction was supported by 
free reduced flavins generated from the endogenous E. coli flavin reducing systems. TnIYD was 
demonstrated to be a functional halotyrosine dehalogenase with severe substrate inhibition at both 
25 and 60 °C. The kcat of TnIYD with 2IP at 60 °C already rivals those of mesophilic IYDs with I-
Tyr at 25 °C, making it a potentially good parent enzyme for designing a halophenol dehalogenase. 
High resolution crystal structure of TnIYD•FMNox with I-Tyr, F-Tyr, or Tyr bound showed overall 
similarity to mesophilic IYDs but demonstrated TnIYD as a structurally minimal halotyrosine 
dehalogenase. TnIYD•FMNox was able to bind Tyr two orders of magnitude more tightly than 
mesophilic IYDs. Yet the crystal structure of TnIYD•FMNox with Tyr resembles mesophilic IYDs 
with I-Tyr and therefore did not suggest the structural basis for its tight binding of Tyr. The crystals 
of TnIYD•FMNox with I-Tyr, Tyr, F-Tyr bound were readily reduced to TnIYD•FMNsq by 
dithionite in less than 5 min but further reduction did not lead to the crystals containing FMN 
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hydroquinone. There is no significant conformational change for TnIYD in the crystal structure 
upon reduction from TnIYD•FMNox to TnIYD•FMNsq, suggesting that the active site of oxidized 
structures are sufficient to stabilize intermediates involving TnIYD semiquinone during catalysis. 
The discovery of an additional binding site for I-Tyr at the dimer interface of TnIYD likely offers 
an explanation for the substrate inhibition of IYDs. 
The re-oxidation rates of HsIYD•FMNhq by I-Tyr measured under pre-steady-state 
conditions were much faster than the kcat of HsIYD with I-Tyr under steady-state conditions. The 
result suggested that the re-oxidation of HsIYD was not rate-determining under steady-state 
conditions. The reduction half of the catalysis therefore could be rate-determining. Single 
equivalents of I-Tyr and Cl-Tyr, but not F-Tyr and Tyr, were indeed found to inhibit the dithionite 
reduction of HsIYD•FMNox by about 5-fold compared to ligand free enzyme. In the presence of 
higher concentrations of I-Tyr (> 1 equivalent to enzyme), reduction of HsIYD•FMNox was slower 
than with re-oxidation of HsIYD•FMNhq and thus is possibly rate-determining.  However, in the 
presence of higher concentrations of Cl-Tyr (> 1 equivalent to enzyme), reduction of 
HsIYD•FMNox outcompeted re-oxidation of HsIYD•FMNhq except at very high concentrations of 
Cl-Tyr (100 equivalent). Reduction inhibited by substrates and substrate analogs was much more 
pronounced for TnIYD as single equivalents of I-Tyr, Cl-Tyr, and F-Tyr all severely inhibited the 
reduction of TnIYD•FMNox by at least 250-fold while Tyr more mildly inhibited reaction by 10-
fold at 25 °C. Higher concentrations of I-Tyr, Cl-Tyr, and F-Tyr (100 equivalent) further slowed 
the reduction of TnIYD. While for the catalytically inactive F-Tyr this is most likely an effect of 
F-Tyr binding, for I-Tyr and Cl-Tyr the reduction of TnIYD•FMNox was further inhibited by the 
faster re-oxidation of TnIYD•FMNhq, which makes reduction a possible rate-determining step for 
TnIYD catalysis as well. At 60 °C, the reduction of TnIYD in the presence of 1 equivalent I-Tyr 





Appendix A: Supporting information for Chapter 2 
Table A1 Degree of freedom allowed at each calculation stage. This table was originally published 
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Table A2 Constrains at each position of the active site lid for the guided Rosetta design approach. 








E 157 A, F, L, M, W 
Non-polar facing protein interior; A, L, and M favor α-
helix formation; Except for A, bulky to fill up the void 
E 158 Not changed Charged on protein surface; Favor α-helix formation 
I 159 E, Q, K, R 
Polar on protein surface; Except for Q, favor α-helix 
formation 
N 160 Not changed 
Conserved in all IYD homologs; Interacts with a few 
nearby residues; Despite disfavors α-helix formation 
and being a polar residue facing protein interior 
Y 161 A, F, L, M, W Same as residue 157 
M 162 K, R 
Charged on protein surface; Favor α-helix formation; 
Positive charge stabilizes helix dipole at the C-terminus 
K 163 G, K 
K is charged on protein surface and presents a positive 
charge stabilizes helix dipole at the C-terminus; G 
stabilizes the α-helix at C-cap position. 
R 164 Not changed 
Conserved in all IYD homologs; Interacts with a few 
nearby residues; Charged on protein surface 
M 165 Not changed Conserved in all IYD homologs 
G 166 G, D, N, S Stabilize the α-helix at N-cap position 
H 167 E, P 
Stabilize the α-helix at N+1 position; E presents a 
negative stabilizes helix dipole at the N-terminus 
R 168 E 
Charged on protein surface; Negative charge stabilizes 
helix dipole at the N-terminus 
W 169 Not changed Conserved in all IYD homologs; π-stacked with Y211 
V 170 A, L, M, Q 
No clear polarity preferences; A, L, M favor α-helix 
formation 
T 171 E, Q, K, R Charged/polar on protein surface; E, K, R favor α-helix  
D 172 Not changed 
Conserved in all IYD homologs; Interacts with a few 
nearby residues; Charged on protein surface; Despite 
disfavors α-helix formation 
L 173 Not changed 
Conserved in all IYD homologs; Non-polar underneath 
2IP; Favor α-helix formation 
K 174 Not changed 
Charged on protein surface; Positive charge stabilizes 
helix dipole at the C-terminus; Favor α-helix formation” 
K 175 Not changed Same as residue 174 
L 176 Not changed Non-polar facing protein interior; Favors α-helix 
R 177 Q, K, R, G 
No clear preference, naturally occurred in IYD 
homologs 
T 178 E, D, N, T, Q Same as residue 177 
N 179 D, N, T Same as residue 177 
W 180 Conserved Conserved in all IYD homologs 
I 181 I, V, E, S, H Same as residue 177 
K 182 M, K 
K may interact with a few nearby residues; M is a bulky 
non-polar residue facing protein interior and may fill up 
the void 
aFactors stabilizing α-helix were based on published studies.66,156,157 
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Table A3 DNA oligonucleotides used for cloning. This table was originally published in Sun, Z.; 







Fg AACTGGATTAAAGAGTACTTGG  
HsIYDc 





















3 GATGAATGGGTCGAAGACCTCAAGAAACTGAACCTGGATTGG  
4  ATGACGCCAATCCAGGTTCAGTTTCTTG   
F  GAAAGATCATTGAGGAGGAAGATGAGAAAAACTGGAAAAG  Assembled 
UD01 R  GGCAGTATCCAAGTACTCATGACGCCAATCCAGGTTC   
UD06 SDM 
F AGATAAGAACAACTGGAAATGCAGGTTTGGAGATGAATG  
UD01 
R  TTTCCAGTTGTTCTTATCTTCCTCCTCAATGATCTTTCG   
UD07 SDM 
F ATGGATCGCAGACCTCAAGAAACTGAACCTGGATTGGC   
UD06 
R  CTTGAGGTCTGCGATCCATTCATCTCCAAACCTGCATTTC  
UD08 SDM 
F GGAATCTTATGAAAACTGGGCAAGAAGGTTTGGAGATGAATG   
UD01 
R  GCCCAGTTTTCATAAGATTCCTCCTCAATGATCTTTCGAATC   
UD03 SDM 
F ATGGGTCGCAGACCTCAAGAAACTGCGCCTGGATTGGCG  
UD07 
R  TTGAGGTCTGCGACCCATTCATCTCCAAACCTGCATTTC  
UD05 SDM 
F TAAGGAAAACTGGGCACGCAGGTTTGGAGATGAATGGGTC   
UD03 


















































 CATCGTTCCATTCCTGTCCCCACCTTTTCAGCCAGTTTTTC   
UD08 IMe 
E157S 
F AGGAGGAAAGCGAGATCAACTACATGAAAAGGATGGGACATC   
HsIYD 
R  GTTGATCTCGCTTTCCTCCTCAATGATCTTTCGAATCTTG   
UD08 IM 
E158Y 
F AGGAGGAAGAGTACATCAACTACATGAAAAGGATGGGACATC   
HsIYD 
R  GTTGATGTACTCTTCCTCCTCAATGATCTTTCGAATCTTG   
UD08 IM 
I159E 
F AGGAGGAAGAGGAGGAAAACTACATGAAAAGGATGGGACATC   
HsIYD 
R  GTTTTCCTCCTCTTCCTCCTCAATGATCTTTCGAATCTTG  
UD08 IM 
Y161W 
F AGATCAACTGGATGAAAAGGATGGGACATCGCTGGGTCACAG   
HsIYD 
R  CATCCTTTTCATCCAGTTGATCTCCTCTTCCTCCTCAATGATC   
UD08 IM 
M162A 
F AGATCAACTACGCGAAAAGGATGGGACATCGCTGGGTCACAG   
HsIYD 
R  CATCCTTTTCGCGTAGTTGATCTCCTCTTCCTCCTCAATGATC   
UD08 IM 
K163R 
F AGATCAACTACATGCGTAGGATGGGACATCGCTGGGTCACAG   
HsIYD 
R  CATCCTACGCATGTAGTTGATCTCCTCTTCCTCCTCAATGATC   
UD08 IM 
M165F 
F AGATCAACTACATGAAAAGGTTTGGACATCGCTGGGTCACAG   
HsIYD 
R  AAACCTTTTCATGTAGTTGATCTCCTCTTCCTCCTCAATGATC   
UD08 IM 
H167D 
F GGATGGGAGATCGCTGGGTCACAGACCTCAAGAAACTGAG  
HsIYD 
R  GACCCAGCGATCTCCCATCCTTTTCATGTAGTTGATCTCC   
UD08 IM 
R178E 
F GGATGGGACATGAATGGGTCACAGACCTCAAGAAACTGAG   
HsIYD 
R  GACCCATTCATGTCCCATCCTTTTCATGTAGTTGATCTCC   
UD08 IM 
T171E 
F TGGGACATCGCTGGGTCGAAGACCTCAAGAAACTGAGAACC  
HsIYD 
R  TTCGACCCAGCGATGTCCCATCCTTTTCATGTAGTTGATC   
UD08 IM 
R177N 
F AAACTGAACACCAACTGGATTAAAGAGTACTTGGATACTGCC   
HsIYD 
R  CCAGTTGGTGTTCAGTTTCTTGAGGTCTGTGACCCAG   
UD08 IM 
T178L 
F AAACTGAGACTGAACTGGATTAAAGAGTACTTGGATACTGCC   
HsIYD 
R  CCAGTTCAGTCTCAGTTTCTTGAGGTCTGTGACCCAG  
UD08 IM 
N179D 
F AAACTGAGAACCGATTGGATTAAAGAGTACTTGGATACTGCC   
HsIYD 
R  CCAATCGGTTCTCAGTTTCTTGAGGTCTGTGACCCAG   
GD08 IM 
I181R 
F AACTGGCGCAAAGAGTACTTGGATACTGCCCCTATTTTG   
HsIYD 
R  GTACTCTTTGCGCCAGTTGGTTCTCAGTTTCTTGAGGTC   
GD08 IM 
K182H 
F AACTGGATTCACGAGTACTTGGATACTGCCCCTATTTTG   
HsIYD 




F AGAGTACATCAACTACGCGAAAAGGATGGGACATCGCTGG   
HsIYD 
R  TCGCGTAGTTGATGTACTCTTCCTCCTCAATGATCTTTCG   
His-tag 
deletion 
F  AGATCATGGTGACAGTATAACACCATCACCATCACCATTAG   HsIYD and 
variants R  TTATACTGTCACCATGATCTGGTCCAGAGGTTTGCGCTTG   









F AGGAGGAATGCTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAGCATTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157D 
F AGGAGGAAGATTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAATCTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157F 
F AGGAGGAATTTTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAAAATTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157G 
F AGGAGGAAGGCTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAGCCTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157H 
F AGGAGGAACATTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAATGTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157I 
F AGGAGGAAATTTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAAATTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157K 
F AGGAGGAAAAATACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTATTTTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157L 
F AGGAGGAACTGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACAGTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157M 
F AGGAGGAAATGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACATTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157N 
F AGGAGGAAAACTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAGTTTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157P 
F AGGAGGAACCGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACGGTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157Q 
F AGGAGGAACAGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACTGTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157R 
F AGGAGGAACGTTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAACGTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157S 
F AGGAGGAAAGCTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAGCTTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157T 
F AGGAGGAAACCTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAGGTTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157V 
F AGGAGGAAGTGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACACTTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157W 
F AGGAGGAATGGTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTACCATTCCTCCTCAATGATCTTTCGAATCTTG  
DM01 SSM 
E157Y 
F AGGAGGAATATTACATCAACTACGCGAAAAGGATGGGACATC  
DM01 
R GTTGATGTAATATTCCTCCTCAATGATCTTTCGAATCTTG  
aAll DNA oligonucleotides are from 5’ end to 3’ end from left to right. bSDM, site directed mutagenesis; cTemplate here 
is the pSMT3 plasmid carrying the indicated enzyme; dGD02, 04, 09 were constructed by two rounds of SDM; eThe 
template for second round SDM is the PCR product of first round SDM as indicated by the number in parenthesis; fSSM, 
site saturation mutagenesis; gF, forward; R, reverse. 
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Table A4 HPLC solvent programs for Tyr, phenol and FMN analysis. This table was originally 
published in Sun, Z.; Rokita, S. E.60 
 
Program 1: resorcinol as internal standard: 
 

























Table A5 The binding affinity and deiodination activity of HsIYD towards 2IP in the absence and 





0.5 mM 2IP 4 mM 2IP 
No Amino acid 2.4 ± 0.1 0.020 ± 0.004 0.121 ± 0.004 
+ 10 mM Gly 2.42 ± 0.08 0.026 ± 0.004 0.164 ± 0.004 
+ 10 mM Ala 2.12 ± 0.07 0.019 ± 0.004 0.119 ± 0.005 
aThree independent measurements were fitted as one curve to obtain the Kd and associated error. bThe V/[E] represent 
the average of three independent measurements. The error is either the standard deviation of three independent 




















Table A6 2IP deiodination activity of HsIYD and its variants generated by Rosetta with 0.5 mM 
2IP. This table was originally published in Sun, Z.; Rokita, S. E.60 
 V/[E] (min-1)a   V/[E] (min-1)a 
HsIYD 0.024 ± 0.004b UD04 0.008 ± 0.004 
GD01 ≤ 0.004c UD05 0.055 ± 0.004 
GD02 ≤ 0.004c UD06 0.017 ± 0.004 
UD01 0.012 ± 0.004 UD07 0.016 ± 0.004 
UD02 0.028 ± 0.004 UD08 0.094 ± 0.006 
UD03 0.016 ± 0.004 UD09 0.007 ± 0.004 
aThe V/[E] represent the average of three independent measurements. The error is either the standard deviation of three 
independent measurements or three times the background of the assay (0.004 min-1), whichever is larger. bData from 







Table A7 2IP deiodination activity of HsIYD variants containing individual mutations that combine 
to generate UD08. This table was originally published in Sun, Z.; Rokita, S. E.60 
  
V/[E] (min-1)a  V/[E] (min-1)a 
0.5 mM 2IP 1 mM 2IP  0.5 mM 2IP 1 mM 2IP 
HsIYD 0.019 ± 0.004b 0.040 ± 0.004b H167D 0.010 ± 0.004 0.021 ± 0.004 
E157S 0.005 ± 0.004 0.011 ± 0.004 R168E 0.022 ± 0.004 0.043 ± 0.004 
E158Y 0.059 ± 0.004 0.117 ± 0.004 T171E 0.017 ± 0.004 0.033 ± 0.004 
I159E 0.012 ± 0.004 0.026 ± 0.004 R177N 0.020 ± 0.004 0.042 ± 0.004 
Y161W 0.011 ± 0.004 0.019 ± 0.004 T178L 0.010 ± 0.004 0.018 ± 0.004 
M162A 0.056 ± 0.004 0.100 ± 0.004 N179D 0.016 ± 0.004 0.031 ± 0.004 
K163R 0.018 ± 0.004 0.034 ± 0.004 I181R 0.011 ± 0.004 0.020 ± 0.004 
M165F 0.006 ± 0.004 0.010 ± 0.004 K182H 0.013 ± 0.004 0.026 ± 0.004 
aThe values of V/[E] represent the average of two independent measurements. The error is either the standard deviation 
of two independent measurements or three times the background of the assay (0.004 min-1), whichever is larger. bData 














Table A8 2IP deiodination activity of E157 substituted DM01 variants measured with 0.5 mM 2IP. 
This table was originally published in Sun, Z.; Rokita, S. E.60 
  V/[E] (min-1)a  V/[E] (min-1)a 
DM01 0.088 ± 0.004 DM01-E157M 0.033 ± 0.004 
DM01-E157A 0.006 ± 0.004 DM01-E157N 0.009 ± 0.004 
DM01-E157C 0.037 ± 0.006 DM01-E157P ≤ 0.004 
DM01-E157D 0.116 ± 0.004 DM01-E157Q 0.006 ± 0.004 
DM01-E157F 0.004 ± 0.004 DM01-E157R ≤ 0.004 
DM01-E157G 0.031 ± 0.004 DM01-E157S 0.021 ± 0.004 
DM01-E157H ≤ 0.004 DM01-E157T 0.010 ± 0.004 
DM01-E157I ≤ 0.004 DM01-E157V ≤ 0.004 
DM01-E157K ≤ 0.004 DM01-E157W ≤ 0.004 
DM01-E157L ≤ 0.004 DM01-E157Y ≤ 0.004 
aThe values of V/[E] represent the average of two independent measurements. The error is either the standard deviation 






Table A9 Characterization of the trypsin digestion products of HsIYD. This table was originally 







































~ 13 kD digestion product No fragments detectedb 
aExperimental and calculated masses of undigested peptide and digested peptide fragments extracted from gel differ by 
integer numbers of oxygens. This number equals to the number of methionines present in the sequence. Therefore, such 
a discrepancy is a result of oxidation of methionines during SDS-PAGE.158 bThe signal to noise ratio for the mass 
spectrometry analysis of this digestion product is very low. This product showed on the gel as a concentrated band 















Figure A1 Overview of computational simulation protocols. (A) Preparation of the starting model 
(B) Fixed backbone design. Numbers in boxes and by arrows indicate dependent repeats-the output 
of last round calculation enters the next round as the starting structure. Numbers by the parenthesis 
represent independent repeats-the same initial starting structure is used for every individual repeat. 
The local minimization differs from the global minimization by the degree of freedom allowed (see 






Figure A2 Sequence logo displaying variability of amino acid in the active site lid of natural IYD 
homologs34 (top), guided Rosetta designs (middle), and unguided Rosetta designs (bottom). The 
sequence alignment was generated with Clustal Omega.159 The sequence logo was constructed by 











Figure A3 SDS-PAGE of Rosetta designed enzymes. L represents protein ladder. This figure was 






Figure A4 SDS-PAGE of highly purified enzymes for substrate binding and Michaelis-Menton 
kinetics characterization. SUMO tag in these enzymes was removed by first cleavage with ULP1 
protease before Ni-NTA affinity column. Despite that the SUMO tag also carries a (His)6 tag, it 
does not bind the nickel resin as strongly as His-tagged HsIYD and its variants. Therefore, SUMO 
can be removed by extensive washing of the Ni-NTA column. This figure was originally published 





Figure A5 SDS-PAGE of HsIYD variants containing individual mutations that combine to 
generate UD08. The intensity of the SUMO bands for HsIYD, K163R, M165F, and H167D are 
higher than those of the other lanes as a result of different buffer exchange methods used in 
purification. Enzymes in these lanes were buffer-exchanged with a desalting column which does 
not differentiate SUMO from mutant enzymes. All the other enzymes were buffer-exchanged with 
a spin concentrator with a 50kD molecular weight cutoff. SUMO is less than 50kD and passes 
through the concentrator together with small molecules. This figure was originally published in 







Figure A6 Model structures of DM01 and HsIYD in complex with 2IP generated by PyRosetta.59 
The backbones of the homodimer are colored as green and cyan. FMN and 2IP are shown in orange 
and yellow sticks, respectively. (A) Model structure of DM01•2IP complex. The active site lid is 
shown in blue. The double mutations E158Y and M162A are shown in pink. Interactions between 
E158Y and W180 are shown by dashed lines. (B) Model structure of HsIYD•2IP complex. The lid 
area subjected to redesign by Rosetta is shown in magenta. Interactions between active site residues 
E157, K182, and N160 are shown by dashed lines. For clarity, a loop on top of FMN containing 





Figure A7 SDS-PAGE of E157 substituted DM01 variants. L represents protein ladder. E157K 
was loaded three times more than other variants. This figure was originally published in Sun, Z.; 







Figure A8 Comparison between the effect of E157 substitution on the 2IP deiodination activity of 
DM01 and the stability of corresponding variants calculated by Rosetta. Gray bars: relative 2IP 
deiodination activity to that of DM01. The negative sign represents decrease of activity. Red dots: 
relative total energy to that of DM01 calculated by Rosetta. The negative sign represents 
destabilization of enzyme•2IP complex. The energies are in Rosetta energy units (REU). This 





Figure A9 Intact protein mass spectra of HsIYD and its ~ 16kD trypsin digestion product.  (A) 
HsIYD (B) HsIYD extracted from SDS-PAGE.  (C) The ~ 16 kD trypsin digestion product of 











Figure A10 Sequences of HsIYD and its ~ 16 kD digestion products identified by mass 
spectrometry (Table A9). The methionines subjected to oxidation were bolded and italicized. This 





Figure A11 The first order decay of the undigested protein in limited proteolysis. Blue and red 
squares represent two independent measurements for HsIYD. Dashed line is the fitting of remaining 
HsIYD over time with first order decay kinetics. The two independent measurements were fitted 
as one curve. Yellow and green circles represent two independent measurements for UD08. Solid 
line is the fitting of remaining UD08 over time with first order decay kinetics. As in the case of 
HsIYD, the two independent measurements were fitted as one curve. This figure was originally 








Figure A12 Trypsin digestion of Nα-Benzoyl-DL-arginine 4-nitroanilide hydrochloride (DL-
BAPNA). (A)  No deiodination substrates present. (B) In the presence of 100 μM I-Tyr. (C) In the 
presence of 10 mM 2IP. Red and blue data sets are two independent measures and are fitted as one 





Script A1 Python scripts for preparation of starting structure. 
 




# Import Rosetta 
from rosetta import * 
init() 
 
# Initialize PyMOL Mover 
pmm = PyMOL_Mover() 
pmm.keep_history(True) 
 
# Pose IYD complex 




scorefxn_fa = get_fa_scorefxn() 
 
print scorefxn_fa(IYD_FMN_MIT_m3) 
print 'Original IYD_FMN_MIT_m3 complex score is:',scorefxn_fa(IYD_FMN_MIT_m3) 
scorefxn_fa.show(IYD_FMN_MIT_m3) 
 
from toolbox import get_hbonds 




# Set up the fold tree 






















# Build working pose 
rp_mi_ful = Pose() 
rp_mi_ful.assign(IYD_FMN_MIT_m3) 
print rp_mi_ful.fold_tree() 
print 'Check pose energy:',scorefxn_fa(rp_mi_ful) 
 
# Build minimization mover 




movemap.set_jump(4,True) # Allow ligand in chain B to move 
movemap.show() # Check the movemap 
 







# Set up job distributor 
jd1 = PyJobDistributor('minimized',50,scorefxn_fa) 
jd1.native_pose = IYD_FMN_MIT_m3 
 
# Set up Monte Carlo Object 
kT = 1.0 
mc = MonteCarlo(rp_mi_ful,scorefxn_fa,kT) 
 
# Repack and minimize IYD_FMN_MIT_m3 complex 
 
for l in range (1,51): 
    rp_mi_ful.assign(IYD_FMN_MIT_m3) 
    mc.reset(rp_mi_ful) 
    for k in range (1,7): 
        for i in range(1,6): 
            print 'Check pose energy:',scorefxn_fa(rp_mi_ful) 
            task_pack = standard_packer_task(rp_mi_ful) 
            task_pack.restrict_to_repacking() 
            task_pack.or_include_current(True) 
            pack_mover = PackRotamersMover(scorefxn_fa,task_pack) 
            pack_mover.apply(rp_mi_ful) 
            print 'For structure',l,'round:',k,'iteration:',i,'Repacked IYD_FMN_MIT_m3 complex score 
is:',scorefxn_fa(rp_mi_ful) 
            for j in range(1,21): 
                min_mover.apply(rp_mi_ful) 
                print 'For structure',l,'round:',k,'iteration:',i,'Minimized repacked IYD_FMN_MIT_m3 
complex score for interation',j,'is:',scorefxn_fa(rp_mi_ful) 
        mc.boltzmann(rp_mi_ful) 
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        mc.show_scores() 
        mc.show_counters() 
        mc.show_state() 
    mc.recover_low(rp_mi_ful) 
    print 'For structure',l,'the lowest energy is:',scorefxn_fa(rp_mi_ful) 
    rp_mi_ful.pdb_info().name('minimized') 
    pmm.apply(rp_mi_ful) 
    scorefxn_fa.show(rp_mi_ful) 
    hbond_set = get_hbonds(rp_mi_ful) 
    hbond_set.show(rp_mi_ful,443) 
    hbond_set.show(rp_mi_ful,444) 
    jd1.output_decoy(rp_mi_ful) 
 




































Script A2 Python scripts for unguided Rosetta design, guided Rosetta design and wildtype control. 
The script for all three protocols were same, except for three different resfiles being used for 
corresponding protocol to guide action on individual residues"  
 




# Import Rosetta 
from rosetta import * 
init() 
 
# Initialize PyMOL Mover 
pmm = PyMOL_Mover() 
pmm.keep_history(True) 
 
# Pose IYD complex 





scorefxn_fa = get_fa_scorefxn() 
 
print scorefxn_fa(IYD_FMN_2IP_m13) 
print 'Original IYD_FMN_2IP_m13 complex score is:',scorefxn_fa(IYD_FMN_2IP_m13) 
scorefxn_fa.show(IYD_FMN_2IP_m13) 
 
from toolbox import get_hbonds 




# Set up the fold tree 






















# Build working pose 
design = Pose() 
design.assign(IYD_FMN_2IP_m13) 
print design.fold_tree() 
print 'Check pose energy:',scorefxn_fa(design) 
 
# Build minimization mover 




movemap_1.set_jump(4,True) # Allow ligand in chain B to move 
movemap_1.show() # Check the movemap 
 







movemap_2 = MoveMap() # Build movemap for the minimization mover 
movemap_2.set_bb_true_range(309,334) # Only allow lid rigion to move 
movemap_2.set_chi_true_range(309,334) 
movemap_2.show() # Check the movemap 
 







# Set up job distributor 
jd1 = PyJobDistributor('Final',100,scorefxn_fa) 
jd1.native_pose = IYD_FMN_2IP_m13 
 
jd4 = PyJobDistributor('mc',600,scorefxn_fa) 
jd4.native_pose = IYD_FMN_2IP_m13 
 
# Set up Monte Carlo Object 
kT = 1.0 
mc = MonteCarlo(design,scorefxn_fa,kT) 
 




for l in range (1,101): 
    design.assign(IYD_FMN_2IP_m13) 
    mc.reset(design) 
    for k in range (1,7): 
        for i in range(1,6): 
            print 'Check pose energy:',scorefxn_fa(design) 
            task_pack_2 = standard_packer_task(design) 
            parse_resfile(design,task_pack_2,"X.resfile") 
            "Insert the coresponidng resfile listed below for each protocol" 
            task_pack_2.or_include_current(True) 
            pack_mover_2 = PackRotamersMover(scorefxn_fa,task_pack_2) 
            pack_mover_2.apply(design) 
            print 'For structure',l,'round:',k,'iteration:',i,'Repacked IYD_FMN_2IP_m13 complex 
sequence is:',design.sequence() 
            print 'For structure',l,'round:',k,'iteration:',i,'Repacked IYD_FMN_2IP_m13 complex score 
is:',scorefxn_fa(design) 
            for j in range(1,21): 
                min_mover_2.apply(design) 
                print 'For structure',l,'round:',k,'iteration:',i,'Minimized repacked IYD_FMN_2IP_m13 
complex score for interation',j,'is:',scorefxn_fa(design) 
        task_pack_1 = standard_packer_task(design) 
        task_pack_1.restrict_to_repacking() 
        task_pack_1.or_include_current(True) 
        pack_mover_1 = PackRotamersMover(scorefxn_fa,task_pack_1) 
        pack_mover_1.apply(design) 
        print 'For structure',l,'mc round:',k,'Repacked IYD_FMN_2IP_m13 complex score 
is:',scorefxn_fa(design) 
        for m in range(1,21): 
            min_mover_1.apply(design) 
            print 'For structure',l,'mc round:',k,'Minimized repacked IYD_FMN_2IP_m13 complex 
score for interation',m,'is:',scorefxn_fa(design) 
        mc.boltzmann(design) 
        mc.show_scores() 
        mc.show_counters() 
        mc.show_state() 
        design.pdb_info().name('mc') 
        pmm.apply(design) 
        jd4.output_decoy(design) 
    mc.recover_low(design) 
    print 'For structure',l,'the lowest energy is:',scorefxn_fa(design) 
    print 'For structure',l,'the sequence is:',design.sequence() 
    design.pdb_info().name('Final') 
    pmm.apply(design) 
    scorefxn_fa.show(design) 
    hbond_set = get_hbonds(design) 
    hbond_set.show(design,443) 
    hbond_set.show(design,444) 
    jd1.output_decoy(design) 
 
print 'Job is done!' 
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Fb TGGCATAAACCATTTTTGG  
HhIYDc 













GCGCCGTTTCTGAAC   HhIYD 
R1  TTCAAATTCCTCTTTTTCAGCAGCTTGTCGGATTTTCGCTTTG 
F2 
GAAAAAGGCGAATATTGGGCAGAAATTATCAAAATTGCGAACTGG













ATTTTTGGAAATTG 1719 (1)e 






























TTTTGGAAATTG 3654 (2)e 
R3 ACCCGGACCTGCAGATGCCTGCGCTTCCTCATAGCGTTC 
aAll DNA oligonucleotides are from 5’ end to 3’ end from left to right. bF, forward; R, reverse. cTemplate here is the 
pSMT3 plasmid carrying the indicated enzyme. dSDM, site directed mutagenesis. 0039, 1719, 3654 were constructed by 
two or three rounds of SDM. eThe template for the next round SDM is the PCR product of the previous round of SDM 




Figure B1 Sequence logo displaying variability of nine redesigned residues in 10000 independent 











Figure B2 SDS-PAGE of HhIYD after the Ni-NTA column and its variants generated by redesign 





Figure B3 Construction and purification of HsIYD_Δlid/loop variant. (A) Co-crystal structure of 
HsIYD and I-Tyr (PDB 4TTC).31 Green and cyan represents two monomeric units of HsIYD. FMN 
and I-Tyr are shown in orange and yellow, respectively. The active site lid (residues 161-177, 
magenta) and a flexible loop nearby (residues 200-208, magenta) were deleted to form the 
HsIYD_Δlid/loop variant. The N- and C-termini of both deletion were linked together without 
further modification, respectively. (B) SDS-PAGE of purified HsIYD_Δlid/loop variant and 
partially purified HsIYD. The variant which is 26 amino acid shorter than HsIYD run visibly further 






Figure B4 Lid sequence of HhIYD loop remodeling variants. Total number of amino acids allowed 
to mutate are listed in parenthesis following the enzyme labels. The residue number of amino acids 
flanking the remodeled lids are shown next to the sequence of J3736. The residues in red are not a 







Figure B5 Trypsin digestion sites on the lids of HhIYD and its variants. (A) Rosetta model of 
HhIYD•2IP. Green and cyan represents two monomeric units of HsIYD. FMN and I-Tyr are shown 
in orange and yellow, respectively. The active site lid is colored in blue. The only digestion site on 
the lid is shown in gray. (B) Rosetta model of J3736•2IP. The only digestion site on the lid is shown 






Figure B6 Side chain packing around the hydrophobic edge of 2IP in the Rosetta model of 
0039•2IP. Green and cyan represents two monomeric units of HsIYD. FMN and I-Tyr are shown 
in orange and yellow, respectively. The active site lid is colored in pink. Residues within 5 Å of 





Figure B7 Trypsin digestion of HhIYD and 0039 in the absence and presence of 2IP analyzed by 
SDS-PAGE. (A) Digestion of HhIYD overtime. (B) Digestion of 0039 overtime. The mass ratio of 









Appendix C: Supporting information for Chapter 4 
Table C1 DNA oligonucleotides used for cloning. 
  DNA oligonucleotides




































aAll DNA oligonucleotides are from 5’ end to 3’ end from left to right. bF, forward; R, reverse. cThis PCR reaction 
introduced NdeI and XhoI restriction sites flanking the sequence of TnIYD. dThe template here is the original pET28 
plamid carrying TnIYD eThis PCR reaction is to introduce a C-terminal (His)6 tag to TnIYD after it was subcloned into 
pET24a vector to facilitate its purification. fOEPCR, overlap extension PCR. gSDM, site directed mutagenesis. hThe 
template here is the final construct of TnIYD in the pET24a vector with a C-terminal (His)6 tag. 











 aSolvent A is 0.44% formic acid in water and solvent B is 0.44% formic acid in acetonitrile. 
 














aSolvent A is 10 mM potassium phosphate pH 6.6, solvent B is acetonitrile, and solvent C is water. 








Time (min) % Solvent Ba % Solvent Ca 
0 0 0 
10 5 0 
40 5 0 
40.01 5 95 
45 80 20 
55 80 20 
60 0 100 
60.01 0 0 






Figure C1 Color of TnIYD during purification. (A) TnIYD eluted from a gravity Ni-NTA column. 








Figure C2 Removal of Tyr from the greenish yellow form of TnIYD via dithionite treatment. 
TnIYD•FMNsq, TnIYD•FMNhq, TnIYD•FMNox represent the semiquinone form, the hydroquinone 
form (fully reduced), and the fully oxidized form of TnIYD, respectively. The TnIYD•FMNox is 




Figure C4 HPLC analysis of 40 μM TnIYD after dithionite treatment. Tyr bound to the greenish 


















Figure C6 Fluoresence quenching of TnIYD’s FMN cofactor upon I-Tyr titration at 25 ºC and 60 
ºC. Each data point represents one single determination. 
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kcat (min-1)a KM (μM)a 
kcat/KM 
(min-1× μM -1) 
Ki (μM) 
TnIYD•FMNhq 25 5.4 ± 0.9 0.02 ± 0.10 270 ± 1000 5 ± 2 
Dithionite 25 0.42 ± 0.07 5 ± 2 0.08 ± 0.03 N. D. 
TnIYD•FMNhq 60 29 ± 4 0.8 ± 0.2 36 ± 10 9 ± 2 
Dithionite 60 15 ± 3 2 ± 1 8 ± 4 N. D. 
 aAll the data and error bars were obtained by fitting of two independent measurements as one curve to substrate inhibition 












                                                          





Figure D1 Structural comparison of TnIYD and the Y112A variant with F-Tyr bound. (A) The co-
crystal structure of TnIYD•FMNox and F-Tyr (PDB 6Q1B). The monomeric polypeptides of TnIYD 
are colored green and cyan, respectively. Y112 and F-Tyr are shown in green and yellow spheres, 
respectively. FMN is represented by orange sticks. (B) Model structure of TnIYD Y112A with F-
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                           Project: Electrochemical detection of carcinoma embryonic antigen based  
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Awards/Honors:   
2018-2019          Rudolph Sonneborn Fellowship, Department of Chemistry, Johns Hopkins  
                           University 
 
2014                    Ernest M. Marks Teaching Award, Department of Chemistry, Johns  
                            Hopkins University 
 
2011, 2009          Third-class Scholarship, Wuhan University 
2010                    Second-class Scholarship, Wuhan University 
2009                    National Scholarship, the Ministry of Education of China 
2009-2011           Merit student in curriculum, morals, and health, Wuhan University 
 
Presentations: 




2018                    Gordon Research Conference, Biocatalysis & Biocatalysis GRS 
2018                    11th Frontiers in Chemistry & Biology Interface Symposium 
2017                    10th Frontiers in Chemistry & Biology Interface Symposium 
Oral:                    Selenocysteine: the 21st Amino Acid 
Presented at: 
2016                    Seminar on the Chemical Literature, Department of Chemistry, Johns  
                            Hopkins University 
 
Teaching Experience: 
2014                    Teaching Assistant for Organic Chemistry II and Advanced Inorganic Lab 
2013                    Teaching Assistant for Introductory Chemistry II (lecture/lab) and  
                             Advanced Inorganic Lab 
2012                     Teaching Assistant for Introductory Chemistry I (lecture/lab) 
Mentoring Experience: 
2013-present         Four graduate students and two undergraduate students 
Professional Membership:   
2016-present          American Chemical Society 
 
